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Preface
The first 60 years of manned space exploration has seen great advances in technol-
ogy and achievement. Not the least of these are the great leaps in knowledge made 
through observation and experimentation in the biological and medical sciences. 
Though the United States National Aeronautics and Space Administration (NASA) 
completed twelve crewed missions to the moon between 1969 and 1972, the vast 
majority of our knowledge of human physiology and response to space flight comes 
from extended stays in low Earth orbit on the space station Mir, the Space Shuttle, 
and the International Space Station.
NASA has expressed its intention to conduct crewed expeditions to the moon in 
the 2020s, working toward the goal of humans visiting Mars in the 2030s. The 
extended duration and distance from Earth these missions entail pose a number of 
new challenges for space agencies seeking to send humans into the abyss and return 
them safely home to Earth. New knowledge and new technology will be needed to 
conquer these challenges.
This book presents a small sample of the physiological changes and human health 
risks that have been observed in low Earth orbit, and that will undoubtedly be 
magnified with extended exploration operations to deep space. This book presents 
the evidence to date and offers a glimpse at what will be needed to take humanity 
further into deep space than ever before.
Robert J. Reynolds, MS MPH PhD
Mortality Research and Consulting Inc.,
Translational Research Institute for Space Health,
Baylor College of Medicine,
USA
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Introductory Chapter: Research 
Methods for the Next 60 Years of 
Space Exploration
Robert J. Reynolds and Mark Shelhamer
1. Introduction
There are many potential health hazards inherent to space travel, and, as the 
chapters in this book make clear, even after 60 years of human space exploration, 
much is left to be learned about how to live and work in space. As a result of the 
diversity of problems that remain to be solved, the scientific methods required to 
research these issues need to be flexible and varied. This is perhaps most true in our 
approach to analyzing data and drawing conclusions from them in the context of 
space medicine.
In a commentary published in the Journal of Applied Physiology, Ploutz-Snyder 
et al. [1] point out that in the study of exotic topics (such as the physiology and health 
of space travelers) the available data are often insufficient to satisfy the sample-size 
requirements for traditional null-hypothesis statistical testing (NHST). They rightly 
point out that if we hold this as the standard of good research, (i.e., if NHST is our 
only, or even our preferred, tool for learning from data) we will be forced to abandon 
whole lines of research. While the authors offer several “approaches for justifying 
small-n research,” even these are attempts to shoehorn small datasets into traditional 
statistical analysis. This misses the broader (epistemological) point: what is needed 
in small-n studies is not just a better way to use statistics, but rather other tools which 
afford the freedom to learn without using statistics at all.
2. The problems of small-n settings
Research on small sample sizes poses a number of challenges. First and foremost 
is the violation of assumptions that frequentist statistical methods often require in 
order to be valid. Secondary to this, but inherent in the nature of small samples, 
is the typical lack of statistical power for detecting differences other than those in 
low-variance settings or those with dramatic effects. Each of these two challenges 
can lead to difficulty in interpreting results.
2.1 Violations of frequentist assumptions
Most frequentist statistical analyses follow a familiar pattern: assume the outcome 
follows a known statistical distribution, then test whether or not the observed data are 
unusual (unexpected) under the null hypothesis. However, beyond basic goodness-
of-fit considerations, such analyses require other assumptions as well, many of which 
are clearly violated much of the time. Perhaps the most important of these assump-
tions is that the observations in a given sample are “iid”—independent and identically 
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distributed. When samples are strictly observational (i.e., not from a randomized 
trial) this assumption is often unwarranted. The implication of violating this assump-
tion can be profound: differential probability of exposure and inequitable distribu-
tions of potential confounders can lead to what is known as confounding by indication, 
a subtle form of bias that can lead to misleading or even wholly wrong conclusions.
2.2 Statistical power
In any statistical analysis our strength of conviction for our conclusions is largely 
dependent on how much data we can observe (sample size), and how consistent 
our outcomes are within those observed data (variance). In the frequentist statisti-
cal context this is reflected in the concept of statistical power. Statistical power is 
defined as the (hypothetical) probability of correctly rejecting the null hypothesis 
when the null hypothesis is indeed false (and false by a pre-set threshold considered 
to be of clinical or practical importance). A commonly desired and accepted level 
of statistical power is 80%. However, it should be noted that even with this level of 
power, there is a 20% chance of making a Type II error (i.e., incorrectly failing to 
reject the null hypothesis). Unless the ratio of the standard deviation to the mean 
(coefficient of variation) is small, the statistical power in small studies is consider-
ably lower than 80%, effectively crippling the ability to confidently draw inferences 
from the data under this framework.
2.3 Interpretation
Both violation of assumptions and low statistical power can frustrate the draw-
ing of inferences under traditional statistical approaches. If we manage to obtain 
a statistically significant effect, how should we interpret it given the potential for 
confounding by indication? If we fail to see any significant effects where we believe 
we ought to a priori, how do we interpret that? Does our assessment of the meaning 
of such results change with larger or smaller variance in our sample? Under tradi-
tional approaches we surrender to the probabilities of committing Type I or Type II 
errors, and resign ourselves to having learned nothing.
2.4 Preference for errors
The ultimate motive for use of the NHST framework is to reach reasonable 
conclusions about a population or process from a (large) subsample of it. However, 
a real yet unintended consequence of the framework is the focus on avoidance of 
error. The framework itself is centered on the concept of errors in inference: when 
we can, we design our studies to avoid Type I error while simultaneously trying to 
limit Type II errors. In so doing we may make these errors—rather than what we 
might learn from our data—the primary consideration of our scientific activity. It 
should come as no surprise that when we make avoidance of error our top priority, 
we fail to learn all we can from our data.
Modern science’s focus on Type I error has proven to be particularly trouble-
some. In our quest to never actively assert a false truth we have no doubt passively 
allowed many truths to go unspoken. It is obvious that Type I errors can cause harm 
in medicine if new treatments are adopted that are actually harmful to patients. 
Less obvious is the harm that may result if research into a truly efficacious treat-
ment is abandoned simply because a p-value was too high. Such harm is every bit 
as real (and every bit as irreversible) as that done by introducing an ineffective 
treatment. It is especially troubling in initial exploratory studies and those where 
data are acquired only with great difficulty or expense.
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3. Methodological solutions for research in space medicine
Having seen the problems that small-n settings create in general, how do we 
solve them? Through a combination of realigning our epistemology, using our 
current tools differently, and utilizing modern analytic tools developed outside the 
field of statistics, we can do better research and advance the field of space medicine 
to meet the challenges of the next 60 years.
3.1 Realigning our epistemology
Cognitive dissonance is the feeling of discomfort one feels when actions fail 
to conform to beliefs. [2] To most scientists, making claims about truth without a 
statistically significant result to point to elicits substantial cognitive dissonance. 
This perhaps more than anything demonstrates our over-reliance on NHST as 
a substitute for a more robust epistemology. There are several things we can do 
to learn from data without suffering from cognitive dissonance—even without 
significance tests. Altogether they amount to a different epistemological approach 
to epidemiology for space exploration.
3.1.1 Guidelines for causation
In 1965 Sir Austin Bradford Hill described nine guidelines for determining 
causation from scientific evidence. [3] It is worth noting that while one of the 
guidelines deals with strength of association, or what we might recognize as effect size, 
none of the criteria deal with significance testing or p-values. Explicitly, Hill called 
for examining the quality of the relationship between exposure and outcome: the 
logical features of how the evidence suggests they interact, and how that fits with 
prior knowledge of the same or similar subject matter. This sort of prescription is 
well-suited to the small-n environment of space medicine.
3.1.2 Modern causal inference theory: assumptions
Similar to Hill’s work, modern causal inference methods may also be of great use 
in space-health research. These methods have sought to mathematically formalize 
causation in order to make valid use of observational data for causal estimation 
and to avoid introducing biases in analyzing such data [4]. Perhaps more important 
than the methods of analysis that this framework has promoted is the understand-
ing of the assumptions necessary to make causal statements from non-randomized 
data. Merely understanding the assumptions of positivity, consistency, and con-
ditional exchangeability—and what happens when one violates them—can be of 
tremendous help when trying to draw inferences based on limited data.
3.1.3 Directed acyclic graphs
A common tool used in modern causal inference is a special type of network 
graph known as the directed acyclic graph (DAG). These are network maps that 
reflect causal relationships. DAGs are drawn according to some simple rules, but 
making and using these diagrams can be quite useful for clarifying thinking and 
formulating testable hypotheses. If we factorize a joint probability distribution over a 
DAG, we create a Bayesian Network, a powerful tool of probabilistic inference. If we 
decompose a correlation or covariance matrix over a DAG, we can do path analysis 
or structural equation modeling, forms of latent-variable analysis. Even without 
any data collected at all, the structure of a DAG implies variable dependencies and 
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independencies, which in turn have implications for what is and is not possible in the 
system from which the data were acquired, and thus can help guide critical thinking 
about problems.
3.1.4 Alternative hypotheses
A final epistemological realignment is to define specific, sensible hypotheses 
given the question at hand, which may or may not conform to the typical NHST 
two-tailed tests of significance. Examples of such alternatives include equivalence 
testing, inferiority testing, and a still more exotic choice, the modus tollens. All of 
these ask different questions than whether the central tendency of a sample shows 
enough difference to evince a significant p-value for the given sample size and 
variance. By changing the testable hypothesis to be more specific to what we really 
would like to know, we can often obtain an answer that is not only more sensible, 
but often more statistically powerful too, which might then bring NHST back into 
the realm of possibility to further refine the analysis.
3.2 Alternative analytic approaches
Yet another strategy for learning from data is the use of more-sophisticated 
analytic methods which do not necessarily rely on NHST. This includes exploiting 
properties of known statistical tests for alternative hypotheses, Bayesian methods, 
and machine learning.
3.2.1 Alternative uses of common statistical models
With a good understanding of common statistical models, it is possible to exploit 
their properties to conduct atypical investigations. Here we use an example from the 
literature on astronaut mortality to demonstrate this idea.
Using data on US astronauts and Soviet and Russian cosmonauts, Reynolds et al. 
[5] demonstrated that mortality from cancer and cardiovascular disease have no 
common causes in this population. This in turn was taken as evidence that doses of 
ionizing radiation received in space cannot have been sufficient to affect mortality 
from both of these causes. This was achieved by showing that a naïve analysis of 
survival curves (where competing causes of death were treated as censoring events) 
were not markedly different from survival curves that account for competing risks. 
That is, the causes of death displayed statistical independence which, in DAG terms, 
means they share no common ancestor.
In this example, the authors exploited the implications of different statistical 
methods for computing survival in presence of competing risks to make infer-
ences regarding the structure of causal relationships. This is but one example, and 
undoubtedly others exist for those who can think broadly and conceptually about 
specific questions to be asked of existing datasets.
3.2.2 Simulation
The advancements in computing power over the last several decades have made 
possible more sophisticated forms of analysis, not least among them being simula-
tion. We refer here to several different well-established approaches, all of which 
have found use in various domains such as statistics, business, and engineering.
Markov-chain Monte Carlo simulation (MCMC) has been used for decades in 
engineering for probabilistic risk assessment. Agent-based simulation has found 
increasing popularity in epidemiology for modeling community-level effects of policy 
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change or change in social environment. Techniques such as the bootstrap and the 
jackknife may be loosely grouped here as well, as they rely upon repeated recalculation 
of sample statistics using algorithms that resample the data in specific ways. Finally, 
simple “what-if” analyses can help find the extremes of what is possible in a process 
or phenomenon, and can be used to eliminate possibilities or competing hypotheses.
3.2.3 Bayesian methods
Though certainly not new, Bayesian methods are still underutilized in research 
in general and in space medicine in particular. This is primarily owing to the unfa-
miliarity of most researchers with these methods, which in turn is due to the lack 
of graduate-level training on them in most scientific programs other than statistics. 
Historically, this was sensible: their mathematical complexity and need for comput-
ing power made them difficult to implement for all but the simplest of applications. 
Fortunately, computer science and computer hardware have both evolved to where 
these methods are easy to implement, creating a large opportunity for researchers 
to work with smaller datasets in meaningful and rigorous ways without reliance on 
NHST and p-values.
3.2.4 Data science
In recent years, Data Science has been turning business analytics upside down. 
In general, data science is understood as the science of learning from data, a seem-
ingly perfect fit to our objectives here. Yet Data Science has seen much slower 
adoption in Academia, perhaps owing to the fact that the only part of Data Science 
that fits with the traditional epistemological approach to research is that part of 
Data Science which uses traditional NHST statistics.
A hallmark of Data Science is the use of machine learning. However, many of the 
methods of machine learning are methods that typically benefit from large datasets: 
those with hundreds of columns and millions of rows. Nevertheless, machine learn-
ing does have techniques that can be of use in the small-n world. Techniques for data 
reduction, data visualization, data mining, and simulation all are powerful tools that 
can often be applied in the domain of small-n research. Perhaps of particular interest 
to space medicine, researchers are able to use these methods for exploratory data anal-
ysis and hypothesis generation, tasks at which unsupervised machine learning excels.
4. Summary and conclusions
In this chapter we have discussed the limits of NHST as a surrogate for a broader, 
more flexible epistemological framework. Over-reliance on NHST can cripple the 
research enterprise when sample sizes and sampling schemes fail to conform to the 
assumptions necessary for valid models, much less valid inference.
A motivating factor for the use of NHST is the desire to draw correct conclu-
sions. This is a valid aim, but may lead to an emphasis on error avoidance at the 
expense of learning from (possibly limited) data. Instead, scientists need to 
consider evidence using Hill’s guidelines for causation, should examine whether or 
not the data in hand conform to or defy the assumptions needed for causal infer-
ence, and should include the use of DAGs to better understand what we already 
know about a given topic, and to clarify what we conjecture to be true a priori. 
Formulating so-called “alternative” hypotheses appropriate to the topic under study 
may even allow us to improve our inferences when using traditional NHST. There is 
no need to restrict ourselves to one approach or the other.
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change or change in social environment. Techniques such as the bootstrap and the 
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not the data in hand conform to or defy the assumptions needed for causal infer-
ence, and should include the use of DAGs to better understand what we already 
know about a given topic, and to clarify what we conjecture to be true a priori. 
Formulating so-called “alternative” hypotheses appropriate to the topic under study 
may even allow us to improve our inferences when using traditional NHST. There is 
no need to restrict ourselves to one approach or the other.
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Alternative methods of analysis can be used to aid our understanding in 
small-data situations. Bayesian methods, more sophisticated uses of well-known 
statistical methods, and methods from data science all provide useful techniques 
that work well with small datasets, provided the scientist is willing to think dif-
ferently about the outcomes of these analyses.
It is our hope that researchers involved in space medicine will adopt these perspec-
tives and methods. To the extent that these ideas and techniques are adopted by the 
broader research community, we expect to see great advancements in our knowledge 
of health and safety in spaceflight. It is this expansion of our collective knowledge 
that will help make possible the space exploration missions of the next 60 years.
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Abstract
The effects of microgravity conditions on neurovestibular, cardiovascular, 
musculoskeletal, bone metabolic, and hemato-immunological systems are 
described. We discuss “space motion sickness,” sensorimotor coordination disor-
ders, cardiovascular deconditioning, muscular atrophy, bone loss, and anemia/
immunodeficiency, including their causes and mechanisms. In addition to the 
previously described deconditioning, new problems related to microgravity, 
spaceflight-associated neuro-ocular syndrome (SANS), and structural changes of 
the brain by magnetic resonance imaging (MRI) are also explained. Our proposed 
countermeasure, artificial gravity produced by a short-arm centrifuge with 
ergometric exercise, is also described in detail, and we confirmed this system to be 
effective in preventing the abovementioned deconditioning caused by micrograv-
ity exposure.
Keywords: microgravity, neurovestibular, neural plasticity, cardiovascular, 
musculoskeletal, bone metabolism, hematology and immunology
1. Introduction
Outer space offers several abnormal and/or unique environmental conditions, 
including microgravity, vacuum/hypovaria, acceleration, extreme temperature, space 
debris, space radiation, and confinement/isolation. As the latter four conditions may 
be mitigated by spacecraft engineering (i.e., pressurization and the bulkhead), we 
focused on microgravity and its effects on human physiology [1–8].
In spaceflight, astronauts face three periods of physiological adaptation induced 
by changing gravity: (1) changes upon entry to microgravity (initial adaptation), 
(2) changes after prolonged exposure to microgravity, and (3) readaptation to 1 G 
gravity on Earth after returning from space. Body systems influenced by micro-
gravity are the neurovestibular, cardiovascular, musculoskeletal, bone metabolic, 
and immuno-hematological systems. The changes associated with these systems 
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1. Introduction
Outer space offers several abnormal and/or unique environmental conditions, 
including microgravity, vacuum/hypovaria, acceleration, extreme temperature, space 
debris, space radiation, and confinement/isolation. As the latter four conditions may 
be mitigated by spacecraft engineering (i.e., pressurization and the bulkhead), we 
focused on microgravity and its effects on human physiology [1–8].
In spaceflight, astronauts face three periods of physiological adaptation induced 
by changing gravity: (1) changes upon entry to microgravity (initial adaptation), 
(2) changes after prolonged exposure to microgravity, and (3) readaptation to 1 G 
gravity on Earth after returning from space. Body systems influenced by micro-
gravity are the neurovestibular, cardiovascular, musculoskeletal, bone metabolic, 
and immuno-hematological systems. The changes associated with these systems 
occur during the adaptation phases outlined above. We will briefly discuss each of 
these body systems.
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2. Neurovestibular system
2.1 Space motion sickness
How do we humans sense our relative positions in three-dimensional space? 
There are three sensory systems in the human body that help us define position: the 
visual, somatosensory, and vestibular systems. Most of the information from the 
outside world is processed by the visual system, but the combination of somatosen-
sory and vestibular systems from the inner body helps define the positional status.
The vestibular organs include the otolith organs and semicircular canals. The 
otolith organs, saccules (sagittal direction) and utriculi (horizontal direction), 
sense linear acceleration. The semicircular canals, anterior, posterior, and horizon-
tal, detect angular velocity of the head. The vestibular organs in the inner ear detect 
and measure linear and angular acceleration. These responses—already a complex 
set of signals—are further integrated with visual and proprioceptive inputs.
Exposure to microgravity alters some of these input signals, leading to misinter-
pretation and inadequate responses by the brain. This may cause vertigo, nausea, 
vomiting, appetite loss, headache, pallor, etc. As the symptoms are like those of 
motion sickness, this set of symptoms is termed “space motion sickness,” but unlike 
conventional motion sickness, antiemetic drugs cannot suppress the symptoms of 
space motion sickness. Approximately 60–80% of astronauts develop the symptoms 
within 2 or 3 days after launch. Space motion sickness is considered important 
because of its potential impact on the astronauts’ operational performance.
Although sensory misinterpretation may play a role in space motion sickness, its 
exact mechanism remains unknown. There are, however, several hypotheses:  
(1) sensory conflict, (2) fluid shift, (3) otolith asymmetry, and (4) orientation 
adaptation [9, 10].
The sensory conflict hypothesis suggests that loss of tilt-related otolith upon 
entry into microgravity causes a conflict between actual and anticipated signals 
from sense organs subserving spatial orientation. Such sensory conflicts are thought 
to induce motion sickness in other environments.
The fluid shift hypothesis suggests that space motion sickness results from the 
caudad fluid shifts, which in turn result from the hydrostatic pressure gradients in 
the lower body to the thoracic cavity or to the cranial cavity when entering micro-
gravity. The cephalad fluid shift leads to visible puffiness in the face and is thought 
to increase the intracranial pressure, the cerebrospinal fluid pressure, or the inner 
ear fluid pressure, altering the response properties of the vestibular receptors and 
inducing space motion sickness.
The otolith asymmetry hypothesis is based on the theory that a mass difference 
in otolith between the left and right ear is the origin of space sickness and that there 
is interindividual susceptibility.
The otolith adaptation theory, or otolith tilt-translation reinterpretation theory, is 
the theory that space motion sickness is caused during the process of the brain learning 
to reinterpret novel otolith quasi-static signals to represent linear acceleration in space 
rather than the usual interpretation of tilt relative to the vertical direction on Earth.
Until now, it was unclear which of these theories (if any) was most likely. 
However, evidence from Space Shuttle missions suggests that the otolith asymmetry 
and otolith adaptation theories are unlikely.
2.2 Countermeasures for space motion sickness
In the Shuttle program and in the case of the International Space Station 
(ISS), the most commonly used countermeasure for space motion sickness is 
15
Effects of Microgravity on Human Physiology
DOI: http://dx.doi.org/10.5772/intechopen.90700
pharmacotherapy. Dornhoffer [11] reported the effects of four drug countermea-
sures (lorazepam, meclizine, promethazine, and scopolamine) for alleviating 
motion sickness induced by vestibular stimulation with a rotary chair and found 
that scopolamine was the only countermeasure to significantly change the mean 
duration of rotation compared with the placebo (p < 0.008), with a > 40% increase 
in rotation time.
In the Shuttle study, administration of promethazine at 20–50 mg was recom-
mended by intramuscular injection or suppository. In the ISS study, meclizine and 
dimenhydrinate with cinnarizine were hypothesized to affect the medial vestibular 
nucleus. Promethazine is a vestibular suppressor, but a more recent report [12] 
demonstrated that d-amphetamine counters this suppression and inhibits the 
effects of fatigue on the saccadic reaction time.
We propose that artificial gravity is also effective in preventing space motion 
sickness because constant gravity on the otolith is effective against all four etiologies 
of this maladaptation.
3. Cardiovascular system
3.1 Effects of microgravity in the cardiovascular system
The changes in the cardiovascular system begin solely with the fluid shift associ-
ated with microgravity, followed by the decreased circulatory blood volume, cardiac 
size, and aerobic capacity, and the most prominent symptom, postflight orthostatic 
intolerance. These symptoms are generically known as “cardiovascular decondition-
ing” [13–17].
When the spacecraft reaches low Earth orbit (LEO), body fluids move from the 
lower body to the thorax, which is associated with the increase in the intraocular 
pressure and morphological alterations in the central nervous system, demon-
strated by changes in the magnetic resonance imaging (MRI).
As a result of fluid shift, the leg volume decreases and the face becomes puffy. 
The leg volume decreases by 1 L, whereas subcutaneous tissue at the forehead 
thickens by as much as 7% compared with in the preflight supine position. The 
pulmonary capillary blood volume increases by approximately 25%, and intraocular 
pressure can nearly double. Fluid shift increases the cardiac volume and stroke 
volume at the beginning of the spaceflight (first 24 to 48 hours), but over time, the 
heart rate, stroke volume, and cardiac output stabilize to the preflight sitting level. 
The arterial blood pressure slightly decreases compared with the preflight level. 
Compared with “space motion sickness,” cardiovascular and fluid balance adapta-
tion is gradual. The symptoms appear in 3–5 days and disappear after 1–2 weeks, 
causing facial edema, nasal stiffness, heavy headedness, papilledema, or jugular 
vein dilatation. These symptoms upon exposure to microgravity disappear at most 
2 weeks after the reduction in circulatory plasma volume [13–17].
The cardiovascular changes in actual spaceflight differ from those in stimula-
tions such as head-down bedrest or dry immersion. First, the volume of fluid shift 
is much larger than the orthostatic change from the supine to upright positions. 
The fluid volume loss during simulated microgravity (e.g., head-down bedrest or 
dry immersion) is less than 50% of that observed in actual spaceflight. Second, the 
central venous pressure measured during spaceflight does not increase as much as in 
head-down bedrest. Third, the diuresis caused during simulated microgravity is to a 
lower degree.
Then what is the cause of reduced blood volume after adaptation to micro-
gravity? Diedrich et al. [18] explained the reduced blood volume in space as (1) 
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a negative balance 2010 of decreased fluid intake and smaller reduction of urine 
output; (2) fast fluid shifts from the intravascular to interstitial spaces as a result of 
lower transmural pressure after reduced compression of all tissues by gravitational 
forces, especially of the thorax cage; and (3) fluid shifts from intravascular to 
muscle interstitial spaces because of lower muscle tone required to maintain body 
posture, and the attenuated diuresis during space flight is due to increased retention 
after stress-mediated sympathetic activation during the initial phase of space flight.
3.2 Decrease in the circulatory blood volume
The centralization of body fluid induces dehydration to adapt to the micrograv-
ity environment. The cephalad fluid shift causes an increase in venous return and 
marked increase in the stroke volume, inducing the alterations in the autonomic 
and endocrine systems to control the cardiovascular system.
On the first day of microgravity exposure, urine volume does not increase, but 
the circulatory blood volume suddenly decreases by 17%, probably due to the shift 
of water from the intravascular to the interstitial spaces and finally to the intracel-
lular space. This induces an increase in the hematocrit level, which suppresses 
erythropoietin production and reduces the erythrocyte volume. Reductions in the 
circulatory plasma volume and erythrocyte volume equal an 11% reduction in the 
total blood volume, and this stabilizes the central blood volume to a new equilib-
rium, which nearly equals the central blood volume in the standing position at 1 G 
on Earth.
Upon the above alterations, the autonomic nervous system stabilizes the blood 
pressure by suppressing the sympathetic functions and activating the vagal func-
tions by reducing the heart rate and suppressing muscle sympathetic nerve activity. 
Alterations include suppression of vasopressin by the Henry-Gauer reflex, facilita-
tion of α-natriuretic peptide secretion, and suppression of the renin-angiotensin-
aldosterone system, all of which facilitate urination. Thus, centralized body fluid 
is excreted, accounting for 10–15% of the circulatory blood volume, increased 
hematocrit level, and adaptation of the cardiovascular system 5–7 days after micro-
gravity exposure. This ameliorates the facial edema and jugular distension. This 
adaptation causes cardiovascular deconditioning, including orthostatic intolerance, 
after returning to 1 G on Earth.
3.3 Reduced heart size
Once exposed to microgravity, the volume and pressure stimuli disappear. 
Constant postural change of lying down from upright standing on Earth loads 
intermittent volume on the heart, which ceases during microgravity. In addition, 
microgravity reduces the overall pressure load on the heart depending on the con-
tent of the countermeasure program. The mean arterial pressure slightly decreases. 
During spaceflight, the myocardial volume decreases by 8–10%.
3.4 Cardiovascular system after stabilization
After adaptation to microgravity, the cardiovascular system stabilizes, and the 
blood pressure is either unchanged or slightly lower [19]. Ambulatory blood pres-
sure recording for 24 hours in eight astronauts revealed that the systolic, diastolic, 
and mean arterial pressures (mean ± se) in space were reduced by 8 ± 2 mmHg 
(p = 0.01; ANOVA), 9 ± 2 mmHg (P < 0.001), and 10 ± 3 mmHg (p = 0.006), 
respectively, with a maintained nocturnal dip of 8 ± 3 mmHg (p = 0.015). The 
cardiac stroke volume and output increased by 35 ± 10% and 41 ± 9% (p < 0.001), 
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respectively, the heart rate and catecholamine concentrations were unchanged, and 
systemic vascular resistance was reduced by 39 ± 4% (p < 0.001).
3.5 Alteration of aerobic exercise capacity
Microgravity exposure reduces the circulatory blood volume; however, the 
maximal oxygen uptake is maintained after a short duration of spaceflight. 
During long-term spaceflight, the aerobic capacity decreases without countermea-
sures, but aerobic exercise training can maintain it, although standard exercise 
only markedly reduces the postflight maximal oxygen uptake. After a short dura-
tion of spaceflight (9–14 days), the maximal oxygen uptake decreased by 22%, 
probably due to decreases in the maximal stroke volume and maximal cardiac 
output without alterations in the maximal heart rate, blood pressure, or whole-
body arteriovenous oxygen. This decrease in maximal oxygen uptake is believed to 
be due to the decreases in intravascular blood volume, stroke volume, and cardiac 
output.
As crew members are expected to work on the Moon/Martian surface, and they 
are exposed to extensive heat stress in the extravehicular suits, this aerobic capacity 
is considered to be significant after landing on the Moon/Mars.
3.6 Alterations in sympathetic neural traffic under microgravity
Sympathetic neural traffic indirectly measured by the plasma noradrenaline 
level has been reported to increase during spaceflight from the preflight control 
level [14, 20], and vagal activity estimated by power spectral analysis of heart rate 
variability was reduced after long-term spaceflight [21, 22].
Microneurographically recorded neural traffic in humans is known to be muscle 
and skin sympathetic nerve activity (MSNA and SSNA), and MSNA controls the 
vasomotor function of the muscular bed, responding to blood pressure changes 
against gravitational stress [23–25]. MSNA was suppressed during exposure to 
short-term microgravity induced by parabolic flight [26], mild lower body positive 
pressure (10–20-mmHg LBPP) [15], and thermoneutral head-out water immersion 
[27] responding to the loading or unloading of cardiopulmonary receptor-stimu-
lated cephalad fluid shift. On the other hand, MSNA was increased after exposure 
to long-term microgravity in spaceflight and its simulation induced by dry immer-
sion [28] or 6° head-down tilt bedrest [17] due to different mechanisms, including 
plasma volume loss, changes in baroreflex, and vascular compliance.
3.7 Postflight orthostatic intolerance
Orthostatic intolerance is usually observed after returning to 1 G on Earth. The 
definition of orthostatic intolerance usually includes simple syncope, lightheaded-
ness, or >20-mmHg reduction in systolic blood pressure.
Astronauts usually notice orthostatic intolerance during prolonged upright 
standing rather than while standing up. Just before fainting, they sometimes have 
tachycardia, suggesting that they have postural orthostatic tachycardia syndrome 
(POTS). This phenomenon is due to a state in which fluid shift easily triggers 
tachycardia, which also easily triggers Bezold-Jarisch reflex, and the vagal response 
suppresses the systolic blood pressure. Although all astronauts stood upright for 
10 min, 63% were unable to finish the stand test in 10 min.
Less important factors for postflight orthostatic intolerance are reduced compli-
ance of the lower legs, reduced baroreflex sensitivity, and increased basal sympa-
thetic tone.
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a negative balance 2010 of decreased fluid intake and smaller reduction of urine 
output; (2) fast fluid shifts from the intravascular to interstitial spaces as a result of 
lower transmural pressure after reduced compression of all tissues by gravitational 
forces, especially of the thorax cage; and (3) fluid shifts from intravascular to 
muscle interstitial spaces because of lower muscle tone required to maintain body 
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On the first day of microgravity exposure, urine volume does not increase, but 
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total blood volume, and this stabilizes the central blood volume to a new equilib-
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pressure by suppressing the sympathetic functions and activating the vagal func-
tions by reducing the heart rate and suppressing muscle sympathetic nerve activity. 
Alterations include suppression of vasopressin by the Henry-Gauer reflex, facilita-
tion of α-natriuretic peptide secretion, and suppression of the renin-angiotensin-
aldosterone system, all of which facilitate urination. Thus, centralized body fluid 
is excreted, accounting for 10–15% of the circulatory blood volume, increased 
hematocrit level, and adaptation of the cardiovascular system 5–7 days after micro-
gravity exposure. This ameliorates the facial edema and jugular distension. This 
adaptation causes cardiovascular deconditioning, including orthostatic intolerance, 
after returning to 1 G on Earth.
3.3 Reduced heart size
Once exposed to microgravity, the volume and pressure stimuli disappear. 
Constant postural change of lying down from upright standing on Earth loads 
intermittent volume on the heart, which ceases during microgravity. In addition, 
microgravity reduces the overall pressure load on the heart depending on the con-
tent of the countermeasure program. The mean arterial pressure slightly decreases. 
During spaceflight, the myocardial volume decreases by 8–10%.
3.4 Cardiovascular system after stabilization
After adaptation to microgravity, the cardiovascular system stabilizes, and the 
blood pressure is either unchanged or slightly lower [19]. Ambulatory blood pres-
sure recording for 24 hours in eight astronauts revealed that the systolic, diastolic, 
and mean arterial pressures (mean ± se) in space were reduced by 8 ± 2 mmHg 
(p = 0.01; ANOVA), 9 ± 2 mmHg (P < 0.001), and 10 ± 3 mmHg (p = 0.006), 
respectively, with a maintained nocturnal dip of 8 ± 3 mmHg (p = 0.015). The 
cardiac stroke volume and output increased by 35 ± 10% and 41 ± 9% (p < 0.001), 
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respectively, the heart rate and catecholamine concentrations were unchanged, and 
systemic vascular resistance was reduced by 39 ± 4% (p < 0.001).
3.5 Alteration of aerobic exercise capacity
Microgravity exposure reduces the circulatory blood volume; however, the 
maximal oxygen uptake is maintained after a short duration of spaceflight. 
During long-term spaceflight, the aerobic capacity decreases without countermea-
sures, but aerobic exercise training can maintain it, although standard exercise 
only markedly reduces the postflight maximal oxygen uptake. After a short dura-
tion of spaceflight (9–14 days), the maximal oxygen uptake decreased by 22%, 
probably due to decreases in the maximal stroke volume and maximal cardiac 
output without alterations in the maximal heart rate, blood pressure, or whole-
body arteriovenous oxygen. This decrease in maximal oxygen uptake is believed to 
be due to the decreases in intravascular blood volume, stroke volume, and cardiac 
output.
As crew members are expected to work on the Moon/Martian surface, and they 
are exposed to extensive heat stress in the extravehicular suits, this aerobic capacity 
is considered to be significant after landing on the Moon/Mars.
3.6 Alterations in sympathetic neural traffic under microgravity
Sympathetic neural traffic indirectly measured by the plasma noradrenaline 
level has been reported to increase during spaceflight from the preflight control 
level [14, 20], and vagal activity estimated by power spectral analysis of heart rate 
variability was reduced after long-term spaceflight [21, 22].
Microneurographically recorded neural traffic in humans is known to be muscle 
and skin sympathetic nerve activity (MSNA and SSNA), and MSNA controls the 
vasomotor function of the muscular bed, responding to blood pressure changes 
against gravitational stress [23–25]. MSNA was suppressed during exposure to 
short-term microgravity induced by parabolic flight [26], mild lower body positive 
pressure (10–20-mmHg LBPP) [15], and thermoneutral head-out water immersion 
[27] responding to the loading or unloading of cardiopulmonary receptor-stimu-
lated cephalad fluid shift. On the other hand, MSNA was increased after exposure 
to long-term microgravity in spaceflight and its simulation induced by dry immer-
sion [28] or 6° head-down tilt bedrest [17] due to different mechanisms, including 
plasma volume loss, changes in baroreflex, and vascular compliance.
3.7 Postflight orthostatic intolerance
Orthostatic intolerance is usually observed after returning to 1 G on Earth. The 
definition of orthostatic intolerance usually includes simple syncope, lightheaded-
ness, or >20-mmHg reduction in systolic blood pressure.
Astronauts usually notice orthostatic intolerance during prolonged upright 
standing rather than while standing up. Just before fainting, they sometimes have 
tachycardia, suggesting that they have postural orthostatic tachycardia syndrome 
(POTS). This phenomenon is due to a state in which fluid shift easily triggers 
tachycardia, which also easily triggers Bezold-Jarisch reflex, and the vagal response 
suppresses the systolic blood pressure. Although all astronauts stood upright for 
10 min, 63% were unable to finish the stand test in 10 min.
Less important factors for postflight orthostatic intolerance are reduced compli-
ance of the lower legs, reduced baroreflex sensitivity, and increased basal sympa-
thetic tone.
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Reduction of the circulatory blood volume is the most important factor for 
postflight orthostatic intolerance. The decrease in stroke volume after spaceflight 
reflects this circulatory blood volume loss. Although this is the main cause, the 
recovery of circulatory blood volume to the normal state is not complete. The crew 
members are recommended to take 8 g of salt and 1 L of water, which ameliorates 
the orthostatic tolerance, albeit not completely.
Another factor is the limitation by vasoconstriction. The postflight blood 
pressure of non-finishers cannot be increased by the total peripheral resistance 
compared with the preflight state. During the postflight upright standing 70° tilt 
test, the total peripheral resistance cannot increase despite activation of muscle 
sympathetic nerve activity, probably due to the alterations in venoarterial reflex and 
smooth muscle atrophy of the resistant vessels. Overall, circulatory blood volume 
reduction and attenuated vasoconstriction are the main factors for orthostatic 
intolerance.
3.8 Cardiovascular deconditioning
What is the cause of this cardiovascular deconditioning? NASA’s criteria of 
orthostatic intolerance are (1) presyncopal symptoms (pallor, cold sweat, nausea, 
blackout, and fainting), (2) gradual systolic blood pressure decrease <80 mmHg, 
(3) sudden systolic blood pressure decrease >15 mmHg, or (4) sudden heart rate 
decrease >15 bpm while on the 70° tilt bed for 15 min. A recent report stated that 
65% of astronauts satisfied these criteria. Previously, this cardiovascular decon-
ditioning was considered to be solely due to circulatory fluid loss, but other causes 
have also been explored.
In addition to the decrease in circulatory blood volume, other causes, i.e., altered 
arterial baroreflex gain, altered leg venous volume, easy fluid pooling in the space 
of atrophied skeletal muscles, attenuated muscle pump effects due to skeletal 
muscle atrophy, hypersensitivity of β-adrenergic receptors, and altered influence 
of vestibular (especially otolith) input, have been considered. Moreover, increased 
venous permeability of lower leg vessels and attenuated cardiopulmonary volume 
receptor reflex after −6° head-down tilt for 14 days were observed in our bedrest 
experiment. These changes are not the only cause of cardiovascular deconditioning, 
and multiple factors act in concert.
3.9 Spaceflight-associated neuro-ocular syndrome (SANS)
Several physiological and pathological neuro-ocular findings in astronauts/
cosmonauts during and after long-term spaceflight, including hyperoptic shifts up 
to +1.75 diopters, optic disc edema (swelling), globe (eyeball) flattening, choroidal 
folds, and “cotton wool” spots in the fundus oculi, have been reported [29]. These 
findings have been documented as spaceflight-associated neuro-ocular syndrome. 
NASA has investigated the clinical, ultrasound, optical coherence tomography 
imaging, and fundus oculi findings of the above symptoms. In 2016, out of 47 or 64 
astronauts examined, approximately 10 developed SANS (disc edema in 10/64, cot-
ton wool spot in 7/64, choroidal folds in 11/47, globe flattening in 12/47, and refrac-
tive error in 9/47). It is unlikely that the duration of spaceflight is unrelated [30].
The exact cause of SANS has not been clarified, but its development is likely 
related to the increase in intracranial pressure due to the cephalad fluid shift. The 
increase in intracranial pressure is not necessarily due to microgravity exposure, 
but some percentage of astronauts had intracranial pressure change and developed 
SANS [29, 30].
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Several countermeasures, e.g., lower body negative pressure, thigh cuffs, an 
impedance threshold device (ITD), vitamin B group administration, and artificial 
gravity, have been considered and are under trial. NASA and collaborating research-
ers continue to investigate SANS in preparation for future manned missions to 
space, including continued trips to the ISS, deep space gateway missions, a return to 
the Moon or Moon base, or a Martian expedition.
3.10 Brain structural plasticity during spaceflight
In 2016, structural changes in the brain during spaceflight were reported.  
Koppelmans et al. [31] evaluated retrospective longitudinal T2-weighted MRI scans 
and balance data from 27 astronauts (13, ~2-week Shuttle crew members, and 14, 
~6-month ISS crew members) to assess spaceflight effects on brain structure. They 
observed extensive volumetric gray matter decreases, including large areas covering 
the temporal and frontal poles and around the orbits, and the effects were larger 
in ISS members than in Shuttle crew members. There were also bilateral focal gray 
matter increases within the medial primary somatosensory and motor cortex.
In 2017, a review on these MRI changes associated with spaceflight (actual 
or simulated) was reported. Van Ombergen et al. [32] discussed neuroplastic 
changes in the central nervous system and concluded that the cerebellum, cortical 
motor areas, and vestibular-related pathways are highly involved, demonstrating 
that these brain regions are indeed affected by actual and simulated spaceflight. 
Structural studies are now in progress, and functional relationships are under 
investigation. Long-term studies will be necessary to clarify the mechanism.
3.11 Effects of artificial gravity
We tested an intermittent short-arm centrifuge of 1.4 G with 60-W ergometric 
exercise with a step-up increase of 0.2 G and 15 W, respectively, for 30 min every 
day for 21 days during −6° head-down bedrest [33]. The circulatory blood volume 
was reduced by 20% in the control subjects, but no reduction was observed in the 
countermeasure subjects. Cardiac output and stroke volume were not changed 
in the countermeasure subjects, but they decreased in the control subjects. The 
baseline level of muscle sympathetic nerve activity (MSNA) was not changed in the 
countermeasure subjects, but it increased in the control subjects.
Therefore, everyday ergometric exercise under artificial gravity maintains the 
preflight cardiovascular state without adapting to microgravity.
4. Musculoskeletal system
4.1 Mechanism of muscle loss under microgravity
The first muscular measurements were performed in Skylab and Space Shuttle 
missions by the United States and in Salyut and Mir by the Soviet Union [34–37]. 
The most prominent muscle loss was observed in the calf muscle (the soleus and 
gastrocnemius) after a few weeks in space. The muscle loss exhibited interindi-
vidual variation, but the maximum loss reached as high as 10%. This volume loss 
in the lower extremities accounts for most of the muscle atrophy and the blood and 
interstitial fluid shift. Although fluid shift away from the legs influences the size 
of these muscles, this phenomenon alone cannot explain the changes in leg volume 
on MRI. Muscle atrophy appears rapidly, usually between 8 and 11 days of flight, 
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Reduction of the circulatory blood volume is the most important factor for 
postflight orthostatic intolerance. The decrease in stroke volume after spaceflight 
reflects this circulatory blood volume loss. Although this is the main cause, the 
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members are recommended to take 8 g of salt and 1 L of water, which ameliorates 
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sympathetic nerve activity, probably due to the alterations in venoarterial reflex and 
smooth muscle atrophy of the resistant vessels. Overall, circulatory blood volume 
reduction and attenuated vasoconstriction are the main factors for orthostatic 
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blackout, and fainting), (2) gradual systolic blood pressure decrease <80 mmHg, 
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ditioning was considered to be solely due to circulatory fluid loss, but other causes 
have also been explored.
In addition to the decrease in circulatory blood volume, other causes, i.e., altered 
arterial baroreflex gain, altered leg venous volume, easy fluid pooling in the space 
of atrophied skeletal muscles, attenuated muscle pump effects due to skeletal 
muscle atrophy, hypersensitivity of β-adrenergic receptors, and altered influence 
of vestibular (especially otolith) input, have been considered. Moreover, increased 
venous permeability of lower leg vessels and attenuated cardiopulmonary volume 
receptor reflex after −6° head-down tilt for 14 days were observed in our bedrest 
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and multiple factors act in concert.
3.9 Spaceflight-associated neuro-ocular syndrome (SANS)
Several physiological and pathological neuro-ocular findings in astronauts/
cosmonauts during and after long-term spaceflight, including hyperoptic shifts up 
to +1.75 diopters, optic disc edema (swelling), globe (eyeball) flattening, choroidal 
folds, and “cotton wool” spots in the fundus oculi, have been reported [29]. These 
findings have been documented as spaceflight-associated neuro-ocular syndrome. 
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ton wool spot in 7/64, choroidal folds in 11/47, globe flattening in 12/47, and refrac-
tive error in 9/47). It is unlikely that the duration of spaceflight is unrelated [30].
The exact cause of SANS has not been clarified, but its development is likely 
related to the increase in intracranial pressure due to the cephalad fluid shift. The 
increase in intracranial pressure is not necessarily due to microgravity exposure, 
but some percentage of astronauts had intracranial pressure change and developed 
SANS [29, 30].
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Several countermeasures, e.g., lower body negative pressure, thigh cuffs, an 
impedance threshold device (ITD), vitamin B group administration, and artificial 
gravity, have been considered and are under trial. NASA and collaborating research-
ers continue to investigate SANS in preparation for future manned missions to 
space, including continued trips to the ISS, deep space gateway missions, a return to 
the Moon or Moon base, or a Martian expedition.
3.10 Brain structural plasticity during spaceflight
In 2016, structural changes in the brain during spaceflight were reported.  
Koppelmans et al. [31] evaluated retrospective longitudinal T2-weighted MRI scans 
and balance data from 27 astronauts (13, ~2-week Shuttle crew members, and 14, 
~6-month ISS crew members) to assess spaceflight effects on brain structure. They 
observed extensive volumetric gray matter decreases, including large areas covering 
the temporal and frontal poles and around the orbits, and the effects were larger 
in ISS members than in Shuttle crew members. There were also bilateral focal gray 
matter increases within the medial primary somatosensory and motor cortex.
In 2017, a review on these MRI changes associated with spaceflight (actual 
or simulated) was reported. Van Ombergen et al. [32] discussed neuroplastic 
changes in the central nervous system and concluded that the cerebellum, cortical 
motor areas, and vestibular-related pathways are highly involved, demonstrating 
that these brain regions are indeed affected by actual and simulated spaceflight. 
Structural studies are now in progress, and functional relationships are under 
investigation. Long-term studies will be necessary to clarify the mechanism.
3.11 Effects of artificial gravity
We tested an intermittent short-arm centrifuge of 1.4 G with 60-W ergometric 
exercise with a step-up increase of 0.2 G and 15 W, respectively, for 30 min every 
day for 21 days during −6° head-down bedrest [33]. The circulatory blood volume 
was reduced by 20% in the control subjects, but no reduction was observed in the 
countermeasure subjects. Cardiac output and stroke volume were not changed 
in the countermeasure subjects, but they decreased in the control subjects. The 
baseline level of muscle sympathetic nerve activity (MSNA) was not changed in the 
countermeasure subjects, but it increased in the control subjects.
Therefore, everyday ergometric exercise under artificial gravity maintains the 
preflight cardiovascular state without adapting to microgravity.
4. Musculoskeletal system
4.1 Mechanism of muscle loss under microgravity
The first muscular measurements were performed in Skylab and Space Shuttle 
missions by the United States and in Salyut and Mir by the Soviet Union [34–37]. 
The most prominent muscle loss was observed in the calf muscle (the soleus and 
gastrocnemius) after a few weeks in space. The muscle loss exhibited interindi-
vidual variation, but the maximum loss reached as high as 10%. This volume loss 
in the lower extremities accounts for most of the muscle atrophy and the blood and 
interstitial fluid shift. Although fluid shift away from the legs influences the size 
of these muscles, this phenomenon alone cannot explain the changes in leg volume 
on MRI. Muscle atrophy appears rapidly, usually between 8 and 11 days of flight, 
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but can appear as early as the fifth day, as observed in one astronaut. Moreover, the 
effects of microgravity differ among muscles, with volume decreasing by 3.9% in 
the calf (the soleus and gastrocnemius) and 6% in the quadriceps femoris.
In addition to the morphological changes, functional alterations are associated 
with structural variations, and the muscular force is known to be reduced after 
spaceflight. In the Skylab 3 mission, it decreased by 20% after 53 days of micrograv-
ity exposure. Muscular electrical activity measured by electromyogram (EMG) had 
a lower EMG amplitude in addition to easy fatigability with a lower resistance.
The main cause of muscular loss is the disappearance of mechanical constraints 
and the subsequent decrease in muscular activity. The reduced muscular activity 
under microgravity is also associated with hypokinesia due to limited movement 
inside the spacecraft, which also can be observed in bedrest studies and animal 
experiments using tail suspension. The structural changes in skeletal muscle are 
also observed by microscopic examination under microgravity, which revealed 
that the proportion of type I red fibers decreased and they were replaced by type II 
white fibers. In 1995, pre- and postflight human muscle biopsies were performed on 
three and five astronauts during 5- and 11-day missions, respectively. In this study, 
the muscle fiber diameter decreased by 15 to 30%, and the number of capillaries 
around the muscle fibers decreased. The proportion of type I fibers changed from 
43 (preflight) to 37% (postflight) after 5-day missions, and that of type II fibers 
changed from 57 to 67%. After 11 days of spaceflight, the proportion of type I fibers 
decreased from 45 to 39%, and that of type II fibers decreased from 55 to 61%, con-
sistent with the animal experiments that demonstrated that gravity can  influence 
genes regulating the protein synthesis of muscle protein degradation enzymes.
These changes were confirmed to be due to both an increase in protein break-
down and decrease in synthesis. Human biochemical examination also revealed a 
higher level of muscle protein degradation, increased level of urinary amino acids, 
and higher level of creatinine. The diet of astronauts is protein-rich, but the deg-
radation process is such that nitrogen losses overcome the gains and the nitrogen 
balance becomes negative.
Recent studies have suggested the mechanism of disuse atrophy of the skeletal 
muscle, especially oxidative stress, to be an important regulator of pathways leading 
to muscle atrophy during periods of disuse. Redox disturbances, such as those 
in skeletal muscle myotubes, increase the expression of key components of the 
proteasome proteolytic system, which is a prominent factor in protein degradation 
in disused muscles.
Another hypothesized mechanism is the degradation of muscle proteins result-
ing from their ubiquitination. These molecular mechanisms underlie protein 
degradation during disuse.
4.2 Countermeasures for muscle loss
In order to prevent muscle loss, several countermeasures were available dur-
ing microgravity exposure in Shuttle missions and continue to be available on the 
ISS. These include aerobic exercise, stretching, strength training, and electrical 
stimulation. Artificial gravity with exercise has been proposed as a potential mea-
sure for muscle loss because ground-based studies confirmed it to be effective, but 
a short-arm centrifuge has not been mounted. In addition to physical stimulation, 
medications, such as antioxidants, growth hormone, growth factors, ubiquitin, 
clenbuterol, anabolic steroids, and amino acids, are candidates against muscle loss.
Aerobic exercise is the most effective countermeasure for maintaining the fast 
twitch red fibers. On the ISS, the combination of an ergometer, treadmill, and the 
Advanced Resistive Exercise Device (ARED) is ideal to maintain muscle power and 
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the morphology of antigravity muscles (empowerment of both fast and slow twitch 
fiber muscles).
Stretching can minimize atrophy by maintaining the muscle as much as possible 
in the stretched condition. In the Russian space program, the penguin suit—a snug 
fitting, full-length, long sleeved jumpsuit made with elastic inserts at the collar, 
waist, wrists, and ankles and along the vertical sides of the suit—loads the body 
along the long axis with an adjustable force of 15–40 kg, while the other elastic 
elements make it possible to adjust the position of the limbs. The angle of the major 
joints, such as the knee and ankle, can be set, allowing the foot to be dorsiflexed, 
which will stretch the soleus. The effects of stretching are not well understood, but 
it is a valid countermeasure considering human physiology.
Strength training by resistance exercise is also employed as a countermeasure 
for muscle loss. Weight training studies recommended a good mix of exercise types 
to be 15% (eccentric), 10% (isometric), and 75% (concentric weight-bearing). The 
most recommended exercise for resistance training is squatting.
Electric stimulation is also expected to increase protein synthesis and prevent 
the decrease in oxidative enzymes inducing disuse atrophy.
4.3 Artificial gravity with exercise
We previously confirmed the effectiveness of artificial gravity in bedrest studies 
[33]. Our results demonstrated that artificial gravity of 1.4 G with ergometric 
exercise maintains the muscle strength and cross-sectional area of the quadriceps 
femoris measured by MRI. Another study revealed that artificial gravity with 
squatting exercise also maintains the function and morphology of the soleus and 
gastrocnemius [38].
5. Bone metabolism system
The main problem of the skeletal system is bone calcium (Ca2+) loss during 
microgravity. The bone becomes fragile during microgravity exposure, which can 
harm an astronaut or cosmonaut even after returning to Earth. Moreover, the risk of 
renal stones is high during long-term missions due to hypercalcemia [39].
Ca2+ plays an essential role in bone structure, contraction of skeletal and cardiac 
muscles, neural transmission, blood coagulation, cell permeability, and hormonal 
signaling. The serum Ca2+ level is well maintained at 8.4–10.2 mg/dL. Ca2+ is 
absorbed from the small intestine (300 mg/day), into the blood, deposited in the 
bone (500 mg/day), and excreted from the kidneys (150 mg/day) or into feces.
In this section, the influences of gravity on bone structure and of hormones on 
bone formation and absorption are described.
5.1 Bone development and restructuring
Gravity influences the long bones of the lower extremities, e.g., the femur, tibia, 
calcaneus, and vertebrae, which support the body in the upright position. Bone 
tissue contains osteocytes, which develop from osteoblasts, and are changed into 
osteoclasts by the action of RANKL (also called osteoclast differentiation factor, 
short for receptor activation of NF-kappa B ligand).
Osteoblasts and osteoclasts are functionally closely related, as is the balance 
between bone formation and bone resorption. Thus, insufficient bone formation 
compared with bone resorption observed in spaceflight reduces the bone mass and 
bone strength, leading to fractures.
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but can appear as early as the fifth day, as observed in one astronaut. Moreover, the 
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the calf (the soleus and gastrocnemius) and 6% in the quadriceps femoris.
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a lower EMG amplitude in addition to easy fatigability with a lower resistance.
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genes regulating the protein synthesis of muscle protein degradation enzymes.
These changes were confirmed to be due to both an increase in protein break-
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the morphology of antigravity muscles (empowerment of both fast and slow twitch 
fiber muscles).
Stretching can minimize atrophy by maintaining the muscle as much as possible 
in the stretched condition. In the Russian space program, the penguin suit—a snug 
fitting, full-length, long sleeved jumpsuit made with elastic inserts at the collar, 
waist, wrists, and ankles and along the vertical sides of the suit—loads the body 
along the long axis with an adjustable force of 15–40 kg, while the other elastic 
elements make it possible to adjust the position of the limbs. The angle of the major 
joints, such as the knee and ankle, can be set, allowing the foot to be dorsiflexed, 
which will stretch the soleus. The effects of stretching are not well understood, but 
it is a valid countermeasure considering human physiology.
Strength training by resistance exercise is also employed as a countermeasure 
for muscle loss. Weight training studies recommended a good mix of exercise types 
to be 15% (eccentric), 10% (isometric), and 75% (concentric weight-bearing). The 
most recommended exercise for resistance training is squatting.
Electric stimulation is also expected to increase protein synthesis and prevent 
the decrease in oxidative enzymes inducing disuse atrophy.
4.3 Artificial gravity with exercise
We previously confirmed the effectiveness of artificial gravity in bedrest studies 
[33]. Our results demonstrated that artificial gravity of 1.4 G with ergometric 
exercise maintains the muscle strength and cross-sectional area of the quadriceps 
femoris measured by MRI. Another study revealed that artificial gravity with 
squatting exercise also maintains the function and morphology of the soleus and 
gastrocnemius [38].
5. Bone metabolism system
The main problem of the skeletal system is bone calcium (Ca2+) loss during 
microgravity. The bone becomes fragile during microgravity exposure, which can 
harm an astronaut or cosmonaut even after returning to Earth. Moreover, the risk of 
renal stones is high during long-term missions due to hypercalcemia [39].
Ca2+ plays an essential role in bone structure, contraction of skeletal and cardiac 
muscles, neural transmission, blood coagulation, cell permeability, and hormonal 
signaling. The serum Ca2+ level is well maintained at 8.4–10.2 mg/dL. Ca2+ is 
absorbed from the small intestine (300 mg/day), into the blood, deposited in the 
bone (500 mg/day), and excreted from the kidneys (150 mg/day) or into feces.
In this section, the influences of gravity on bone structure and of hormones on 
bone formation and absorption are described.
5.1 Bone development and restructuring
Gravity influences the long bones of the lower extremities, e.g., the femur, tibia, 
calcaneus, and vertebrae, which support the body in the upright position. Bone 
tissue contains osteocytes, which develop from osteoblasts, and are changed into 
osteoclasts by the action of RANKL (also called osteoclast differentiation factor, 
short for receptor activation of NF-kappa B ligand).
Osteoblasts and osteoclasts are functionally closely related, as is the balance 
between bone formation and bone resorption. Thus, insufficient bone formation 
compared with bone resorption observed in spaceflight reduces the bone mass and 
bone strength, leading to fractures.
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Two hormones, calcitonin and parathormone (PTH), and vitamin D play an 
essential role in Ca2+ metabolism. Calcitonin is secreted from C cells of the thyroid 
gland. The secretion of calcitonin is promoted by an increase in the blood cal-
cium concentration and is suppressed by the decrease in the serum calcium level. 
Calcitonin acts on the calcitonin receptor in osteoclasts to suppress the release of 
Ca2+ from the bone and promotes the deposition of calcium and phosphate on the 
bone. Calcitonin also promotes the excretion of calcium and phosphate into the 
urine. As a result, the serum level of Ca2+ decreases.
PTH is secreted from the parathyroid gland, increasing the release of Ca2+ from 
bone. PTH binds to osteoblasts to increase the expression of RANKL and inhibits 
their secretion of osteoprotegerin (OPG), which competitively binds to RANKL, 
preventing RANKL from interacting with RANK (receptor for RANKL). The bind-
ing of RANKL stimulates osteoclast precursors to fuse, forming new osteoclasts. As 
a result, PTH increases bone resorption, thereby increasing the serum Ca2+ level.
Vitamin D (25-hydroxycholecalciferol) acts on the parathyroid gland and 
suppresses the synthesis and secretion of PTH. The intestinal tract promotes the 
absorption of calcium and phosphorus. Vitamin D is essential for bone formation, 
but its direct action on bone formation remains unclear. It is also necessary for 
the formation of osteoclasts, affects the bone action of PTH, and promotes bone 
resorption itself at a high concentration. In the kidney, vitamin D increases Ca2+ 
reabsorption in the distal tubule and promotes the Ca2+ reabsorption action of PTH.
5.2 Effects of microgravity on bone metabolism
The main factor of bone metabolism is mechanical impact. Gravity creates 
weight and is responsible for the pressure exerted on a large part of the skeleton, 
resulting in a mechanical impact on bones. These gravitational impacts provide 
mechanical constraints on the femurs, tibias, calcaneus, and vertebrae. Thus, 
decalcification and bone loss are observed as the result of bone resorption, and the 
disappearance of gravity from the body axis components induces bone loss and 
resultant osteoporosis [2, 40].
5.3 Effects of spaceflight on bone metabolism
In microgravity conditions, decalcification was observed in 12 of the astronauts 
on the Gemini and Apollo 7 and 8 flights in 1969 [8]. Based on bone density mea-
sured using X-rays, the bone Ca2+ loss was 3.2%.
The bone mineral density was measured before and after the Mir program. The 
changes were as follows: +0.6% in the skull, +0.1% in the arm, −1.07% in the spine, 
−1.35% in the pelvis, −1.16% in the femoral neck, −1.58% in the trochanter major, 
−1.25% in the tibia, and −1.50% in the calcaneus per month, with comparable 
results from the ISS [41]. The most affected bones during spaceflight are weight-
bearing bones, e.g., the pelvis (os coxae), the trochanter major of the femur, the 
femoral neck, the tibia, and the calcaneus.
Mir studies using dual photonic densitometry demonstrated a mean decrease 
in bone mineral density of approximately 0.3%/month in the cortical bone and up 
to 0.9%/month in cancellous tibial bone. Decalcification only occurs in the weight-
bearing bones, and demineralization is correlated with mission duration. During 
spaceflight, hypercalcemia and hyperphosphatemia develop due to demineraliza-
tion, and Ca2+ excretion into the urine increases before stabilization at around the 
30th day of flight [42].
The National Aeronautics and Space Administration (NASA) of the United 
States documented a bone mineral loss rate/month of 1–2% during spaceflight 
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(https://science.nasa.gov/science-news/science-at-nasa/2001/ast01oct_1), and 
bone density loss of 5–6% was reported in Apollo 15 crewmembers [43]. Bone loss is 
influenced by the spaceflight duration.
Tail suspension studies on rats demonstrated that simulated microgravity 
reduces bone formation, alters the Ca2+ balance, and inhibits the proliferation 
and differentiation of osteoprogenitor cells [44]. Osteocytes can also be affected 
by unloading stimulus in a bioreactor, with high expression of inhibitors of bone 
formation (sclerotin) and stimulators of bone resorption (RANKL) [45].
Osteoporosis can be irreversible. After returning to Earth without appropriate 
rehabilitation, the bone may be unable to return to normal activity under loads 
and may be weaker, easily inducing fractures. Reloading after a period of a week 
can ameliorate bone weakness, but even 2 weeks of bone restoration was not 
satisfactory. The length of spaceflight influences the bone density loss; however, 
another report stated that the bone loss at 1 month continued to increase after 
6 months, suggesting that the length of spaceflight does not determine the bone 
density loss [42].
5.4 Effects of mechanical impact on hormonal influence
Wolff ’s law characterizes how the bone adapts to functionally withstand its 
mechanical environment [46]; however, several studies found that mechanical 
loading per se is not the direct stimulus for bone remodeling [47–51].
Then what are the effects of mechanical impact on calcitonin? Calcitonin 
receptors were not observed on osteoblasts [52] but were present on osteoclasts [53] 
and osteocytes [54]. Calcitonin was reported to inhibit apoptosis of osteoblasts and 
osteocytes, demonstrating a potential indirect influence on bone formation. These 
data confirmed that mechanical impact is not directly related to bone formation.
One notable property of PTH is that although chronic increases in PTH levels 
increase bone resorption, intermittent stimulation accelerates bone formation. PTH 
stimulates osteoclast formation by binding to PTH receptor 1 on stromal/osteoblas-
tic cells and thereby increases the production of receptor activator of RANKL and 
macrophage colony-stimulating factor (M-CSF) and suppresses the RANKL decoy 
receptor osteoprotegerin. Moreover, PTH controls the production of osteoblasts 
through actions on osteocytes through Wnt signaling in osteoblastogenesis [55].
The action of osteocytes, which can directly sense a mechanical unloading 
stimulus, increased the expression of both inhibitors of bone formation (SOST/
sclerotin) and stimulators of bone resorption (RANKL) through Wnt signaling [45]. 
These results support the hypothesis that intermittent mechanical impacts induce 
osteocyte action, which inhibits bone formation and stimulates bone resorption, 
and that an intermittent increase in PTH controls the production of osteoblasts.
5.5 Sympathetic alteration of bone metabolism during spaceflight
It has been reported that sympathetic neural traffic to bone inhibits the function 
of osteoblast and increases that of osteoclast, thus facilitating bone loss. Possible 
roles of the sympathetic nervous system in the mechanisms of bone loss in humans 
exposed to long-term spaceflight will be discussed.
Prolonged exposure to microgravity in space for 14 days increased sympathetic 
neural traffic in humans based on results from the Neurolab mission [14, 56–58], 
with comparable increases in noradrenaline spillover and clearance in space [14]. 
Concordant results were obtained during simulated microgravity, including dry 
immersion [28] or head-down bedrest [17]. In general, elderly people have a low 
bone density and high sympathetic neural traffic to muscles [59]. Our preliminary 
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receptors were not observed on osteoblasts [52] but were present on osteoclasts [53] 
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exposed to long-term spaceflight will be discussed.
Prolonged exposure to microgravity in space for 14 days increased sympathetic 
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Concordant results were obtained during simulated microgravity, including dry 
immersion [28] or head-down bedrest [17]. In general, elderly people have a low 
bone density and high sympathetic neural traffic to muscles [59]. Our preliminary 
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study demonstrated that changes in sympathetic neural traffic to muscles after 
long-term bedrest of 20 days were significantly correlated with changes in the 
urinary secretion level of deoxypyridinoline [25, 60], which is used as a specific 
marker of bone resorption [61]. Based on these findings, exposure to prolonged 
microgravity may increase sympathetic neural traffic to the bone, which increases 
the noradrenaline level, thereby inhibiting osteogenesis and facilitating osteolysis 
through β-receptors to induce bone mineral loss.
5.6 Countermeasures for space-related osteoporosis
1. Physical factors
Exercise during weightlessness has been incorporated into the present counter-
measure programs; however, exercise alone cannot prevent bone loss. The current 
exercise program for the ISS is a combination of aerobic and resistive exercise for 
2.5 hours, 6 days/week. Data from spaceflight revealed that bone loss occurs mainly 
in the femur, tibia, calcaneus, and vertebrae. Therefore, exercise should be concen-
trated on these bones, and impact loading should be primarily provided rather than 
static loading [62].
2. Pharmacological factors
As bone mass is sufficient at the onset of the spaceflight, the optimal strategy for 
the pharmacotherapy against bone loss is the prevention of bone loss, not the accel-
eration of bone formation, when loading is removed during spaceflight. Several 
drugs have been proposed to prevent bone loss under microgravity.
3. Bisphosphonates
Bisphosphonates have two phosphonate (PO3) groups and are similar in struc-
ture to pyrophosphate. They bind to hydroxyapatite in bone matrix and prevent 
bone loss by inhibiting osteoclastic bone resorption. Bisphosphonates have been 
demonstrated to be effective in preventing bone loss during bedrest studies [63–66]. 
Among several types of bisphosphonates, pamidronate has been confirmed to sup-
press bone mineral loss and to prevent the formation of renal stones during bedrest 
studies [67].
In 2010, LeBlanc and Matsumoto [68] proposed an experiment for the effective-
ness of bisphosphonate as a countermeasure to spaceflight-induced bone loss. The 
astronauts chose either oral administration of alendronate at 70 mg once per week 
or intravenous administration of zoledronate at 4 mg before the flight, and their 
bone densities were examined by DXA, QCT, and pQCT, and bone metabolism 
markers, including bone formation and resorption markers, and renal stone forma-
tion were assessed. One of the co-investigators (Ohshima) reported successful 
suppression of spaceflight-induced bone loss and renal stone formation (Ohshima, 
personal communication).
The disadvantages of bisphosphonates are local irritation of the upper gastroin-
testinal (GI) tract and poor absorption from the GI tract. Therefore, the oral admin-
istration of bisphosphonates requires drinking 200 mL of water while remaining 
in an upright posture for at least 30 min until after their first meal of the day to 
facilitate delivery to the stomach. This poses a problem as there is no upright pos-
ture in space due to microgravity. Another potential problem is osteonecrosis of the 
maxilla and the mandible, although the incidence is low [69]. These osteonecrotic 
or osteolytic phenomena always accompany physiological stress (mastication), 
iatrogenic trauma (tooth extraction/denture injury), or tooth infection [70, 71].
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Bisphosphonates are difficult to metabolize, and high concentrations of them are 
maintained in the bones for long periods. As bone formation is closely coupled with 
bone turnover, long-term use of the compound with resultant suppression of bone 
turnover can compromise healing of even physiological microinjuries within the 
bone. Osteonecrosis of the maxilla and mandible likely results from the inability of 
the hypodynamic and hypovascular bone to meet the increased demand for repair 
and remodeling because several alterations are associated with this necrosis.
4. Parathormone
Parathormone has anabolic effects on the bone and also functions in the kidney 
to stimulate the reabsorption of Ca2+ and increase the synthesis of vitamin D. In 
this sense, parathormone may stimulate bone formation, increase vitamin D 
synthesis, and stimulate Ca2+ reabsorption. As suppressing bone reabsorption is 
favorable for stimulating bone formation during spaceflight, the administration of 
parathormone is strategically unfavorable.
In conclusion, it is favorable to administer bisphosphonate orally under artificial 
gravity with exercise in order to prevent osteoporosis in space. Monitoring the blood 
and urine samples on the ISS or spacecraft by a simple method is necessary to assess 
the effectiveness of the countermeasure.
6. Immunology and hematology
6.1 Space anemia
The circulatory blood volume is 5 L on average and contains plasma and cellular 
components, including erythrocytes, leukocytes (neutrophils, eosinophils, baso-
phils, and lymphocytes), and platelets [72–74]. Among them, reduction in cellular 
components, especially erythrocytes (RBC), is associated with anemia, whereas the 
function of leukocytes is related to immunological response.
In the early stages of space development, cases of “space anemia” (hematocrit 
reduction) were reported on Gemini, Apollo, Skylab, and Shuttle missions and in the 
cosmonauts in the Salyut and Mir missions. However, in spaceflight, microgravity 
causes cephalad fluid shift, meaning this “space anemia” was actually a misinterpre-
tation of symptoms. The true effects of microgravity can be measured through the 
total RBC count calculated from the hematocrit and plasma volume measurements. 
In this way, “space anemia” corresponded to a reduction in the total RBC count.
After 10 days aboard Spacelab-1, the total RBC count was reduced by 9% and 
by 15% after several weeks. After returning to Earth, the total RBC count did not 
recover even after 6 weeks and, in the case of Skylab astronauts, had not recovered 
after more than 3 months.
This suggested that microgravity is responsible for “space anemia,” and many 
investigations were carried out to reveal whether anemia is the result of an increase 
in RBC destruction or a decrease in their production. Using labeled RBC by the 
uptake of 14C glycine, RBC destruction was found to be three times greater in rats 
having flown aboard Cosmos-782 than in the control rats. On the other hand, 
reduced RBC production is unlikely because the number of stem cells measured by 
the number of cellular colonies that developed in vitro from samples of bone mar-
row taken from rats that flew aboard the Soviet Biosatellite—2044 for 14 days—was 
unchanged.
Human studies carried out by [75] on Shuttle missions for 9 to 14 days dem-
onstrated that space anemia is due mainly to a lower production of RBC, causing 
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by 15% after several weeks. After returning to Earth, the total RBC count did not 
recover even after 6 weeks and, in the case of Skylab astronauts, had not recovered 
after more than 3 months.
This suggested that microgravity is responsible for “space anemia,” and many 
investigations were carried out to reveal whether anemia is the result of an increase 
in RBC destruction or a decrease in their production. Using labeled RBC by the 
uptake of 14C glycine, RBC destruction was found to be three times greater in rats 
having flown aboard Cosmos-782 than in the control rats. On the other hand, 
reduced RBC production is unlikely because the number of stem cells measured by 
the number of cellular colonies that developed in vitro from samples of bone mar-
row taken from rats that flew aboard the Soviet Biosatellite—2044 for 14 days—was 
unchanged.
Human studies carried out by [75] on Shuttle missions for 9 to 14 days dem-
onstrated that space anemia is due mainly to a lower production of RBC, causing 
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increased plasma volume, reduced hemoglobin concentration, and increased serum 
erythropoietin. This reflects a decrease in the RBC life span and slower production.
Rizzo et al. [76] analyzed the cause of the shortened RBC life span and reported 
altered cell membrane composition and an increase in lipid peroxidation products. 
They suggested that antioxidant defense systems in the erythrocytes were induced, 
with a significant increase in glutathione content.
The mechanism underlying anemia was also confirmed by measuring the 
erythropoietin (EPO) level [77]. Radioimmunoassay revealed that the EPO level 
decreases after 24 hours of flight and is reduced by 30–40% on the third day com-
pared with preflight levels. This low secretion of EPO will inhibit RBC maturation 
and cause hemolysis due to suppressed erythropoiesis.
Other changes in leukocytes (WBC) are in their polymorphonuclear charac-
teristics. The composition of WBC is changed such that there is a slight increase in 
neutrophils and decrease in eosinophils. The percentage of lymphocytes, especially 
T cells, decreases, whereas that of monocytes slightly increases. These changes 
quickly disappear upon returning to 1 G on Earth.
6.2 Immunological changes during weightlessness
Recent studies confirmed dysregulation of the immunological response in 
humans and the reactivation of latent herpes virus, which persisted for the duration 
of a 6-month orbital spaceflight [78]. Blood samples from ISS crew members dem-
onstrated that long exposure to microgravity reduced their T lymphocyte counts, 
suggesting the attenuation of cytotoxic function and viral reactivation in the space 
environment.
As the immune system is highly sensitive to different types of stressors, includ-
ing psychological, physical, and local environmental stressors (e.g., oxidative and 
radiation exposure), exposure to the space environment suppresses T helper cells, 
which leads to susceptibility to viruses.
7.  Artificial gravity as a total countermeasure for spaceflight 
deconditioning
For human space voyages lasting several years, such as those envisioned for the 
exploration of Mars, astronauts will be at risk of catastrophic consequences should 
any of the systems that provide air, water, food, or thermal protection fail. Beyond 
that, astronauts will face serious health and/or safety risks resulting from marked 
physiological deconditioning associated with prolonged weightlessness [1, 79]. The 
principal physiological deconditioning risks are related to physical and functional 
deterioration, and the loss of regulation of the several systems, including blood 
circulation, decreased aerobic capacity, musculoskeletal systems, and altered 
sensorimotor system performance. These physiological effects of weightlessness are 
generally adaptive to spaceflight and present a hazard only following G transitions 
upon returning to Earth or landing on another planet [80]. Among them, bone 
mineral metabolism will be greatly affected during prolonged spaceflight.
7.1 Why artificial gravity
Space biomedical researchers have been working for many years to develop 
“countermeasures” to reduce or eliminate the deconditioning associated with 
prolonged weightlessness. Intensive and sustained aerobic exercise on a treadmill, 
bicycle, or rowing machine coupled with intensive resistive exercise has been 
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used on US and Russian spacecraft to minimize these problems. The procedures 
were uncomfortable and excessively time-consuming for many astronauts, and 
their effectiveness for maintaining bone, muscle, and aerobic fitness has not 
been demonstrated due in part to the low reliability of the devices flown to date. 
Furthermore, they have had inconsistent effects on postflight orthostatic hypoten-
sion or sensorimotor adaptive changes. With the exception of fluid loading before 
reentry, other countermeasures (e.g., diet, lower body negative pressure, or wearing 
a “penguin suit” to force joint extension against a resistive force) either have been 
marginally effective or presented an inconvenience or hazard.
To succeed in the near-term goal of a human mission to Mars during the second 
quarter of this century, the human risks associated with prolonged weightlessness 
must be mitigated well beyond our current capabilities. Indeed, during nearly 
45 years of human spaceflight experience, including numerous long-duration 
missions, no single countermeasure or combination of countermeasures that is 
completely effective has been developed. Current operational countermeasures 
have not been rigorously validated and have not fully protected any long-duration 
(>3 months) astronauts in low Earth orbit. Thus, it is unlikely that they will suf-
ficiently protect astronauts journeying to Mars and back over a 3-year period.
Although improvements in exercise protocols, changes in diet, or pharmaceuti-
cal treatments of individual systems may be of value, they are unlikely to eliminate 
the full range of physiological deconditioning. Therefore, a complete research and 
development program aimed at substituting the missing gravitational cues, and 
loading in space is warranted.
The urgency of exploration-class countermeasures is compounded by the lim-
ited availability of flight resources for validating a large number of system-specific 
countermeasure approaches. Furthermore, recent evidence of the rapid degradation 
of pharmaceuticals flown aboard long-duration missions, putatively because of 
radiation effects, raises concerns regarding the viability of some promising coun-
termeasure development results. Although the rotation of a Mars-bound spacecraft 
will not be a panacea for all human risks of spaceflight (artificial gravity cannot 
solve the problems associated with radiation exposure, isolation, confinement, and 
environmental homeostasis), artificial gravity does offer significant promise as an 
effective, efficient, multi-system countermeasure against the physiological decon-
ditioning associated with prolonged weightlessness. Virtually all of the identified 
risks associated with cardiovascular deconditioning, myatrophy, bone loss, neu-
rovestibular disturbances, space anemia, immune compromise, and neurovegeta-
tive state may be alleviated by sufficient artificial gravity.
7.2 Why artificial gravity with exercise
Although a short-radius centrifuge has been proposed several times, loading 
with artificial gravity has not been demonstrated to be effective at preventing 
spaceflight deconditioning on its own. Making a human-powered short-arm cen-
trifuge is an effective method to create exercise loads for astronauts. Considering 
the size of the ISS, it is appropriate to employ a short-radius centrifuge rather 
than a large-radius human centrifuge; however, it may be beneficial to rotate the 
spacecraft itself to provide the artificial gravity for long-duration spaceflight such 
as Mars expeditions.
In 1999, Iwase proposed the creation of artificial gravity by ergometric exercise, 
and it was installed at Nagoya University [33]. Several studies were performed using 
this short-radius centrifuge with an ergometer. In 2002, a bedrest study was car-
ried out to evaluate the effectiveness of artificial gravity with ergometric exercise. 
In 2005, the facility was moved to Aichi Medical University, and bedrest studies 
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marginally effective or presented an inconvenience or hazard.
To succeed in the near-term goal of a human mission to Mars during the second 
quarter of this century, the human risks associated with prolonged weightlessness 
must be mitigated well beyond our current capabilities. Indeed, during nearly 
45 years of human spaceflight experience, including numerous long-duration 
missions, no single countermeasure or combination of countermeasures that is 
completely effective has been developed. Current operational countermeasures 
have not been rigorously validated and have not fully protected any long-duration 
(>3 months) astronauts in low Earth orbit. Thus, it is unlikely that they will suf-
ficiently protect astronauts journeying to Mars and back over a 3-year period.
Although improvements in exercise protocols, changes in diet, or pharmaceuti-
cal treatments of individual systems may be of value, they are unlikely to eliminate 
the full range of physiological deconditioning. Therefore, a complete research and 
development program aimed at substituting the missing gravitational cues, and 
loading in space is warranted.
The urgency of exploration-class countermeasures is compounded by the lim-
ited availability of flight resources for validating a large number of system-specific 
countermeasure approaches. Furthermore, recent evidence of the rapid degradation 
of pharmaceuticals flown aboard long-duration missions, putatively because of 
radiation effects, raises concerns regarding the viability of some promising coun-
termeasure development results. Although the rotation of a Mars-bound spacecraft 
will not be a panacea for all human risks of spaceflight (artificial gravity cannot 
solve the problems associated with radiation exposure, isolation, confinement, and 
environmental homeostasis), artificial gravity does offer significant promise as an 
effective, efficient, multi-system countermeasure against the physiological decon-
ditioning associated with prolonged weightlessness. Virtually all of the identified 
risks associated with cardiovascular deconditioning, myatrophy, bone loss, neu-
rovestibular disturbances, space anemia, immune compromise, and neurovegeta-
tive state may be alleviated by sufficient artificial gravity.
7.2 Why artificial gravity with exercise
Although a short-radius centrifuge has been proposed several times, loading 
with artificial gravity has not been demonstrated to be effective at preventing 
spaceflight deconditioning on its own. Making a human-powered short-arm cen-
trifuge is an effective method to create exercise loads for astronauts. Considering 
the size of the ISS, it is appropriate to employ a short-radius centrifuge rather 
than a large-radius human centrifuge; however, it may be beneficial to rotate the 
spacecraft itself to provide the artificial gravity for long-duration spaceflight such 
as Mars expeditions.
In 1999, Iwase proposed the creation of artificial gravity by ergometric exercise, 
and it was installed at Nagoya University [33]. Several studies were performed using 
this short-radius centrifuge with an ergometer. In 2002, a bedrest study was car-
ried out to evaluate the effectiveness of artificial gravity with ergometric exercise. 
In 2005, the facility was moved to Aichi Medical University, and bedrest studies 
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were performed to finalize the protocol. This daily AG-EX step-up protocol was 
confirmed to be effective at preventing cardiovascular, musculoskeletal, and bone 
metabolism deconditioning in 2006, whereas the alternate-day (every-other-day) 
protocol (loading the AG-EX every other day) did not improve the spaceflight 
deconditioning associated with the microgravity exposure analogue of −6° head-
down bedrest.
The authors applied for the installation of a short-radius centrifuge facility on 
the ISS and proposed it as a method to prevent spaceflight deconditioning, includ-
ing bone loss. This project, Artificial Gravity with Ergometric Exercise (AGREE 
project), was promising to prevent space deconditioning during spaceflight, but it 
was canceled halfway through (Figure 1).
8. Conclusion and summary
Several deconditioning states in the neurovestibular, cardiovascular, ocular, 
musculoskeletal, bone metabolic, hematological and immunological, and central 
nervous systems have been documented, and efforts to ameliorate the symptoms 
have been made. In the near future, space medicine will play an increasingly impor-
tant role in missions to the Moon and Martian expeditions as well as in future deep 
space exploration.
Historically, space medicine examined early adaptation to microgravity and 
early readaptation to the terrestrial 1 G state. However, the philosophy of the 
authors is to avoid adaptation to microgravity using artificial gravity. Under this 
scenario, short exposure to microgravity is permitted, but longer adaptation will be 
unnecessary. With this philosophy, the authors believe that the humans will achieve 
safe and comfortable spaceflight without deconditioning.
Figure 1. 
Structure of the device of artificial gravity with exercise for AGREE project 2012.
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Abstract
Spaceflight is an adverse environment characterized by a unique combination of 
stressors affecting almost all physiological systems, including the immune system. 
Indeed, several studies have shown that about 50% of the astronauts have faced 
immunological troubles. Here, we will review how spaceflight affects immune cell 
development, innate as well as adaptive immunity, required to ensure an efficient 
protection of the host, with a particular focus on T and B cells. Indeed, to bet-
ter appreciate the risks associated to future long-duration space missions and to 
develop pharmacologic or nutritional countermeasures allowing immune system 
protection, it is mandatory to fully understand how these cell types are affected by 
space conditions. Finally, we will compare immune changes observed in astronauts 
with those encountered in the elderly, thereby illustrating the societal interest of 
space research.
Keywords: space exploration, immunity, lymphocytes, stress, aging
1. Introduction
Since Yuri Gagarin became the first human to leave the Earth’s confines in 1961, 
more and more humans have traveled into space, and manned space stations have 
been built. During spaceflights, the organism is subjected to a variety of chronic 
and acute stressors. The first category comprises factors such as microgravity, 
confinement, isolation, radiation, and disturbed circadian rhythm. The second 
category covers periods of intense activity, such as spacewalks, but also hypergrav-
ity exposure during takeoff and landing. While acute stressors have been described 
as beneficial to the host as they can mobilize individual’s defense capacities, several 
studies have shown that chronic stress has deleterious effects, as it contributes to 
the weakening of the immune system and the development of pathologies such as 
inflammatory disease, infections, and cancers [1–5]. In that context, it is interesting 
to note that 15 of the 29 astronauts involved in the Apollo missions developed bacte-
rial or viral infections during, immediately after, or within a week of landing [6]. In 
addition, the very first epidemiological study based on medical data collected from 
46 astronauts who spent 6 months on the ISS showed that 46% of them exhibited 
significant immunological problems [7]. Among notable events, 40% were clas-
sified as rashes/hypersensitivities and 27% as infectious diseases. Taken together, 
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1. Introduction
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confinement, isolation, radiation, and disturbed circadian rhythm. The second 
category covers periods of intense activity, such as spacewalks, but also hypergrav-
ity exposure during takeoff and landing. While acute stressors have been described 
as beneficial to the host as they can mobilize individual’s defense capacities, several 
studies have shown that chronic stress has deleterious effects, as it contributes to 
the weakening of the immune system and the development of pathologies such as 
inflammatory disease, infections, and cancers [1–5]. In that context, it is interesting 
to note that 15 of the 29 astronauts involved in the Apollo missions developed bacte-
rial or viral infections during, immediately after, or within a week of landing [6]. In 
addition, the very first epidemiological study based on medical data collected from 
46 astronauts who spent 6 months on the ISS showed that 46% of them exhibited 
significant immunological problems [7]. Among notable events, 40% were clas-
sified as rashes/hypersensitivities and 27% as infectious diseases. Taken together, 
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these data show that spaceflight-associated stressors affect, on average, the immune 
system of one out of two astronauts. Furthermore, these data demonstrate that 
immune system dysregulation occurs not only after landing but also during the 
flight [7].
In parallel of this immunological weakening, it is important to keep in mind 
that changes in microbial growth and pathogenicity have been observed [8, 9]. 
Depending on the bacteria studied, increased or decreased virulence [10, 11], altered 
sensitivity to antibiotics [12, 13], and/or increased biofilm formation [11, 13, 14] 
have been described as a result of the modulation of gene expression [9–11, 15, 16]. 
Moreover, there is some evidence to suggest that antibiotics may be less effective in 
space [12, 17, 18].
These microbial changes, combined with dysregulation of the immune system,  
certainly contribute to explain the increased susceptibility to infections observed 
in astronauts [19] (Figure 1). It is also noteworthy to keep in mind that, as the 
duration of space missions will increase, the potential for infectious diseases 
to arise during flight may become a critical issue because the probability of 
Figure 1. 
Environmental changes associated with spaceflight (stressors) such as gravity change, the perturbation of 
the circadian rhythm (every day the residents of the ISS witness 16 sunrises and 16 sunsets), confinement, 
increased radiation, sleep deprivation, and nutritional factors weaken the immune system of about 50% of the 
astronauts. Most frequent immune changes consist in viral reactivations and lower responses of T and natural 
killer (NK) cells. These changes could be due to changes in cytokine expression and increased levels of stress 
hormones. In parallel, spaceflight environment might increase the virulence, resistance, and proliferation of 
some pathogens.
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cross-contamination between crewmembers will increase. Additionally, microbial 
mutation rates may increase. Solar and cosmic radiation met during space missions, 
with a cumulative dose obviously increasing with mission duration, could contrib-
ute to the appearance of mutations potentially associated to resistance or diseases 
during such long and stressful endeavor as interplanetary missions.
Thus, caution should be paid to precisely understand how the immune system 
adapts, is modified/hampered, by unique environmental changes encountered dur-
ing spaceflight. This knowledge is mandatory to allow the development of efficient 
biomedical strategies to preserve astronauts’ heath during prolonged deep space 
exploration missions. In this chapter, we will review how spatial conditions affect 
the maturation of immune cells as well as the functions of mature immune cells 
required for the effective protection of the individual.
2. Effects on the maturation of immune cells
Cells that make up our immune system are derived from hematopoietic stem 
cells (HSC). These HSC will give rise to common myeloid progenitors (CMPs) 
and common lymphoid progenitors (CLPs). After several differentiation steps, 
CMPs will give raise to myeloid cells (granulocytes, monocytes, macrophages, and 
dendritic cells) and CLPs to lymphoid cells (B and T lymphocytes and NK cells). All 
of these cells are involved in natural and/or specific immunity.
A number of studies have analyzed the impact of spaceflight on the develop-
ment of cells belonging to the myeloid lineage (or myelopoiesis). A decrease in 
the number of granulocyte and monocyte progenitors in rodents that have been in 
space or subjected to anti-orthostatic suspension (a model commonly used in the 
laboratory to reproduce many of the physiological changes observed in flight) has 
been demonstrated [20, 21]. The culture of human CD34+ progenitors in flight has 
confirmed the inhibitory effect of microgravity on erythropoiesis (red blood cell 
production) [22]. Other studies have shown that the stressors encountered during 
spaceflight impact lymphocyte development (or lymphopoiesis). Diverse animal 
models have been used to address this question, such as mouse or the Iberian ribbed 
newt (Pleurodeles waltl, a urodele amphibian). The latter lends itself well to the con-
straints associated with space experiments and has all the cardinal elements of the 
mammalian immune system [23]. It has notably been observed that P. waltl larvae 
developed on board the ISS exhibit changes in the expression of IgM heavy-chain 
transcripts as well as a disruption in the expression of the Ikaros gene encoding 
transcription factors required for lymphopoiesis, suggesting that the latter could 
be weakened under spatial conditions [24]. This hypothesis was then confirmed 
in mice subjected to 21 days of anti-orthostatic suspension, which corresponds to 
a long-term mission at the human scale. It has been shown that this model induces 
a decrease in the number of CLPs and cells at the pro-B, pre-B, immature B, and 
mature B stages in the femoral bone marrow of suspended mice compared to 
control mice [25]. Furthermore, various causes of this weakening have been identi-
fied, such as a decrease in signal transduction by the interleukin-7 receptor and a 
decrease in the expression of transcription factors essential for B-cell development 
within the bone marrow. It has also been noted that this decrease in B lymphopoi-
esis is coupled with the remodeling of the bone tissue induced by the suspension, 
thereby reminding that all physiological systems interact within an organism and 
that these interactions have to be taken into account when analyzing the impact of 
stressors such as modeled microgravity. Finally, this sensitivity of hematopoiesis 
and the link with bone remodeling was confirmed in mice embarked on board the 
BION-M1 satellite for 30 days [26]. A decrease by a factor of two in the number of 
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newt (Pleurodeles waltl, a urodele amphibian). The latter lends itself well to the con-
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mammalian immune system [23]. It has notably been observed that P. waltl larvae 
developed on board the ISS exhibit changes in the expression of IgM heavy-chain 
transcripts as well as a disruption in the expression of the Ikaros gene encoding 
transcription factors required for lymphopoiesis, suggesting that the latter could 
be weakened under spatial conditions [24]. This hypothesis was then confirmed 
in mice subjected to 21 days of anti-orthostatic suspension, which corresponds to 
a long-term mission at the human scale. It has been shown that this model induces 
a decrease in the number of CLPs and cells at the pro-B, pre-B, immature B, and 
mature B stages in the femoral bone marrow of suspended mice compared to 
control mice [25]. Furthermore, various causes of this weakening have been identi-
fied, such as a decrease in signal transduction by the interleukin-7 receptor and a 
decrease in the expression of transcription factors essential for B-cell development 
within the bone marrow. It has also been noted that this decrease in B lymphopoi-
esis is coupled with the remodeling of the bone tissue induced by the suspension, 
thereby reminding that all physiological systems interact within an organism and 
that these interactions have to be taken into account when analyzing the impact of 
stressors such as modeled microgravity. Finally, this sensitivity of hematopoiesis 
and the link with bone remodeling was confirmed in mice embarked on board the 
BION-M1 satellite for 30 days [26]. A decrease by a factor of two in the number of 
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B lymphocytes present in the bone marrow and a statistically significant decrease 
in the expression of factors required for the development of immune and bone cells 
were observed 7 days after returning to Earth but not on landing (Figure 2). This 
time delay can be explained by the fact that bone loss worsens after landing [27].
Note that in addition to the explanations presented above, glucocorticoids 
produced in response to chronic stress may contribute to altering B lymphopoiesis. 
Indeed, it has been demonstrated that continuous administration of corticosterone, 
via a subcutaneous implant, induces reprogramming of lymphopoiesis in mice, with 
a reduction of 30–70% of pro-B, pre-B, and immature B cells after 24 hours and a 
drop of 70–80% of pro-B and pre-B cells after 36 hours of treatment [29].
T lymphopoiesis (T-cell development in the thymus) is also affected by micro-
gravity, as a decrease in T cells was observed in double-positive (CD4+CD8+) and 
single-positive (CD4+ or CD8+) maturation stages, when murine fetal thymuses 
were cultivated under simulated microgravity or spatial conditions [30]. This 
observation can be explained, at least in part, by the high sensitivity of thymocytes 
to stress [31]. Indeed, significant changes in mRNA expression from genes known 
to regulate stress and glucocorticoid receptors were observed in the thymus of mice 
subjected to a 13-day flight [32]. Another study did analyze the impact on murine 
T-cell antigen receptor (TCR) of being conceived and born under increased G force 
(2 G). This study revealed a disruption in TCR signaling and in the diversity of 
these receptor binding sites [33] (Figure 3) required for an individual to be able to 
specifically recognize peptides derived from the numerous antigens present in the 
Figure 2. 
Analysis of the femur from mice flown for 1 month on board the BION-M1 biosatellite revealed a decrease 
in the expression of 10 out of 11 proteins involved in immune cell and skeletal development, a decrease of the 
expression of 17 other immune-related proteins, and a 50% decrease in the number of B cells present in the bone 
marrow. Furthermore, this study showed that spaceflight effects were aggravated 1 week after landing [26]. 
Picture of mice in BION-M1 habitat from [28].
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environment; 85% of the TCR repertoire was different in 2 G pups compared to 
control pups. Thus, the diversity of T-cell antigen receptor repertoire is significantly 
altered by 2 G exposure, which will likely affect host defense.
The impact of a model aiming at mimicking socio-environmental stresses expe-
rienced by astronauts [34] was then studied. This model involves the chronic expo-
sure of mice to unpredictable socio-environmental stresses of various types (e.g., 
confinement, isolation, cage tilt, paired housing, perturbed circadian rhythm) 
and moderate intensity. It was demonstrated that this type of stressors only modi-
fies 25% of the TCR repertoire [35]. Consequently, it appears that a change in the 
gravitational force has a much greater impact than socio-environmental stresses on 
the T-cell antigen receptor repertoire.
3. Effects on phagocytic and NK cells
Natural or innate immunity is the body’s first line of defense against a pathogen 
after the skin and epithelial surfaces. It enables a non-specific response to be imple-
mented, involving various types of immune cells such as neutrophils, monocytes, 
Figure 3. 
Exposure to hypergravity during pregnancy affects TCR binding sites, thereby suggesting that the protection of 
the host might be affected [33]. T cells recognize an antigenic peptide on an MHC molecule at the surface of 
an antigen-presenting cell (APC) (dendritic cell, monocyte, macrophage, B cell). This recognition is ensured 
by the T-cell receptor (TCR) whose binding site is composed of six small polypeptide loops: two CDR1 loops, 
two CDR2 loops, and two CDR3 loops. CDR1 and CDR2 loops bind the MHC molecule. CDR3 loops bind the 
peptide. This figure presents the frequency of hydrophobic, acid, basic and polar amino acids at each position 
within TCR CDR3 loops from murine pups conceived and born at 1 or 2 G.
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and macrophages, to destroy pathogens by phagocytosis and the release of microbi-
cide substances.
Several studies have been conducted to understand how the space environment 
affects this immunity. For instance, an increase in the level of blood neutrophils 
in both humans and animals has often been observed after landing and can be 
attributed to the stresses encountered during this phase. Indeed, stress can induce 
the mobilization of these cells stored in the bone marrow [36, 37]. However, other 
explanations are also possible, such as changes in the expression of adhesion mol-
ecules [38]. It has also been shown that spatial conditions decrease the phagocytic 
and oxidative functions of neutrophils [39, 40] and induce, in monocytes, dys-
regulation in cytokine production, a reduced capacity to engulf Escherichia coli as 
well as lower reactive oxygen species (ROS) production and degranulation [41, 42]. 
Lower cytotoxicity of natural killer cells that provide immunological resistance and 
defense against foreign microorganisms but also against cells transformed because 
of, for example, a viral infection was observed [43, 44]. In addition, the reactivation 
of latent herpes viruses has frequently been reported. For example, Varicella-zoster 
virus (VZV) DNA has been detected in the saliva of astronauts during and immedi-
ately after a flight, while no VZV DNA was detected before launch [45]. Additional 
studies have revealed the presence of VZV in the saliva of 50% of astronauts during 
short spaceflights [46] and have shown that this percentage can increase up to 
65% during long-duration missions [47]. Significantly, a few cases resulted in the 
development of shingles [45]. These viral reactivations are frequently coupled with 
Figure 4. 
Stressors encountered during space missions can induce the production of glucocorticoids, catecholamine, 
and endocannabinoids. Numerous immune cell types have receptors for these molecules. Their functions can 
therefore be directly affected by the binding of these molecules on these receptors. GR, glucocorticoid receptor; 
ADRB2, beta-2 adrenergic receptor; CNR2, cannabinoid receptor type 2.
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a decrease in the production of interferons (cytokines constituting a first response 
in the event of viral infection) and to a higher level of stress hormones known to be 
able to regulate immune functions. Indeed, a variety of immune cells expresses glu-
cocorticoid receptors, cannabinoid receptors, and adrenergic receptors (Figure 4). 
Thus, molecules produced in response to stressing events can directly affect 
immune cells and can be responsible for the reactivation of latent viruses [48–53].
Furthermore, virus reactivation could be a good biomarker of immunity weak-
ening [54]. In support of this neuromodulation of the immune system, studies 
conducted on humans subjected to acute- (parabolic flight), medium- (1–2 weeks 
on board the ISS), or long-duration (4–7 months on board the ISS) gravitational 
stress demonstrated that there is a shift from an alert state of natural immune 
cells after acute gravitational stress to a decrease of their activity after spaceflight 
[55–57]. These changes were associated with changes in stress response, with a 
predominance of sympathetic nervous system responses after short flights, whereas 
long flights were characterized by glucocorticoid-induced changes. These data dem-
onstrate that beside gravity change, stress responses are an important contributor 
to spaceflight-associated immune changes and once again highlight the importance 
of taking into account interconnections between physiological systems (here the 
nervous and immune systems).
4. Effects on antigen-presenting cells and lymphocytes
Specific or adaptive immunity is the second line of defense against the entry 
of foreign substances, particles, or cells into the organism. It involves natural and 
specific immune cells (antigen-presenting cells and lymphocytes) that will cooper-
ate to develop a response specifically directed against the intruder.
APCs are a heterogeneous group that treat and present antigens in the form 
of peptides to CD4+ T lymphocytes unable to recognize a native antigen via their 
TCR. These cells are crucial in triggering an immune response. This group includes 
dendritic cells, monocytes/macrophages, and B lymphocytes.
Even though the antigen presentation function is an essential immune process, 
very little information is available on the impact that environmental conditions 
encountered during spaceflights could have on this function. Only one study has 
been published on dendritic cells and revealed that microgravity reduces their pro-
duction, their phagocytic capacities, and the surface expression of costimulatory/
adhesion molecules involved in the presentation of antigenic peptides [58]. These 
data suggest that certain functions of antigen-presenting cells, required for the 
development of an effective immune response, may be disrupted in microgravity.
On the other hand, numerous studies have shown a significant reduction in 
T-cell activity under both real and simulated microgravity. This lower activity [59] 
results from spaceflight-induced modifications of the expression of genes essential 
for the proper functioning of T cells such as those encoding interleukin-2 and its 
receptor [60], translation of mRNAs [61], cell-cell interactions [62], alterations 
of the structure of the cytoskeleton [63–66], signal transduction enabling T-cell 
activation [67–69], and cell cycle regulation [70].
B lymphocytes are another cell type that acts in synergy with T lymphocytes 
to ensure optimal protection of the individual. These cells, at the maturation stage 
called plasmocyte, produce large quantities of antibodies, which, by binding 
specifically to the antigen, contribute to its elimination. Antibodies and B lympho-
cytes constitute humoral immunity whose modulation by spatial conditions has 
been much less studied than that of T lymphocytes. For many years, researchers 
have been satisfied with the quantification of antibodies present in the serum/
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plasma of astronauts, but these studies generated conflicting results. For example, 
Konstantinova et al. [71] reported increased levels of serum IgA and IgM, while 
Rykova et al. [40] indicated that the amounts of serum IgA, IgG, and IgM were not 
affected after prolonged space missions. Subsequently, further studies were con-
ducted to determine how changes in gravity affect humoral immunity and demon-
strated that stresses encountered during spaceflight quantitatively and qualitatively 
affect the production of antibodies in response to antigenic stimulation. Changes in 
the expression of VH gene segments, encoding a large part of the antibody binding 
sites, have been observed in adult P. waltl immunized on board the Mir space station 
[72, 73] as well as a twofold decrease in the frequency of somatic hypermuta-
tions (SHM) that enable the diversification of antibody binding sites, in order to 
improve their affinity for the antigen [74] (Figure 5). Very recently, changes in the 
use of the gene segments required to create the antibody repertoire have also been 
observed in immunized mice subjected to anti-orthostatic suspension [75]. The 
antibody repertoire is therefore most likely modified under either real or simulated 
microgravity. In addition, a decrease in the expression of several effectors involved 
in immunity was observed 7 days after landing in mice that had been on board 
the BION-M1 biosatellite for 30 days [26]. This observation confirms the negative 
effect of spaceflight on the immune system and demonstrates that this impairment 
persists for at least 7 days after the return to Earth. This conclusion is in line with 
the studies that revealed disruptions in the production of antibodies in P. waltl still 
visible 10 days after landing [72–74].
Finally, it has been shown that the proliferative responses of B and T lympho-
cytes are reduced when mice are subjected to gravity changes (anti-orthostatic 
Figure 5. 
Somatic hypermutations (SHM) are nucleotide substitutions whose purpose is to improve the affinity of 
antibody binding sites. The frequency of these mutations was determined in adult P. waltl immunized on board 
the Mir space station and in adult P. waltl immunized with the same antigen on Earth. This study showed that 
the frequency of these mutations is two times lower when animals are immunized on board the space station 
[74]. IE, P. waltl immunized on Earth; IS, P. waltl immunized in space; NI, not immunized.
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suspension or 2 G hypergravity) for 3 weeks [76, 77]. However, the responses from 
these lymphocytes were not altered after 3 weeks of exposure to the model mimick-
ing socio-environmental stressors encountered in flight [34]. These data suggest 
that the lower reactivity in lymphocytes induced by spaceflight is mainly due to 
gravity change.
Note that there is a break in the adaptation of mice at 3 G, which results in an 
increase in the serum corticosterone concentration and the level of anxiety [76]. 
These changes persist beyond 2 weeks after the return to normal gravity. This 
demonstrates that the hypergravity model should be used with caution if the effects 
of hypergravity are to be distinguished from those of a stress response. From 3 G, 
these two variables are cumulative.
5. Spaceflight as a model of accelerated immunosenescence
Certain immunological changes observed in astronauts or rodents on space mis-
sions can also be found in the elderly. For example, thymus involution, increased 
susceptibility to infections, and decreased response to vaccines may be correlated 
with impaired development of B- and T-lymphocyte function in the elderly [78, 79]. 
This thymus involution and changes in the development and response of immune 
cells are also observed when the gravitational force is altered, as illustrated by the 
reactivation of latent viruses in astronauts and the elderly. In addition, a recent 
study suggests that long-term spaceflight could induce an increase in inflamma-
tion as in the elderly (inflammaging), which could increase the risk of allergies or 
autoimmune diseases in astronauts [80]. Finally, aging is accompanied by changes 
in antibody production similar to those observed in flight. There is a decrease in 
antibody affinity [78] and a change in the use of antibody VH gene segments [81] 
as observed in P. waltl immunized in flight [73, 74], which affects the diversity of 
the antibody repertoire. It therefore appears that stresses encountered during space 
missions could lead to premature aging of the immune system.
6. Conclusion and perspectives
Studies conducted so far show that on average one out of two astronauts encoun-
ters immunological problems and that stressors encountered during spaceflights 
can affect all components of the immune system. It is therefore mandatory to 
understand in details how all immune cell types are affected by space conditions 
by unraveling the cellular and molecular mechanisms modified within these cells. 
Indeed, the impact of spatial conditions on certain cells and functions of the 
immune system have not yet been precisely determined. Furthermore, the impact 
of long-term missions is largely under-investigated. This is because, up to now, 
most scientific data are derived from space missions not exceeding 6 months in 
duration. In addition, the impact of spatial conditions on interconnections between 
the immune and other systems (such as the musculoskeletal, nervous, respiratory, 
and cardiovascular systems) should be studied using interdisciplinary approaches. 
All this knowledge is required (i) to gain a better understanding of the risks 
incurred during future long-duration space missions (such as planned mission to 
Mars), where the crew will be left to their own with no possibility of a rapid return 
to Earth, and (ii) to develop nutritional, psychosocial, and/or pharmacological 
countermeasures to reduce stress, preserve the immune system, and prevent the 
development or aggravation of diseases [82]. Another aspect that should be taken 
into account is in-flight monitoring of astronaut’s health and diagnostic data using 
Beyond LEO - Human Health Issues for Deep Space Exploration
42
plasma of astronauts, but these studies generated conflicting results. For example, 
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strated that stresses encountered during spaceflight quantitatively and qualitatively 
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suspension or 2 G hypergravity) for 3 weeks [76, 77]. However, the responses from 
these lymphocytes were not altered after 3 weeks of exposure to the model mimick-
ing socio-environmental stressors encountered in flight [34]. These data suggest 
that the lower reactivity in lymphocytes induced by spaceflight is mainly due to 
gravity change.
Note that there is a break in the adaptation of mice at 3 G, which results in an 
increase in the serum corticosterone concentration and the level of anxiety [76]. 
These changes persist beyond 2 weeks after the return to normal gravity. This 
demonstrates that the hypergravity model should be used with caution if the effects 
of hypergravity are to be distinguished from those of a stress response. From 3 G, 
these two variables are cumulative.
5. Spaceflight as a model of accelerated immunosenescence
Certain immunological changes observed in astronauts or rodents on space mis-
sions can also be found in the elderly. For example, thymus involution, increased 
susceptibility to infections, and decreased response to vaccines may be correlated 
with impaired development of B- and T-lymphocyte function in the elderly [78, 79]. 
This thymus involution and changes in the development and response of immune 
cells are also observed when the gravitational force is altered, as illustrated by the 
reactivation of latent viruses in astronauts and the elderly. In addition, a recent 
study suggests that long-term spaceflight could induce an increase in inflamma-
tion as in the elderly (inflammaging), which could increase the risk of allergies or 
autoimmune diseases in astronauts [80]. Finally, aging is accompanied by changes 
in antibody production similar to those observed in flight. There is a decrease in 
antibody affinity [78] and a change in the use of antibody VH gene segments [81] 
as observed in P. waltl immunized in flight [73, 74], which affects the diversity of 
the antibody repertoire. It therefore appears that stresses encountered during space 
missions could lead to premature aging of the immune system.
6. Conclusion and perspectives
Studies conducted so far show that on average one out of two astronauts encoun-
ters immunological problems and that stressors encountered during spaceflights 
can affect all components of the immune system. It is therefore mandatory to 
understand in details how all immune cell types are affected by space conditions 
by unraveling the cellular and molecular mechanisms modified within these cells. 
Indeed, the impact of spatial conditions on certain cells and functions of the 
immune system have not yet been precisely determined. Furthermore, the impact 
of long-term missions is largely under-investigated. This is because, up to now, 
most scientific data are derived from space missions not exceeding 6 months in 
duration. In addition, the impact of spatial conditions on interconnections between 
the immune and other systems (such as the musculoskeletal, nervous, respiratory, 
and cardiovascular systems) should be studied using interdisciplinary approaches. 
All this knowledge is required (i) to gain a better understanding of the risks 
incurred during future long-duration space missions (such as planned mission to 
Mars), where the crew will be left to their own with no possibility of a rapid return 
to Earth, and (ii) to develop nutritional, psychosocial, and/or pharmacological 
countermeasures to reduce stress, preserve the immune system, and prevent the 
development or aggravation of diseases [82]. Another aspect that should be taken 
into account is in-flight monitoring of astronaut’s health and diagnostic data using 
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miniature and autonomous biosensors to help establish personalized treatments. 
This corresponds to a new field of research, space biotechnology, which aims to 
use advanced techniques (“omics” techniques) for the quantitative detection of 
proteins, nucleic acids, and metabolites in situ [83–86]. Such biosensors capable of 
analyzing minimum quantities of body fluids and of generating semiquantitative 
or quantitative results in a few minutes and with minimal resource consumption 
in terms of weight, volume, reagent storage, and energy will be required to allow 
deep space exploration. These researches and technological developments could 
also improve health on Earth as they could led to new therapeutic strategies to treat 
age- and stress-related immunosuppression and could likely contribute to improve 
point-of-care diagnostics at a patient’s bedside, in a doctor’s office, or hospital.
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Oral Tissue Responses to Travel  
in Space
Maija I. Mednieks and Arthur R. Hand
Abstract
The oral cavity functions in taste, mastication, solubilization and digestion 
of nutrients, as well as in respiration and speech, and participates in innate and 
adaptive immunity. Saliva creates and regulates the environment of the oral cavity, 
and changes in its composition and rate of secretion have significant effects on oral 
tissues as well as on systemic health. The effects of microgravity on the salivary 
glands, mandible and teeth were studied in mice flown on US space shuttle STS-131 
and STS-135 missions, and the Russian Bion-M1 biosatellite. Significant changes in 
morphology and secretory protein expression occurred in parotid glands; subman-
dibular glands were affected only on the 30-day Bion-M1 mission, indicating tissue 
specificity of the effects due to changes in gravity which may be similar to those 
taking place in humans. Changes also occurred in mandibular bone and incisor 
teeth. Collection of saliva is a non-invasive procedure for assessing physiological 
status and diagnosis of several disorders and provides a simple method for monitor-
ing astronaut health during extended spaceflight.
Keywords: salivary glands, mandible, teeth, morphology, protein expression
1. Introduction
The oral cavity is the body’s portal for the intake and initial processing of food 
and liquids, functioning in taste, mastication, solubilization and digestion of 
nutrients. Additionally, the oral cavity plays a role in respiration and speech as well 
as in innate and adaptive immunity. The components of the oral cavity include 
the teeth, consisting of three types of mineralized tissue, and their supporting 
structures, the bones of the maxilla and mandible and alveolar processes, and the 
periodontal ligament. The oral mucosa, which covers the alveolar processes, tongue, 
palate, cheeks, inside of the lips and floor of the mouth, consists of keratinized and 
non-keratinized epithelium overlying the connective tissues of the lamina propria 
and submucosa.
Located extraorally are the major salivary glands: the parotid, the submandibu-
lar and the sublingual, which convey their product, saliva, to the oral cavity via 
long ducts. Saliva, consisting of water, electrolytes and a large number of proteins, 
glycoproteins and small organic substances, creates and regulates the environ-
ment of the oral cavity. Changes in composition and rate of secretion of saliva have 
significant effects on oral tissues as well as on general health. In addition to the 
major glands, numerous small minor salivary glands are present in the subepithelial 
connective tissue throughout much of the oral cavity.
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connective tissue throughout much of the oral cavity.
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Among the organic constituents of saliva are digestive enzymes, calcium bind-
ing proteins, a variety of growth factors and regulatory molecules, antimicrobial 
components and immunoglobulins, and mucins that lubricate and moisten the oral 
tissues [1]. Other protective components of saliva include those involved in buffer-
ing and neutralizing acids produced by oral microorganisms and ingested with 
food and drink. Most are produced and secreted by the cells of the salivary glands, 
nevertheless a number of other proteins derived from other cells, tissues and organs 
also find their way into saliva. The presence of these substances and the ease of, and 
the noninvasive means of, collecting saliva have led to a great deal of interest for its 
use as a diagnostic fluid. Consequently, significant progress has been made in using 
saliva to detect oral and other cancers, several oral and systemic diseases, and to 
assess physiological and environmental stressors [2].
Our early studies of rats flown on Spacelab-3 [3, 4] indicated that exposure to 
microgravity resulted in specific changes in salivary gland structure and biochem-
istry. Accordingly, the premise for our recent studies of mice flown on the US space 
shuttles and the Russian Bion-M1 biosatellite, was that changes in the expression of 
salivary gland secretory proteins appear to occur in microgravity, and that the pat-
tern of changes detectable in saliva could be employed to assess important aspects 
of the physiological status of astronauts.
In addition to studying salivary gland tissues, we examined the effects of micro-
gravity on the mandibles and teeth of mice flown in space. Numerous studies have 
been carried out documenting the effects of spaceflight on bones of the weight-
bearing skeleton, especially the bones of the lower limbs and vertebrae (see reviews in 
[5–7]). However, only a few studies have focused on non-weight-bearing bones, such 
as the mandible and cranial bones, and teeth [8, 9]. Teeth, once formed, are relatively 
stable structures, but can be affected by changes in the oral environment. An under-
standing of the effects of microgravity on tooth development, which can be studied 
using the continuously erupting rodent incisor, is important especially in view of 
future possibilities of long-term space journeys and colonization of other planets.
2. Effects of spaceflight on salivary glands
2.1 Morphology
The parenchyma of salivary glands consists of a collection of secretory end-
pieces, or acini, connected to a ductal system that conveys saliva to the oral cavity 
[10, 11] (Figure 1A). The acini produce the primary saliva containing the majority 
of the proteins, most of the electrolytes and all of the water present in the final 
saliva. Serous acinar cells (Figure 1B) produce proteins and glycoproteins; seen in 
transmission electron micrographs (TEMs) the content of their secretory granules 
has a moderate to high density. Mucous acinar cells produce mainly mucins; their 
secretory granules exhibit a low density and often are fused with adjacent granules. 
The acinar secretory cells form a roughly spherical structure, their bases resting on 
the interstitial connective tissue, their apices facing a central lumen, and adjacent 
cells are joined by junctional complexes separating the interstitial from the luminal 
compartments. The cells contain abundant rough endoplasmic reticulum (RER), 
a prominent Golgi complex, and numerous secretory granules in the supranuclear 
cytoplasm. Secretory proteins synthesized by the cells are stored in the granules 
until their contents are released into the lumen by exocytosis. Consequently, analy-
sis of the glandular tissue provides information about the composition of saliva.
Saliva produced in the acini flows into the initial portion of the ductal sys-
tem, the intercalated ducts. These small ducts merge, forming larger ducts that 
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eventually empty into the main ductal component, the striated ducts. The cells 
of these ducts are columnar in shape, and have abundant mitochondria nestled 
between infoldings of the basal cell membrane. Primary saliva produced by the aci-
nar cells is modified by the striated (and excretory) ducts principally by reabsorp-
tion of Na+ and Cl− and addition of a few proteins; the final saliva is hypotonic with 
a pH near neutrality. The striated ducts become excretory ducts as they enter the 
connective tissue septa that partition the gland into lobules and lobes. The excretory 
ducts gradually merge into larger ducts and finally form the main excretory duct 
that empties into the oral cavity.
In humans, the acinar cells of the parotid gland (PG) are all serous. The sub-
mandibular gland (SMG) is a mixed gland, with mostly serous acini but also some 
mucous acini that are capped by serous cells forming a structure called a demilune. 
The sublingual gland (SLG) also is a mixed gland; its acini are predominantly mucous 
with serous demilunes. The acini and ductal systems of the rodent PG and SLG are 
very similar to those of the human (Figure 2). The structure of the rodent SMG 
(Figure 3) differs significantly from that of the human. The acini in rodents are all 
seromucous and produce a number of proteins and glycoproteins as well as mucins. 
As the animals become sexually mature, the cells of first portion of the striated ducts 
Figure 1. 
(A) Diagram showing the main parenchymal components of mammalian salivary glands. (B) Transmission 
electron micrograph (TEM) of a serous acinar cell of a rodent parotid gland (PG) (modified, with permission, 
from ([10], Chapter 11, pp. 224, 225)).
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enlarge and synthesize a number of growth factors and proteases that are stored in 
large secretory granules in the apical cytoplasm. The development of this portion of 
the duct, called the granular convoluted duct, is strongly influenced by androgens; 
the granular convoluted duct is, therefore, more prominent in males than in females. 
Another feature of the sexual dimorphism seen in the rodent SMG is the presence 
in females of terminal tubule cells, or granular intercalated duct cells, at the acinar-
intercalated duct junction. These cells are remnants of the early development of the 
gland; in males they are entirely eliminated by apoptosis by about 1 month of age.
Specific morphological changes were seen in the PG after a 13- to 15-day flight 
on the STS-135 and STS-131 shuttle missions, and 30 days on the Bion-M1 biosatel-
lite [12, 13]. In the acinar cells autophagic vacuoles were common, and apoptotic 
Figure 2. 
TEMs of (A) PG serous acinar cells from a STS-135 flight mouse, and (B) sublingual gland (SLG) mucous 
acinar cells and serous demilune cells from a STS-131 habitat ground control mouse. Mucous acinar cells are 
filled with electron lucent mucous granules (MG). Serous demilune cells (lower right) contain electron dense 
secretory granules (SG). Lumen (L), mitochondria (M), nucleus (N), rough endoplasmic reticulum (RER), 
Golgi complex (arrowheads), intercellular canaliculi (arrows).
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cells were seen more frequently (Figure 4A). The autophagic vacuoles often 
contained degenerating secretory granules as well as other organelles. Some cells in 
the intercalated and striated ducts had large endocytic vacuoles containing dense 
content in the apical cytoplasm (Figure 4B). Immunogold labeling showed the 
presence of acinar secretory proteins in these vacuoles.
Figure 3. 
TEMs of submandibular gland (SMG). (A) seromucous acinar cell from a STS-131 flight mouse, (B) 
intercalated duct and terminal tubule cell from a STS-131 habitat control mouse, and (C) granular convoluted 
duct from a Bion-M1 flight mouse. Acinar cells have a basal nucleus (N) and RER, and large secretory granules 
(SG) with a granular content of low density. In female mice, terminal tubule cells (TT) often are present in 
the intercalated ducts (ID) adjacent to the acinar cells. Columnar shaped granular convoluted duct cells of the 
male gland have a basal nucleus and mitochondria, and numerous dense secretory granules in the supranuclear 
cytoplasm. Lumen (L), mitochondria (M), Golgi complex (arrowheads), intercellular canaliculus (arrow).
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the intercalated and striated ducts had large endocytic vacuoles containing dense 
content in the apical cytoplasm (Figure 4B). Immunogold labeling showed the 
presence of acinar secretory proteins in these vacuoles.
Figure 3. 
TEMs of submandibular gland (SMG). (A) seromucous acinar cell from a STS-131 flight mouse, (B) 
intercalated duct and terminal tubule cell from a STS-131 habitat control mouse, and (C) granular convoluted 
duct from a Bion-M1 flight mouse. Acinar cells have a basal nucleus (N) and RER, and large secretory granules 
(SG) with a granular content of low density. In female mice, terminal tubule cells (TT) often are present in 
the intercalated ducts (ID) adjacent to the acinar cells. Columnar shaped granular convoluted duct cells of the 
male gland have a basal nucleus and mitochondria, and numerous dense secretory granules in the supranuclear 
cytoplasm. Lumen (L), mitochondria (M), Golgi complex (arrowheads), intercellular canaliculus (arrow).
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The underlying basis for these changes is believed at least in part to be the loss of 
neural stimulation due to reduced masticatory activity. This is indicated by experi-
ments where withholding food for 24–48 h, or feeding rats a liquid diet, results in 
numerous autophagic vacuoles containing degenerating secretory granules and an 
increase in the number of apoptotic cells in the PG [14–17].
The mice from the Bion-M1 mission all gained weight during the flight but were 
fed a soft paste diet. The mice from the space shuttle missions had ad libitum access 
to NASA rodent food bars [18], but lost a small amount of weight, as did the habitat 
control mice (maintained on the ground for the same length of time in the same 
habitats as the flight mice). This suggests that the mice on the space shuttle flights 
may not have eaten the amount of food sufficient to maintain their body weight. Since 
the number of autophagic vacuoles and frequency of apoptosis was greater in flight 
mice than in the habitat controls, microgravity also appears to affect these processes.
Endocytosis of salivary proteins by duct cells occurs in experimental diabetes 
[19, 20]. This suggests that the proteins may have an altered structure that is rec-
ognized as foreign by the duct cells; these cells are capable of endocytosing foreign 
proteins introduced in a retrograde fashion via the main excretory duct [21–23]. 
Alternatively, duct cell function in the flight mice may have been altered.
In contrast to the PG, no morphological changes were evident in the SMG or 
SLG of the flight mice. Similarly, feeding a liquid diet has no apparent effect on the 
morphology of the rat SMG and SLG [24].
2.2 Salivary protein expression studied using two major approaches
2.2.1 Electron microscopic immunogold labeling
Relative changes in secretory protein expression can be analyzed by electron micro-
scopic immunogold labeling. Determination of the labeling density (gold particles/μm2) 
Figure 4. 
TEMs of PG from STS-135 flight mice. (A) An acinar cell contains 2 autophagic vacuoles (AV), and a macrophage 
(Mac) has engulfed an apoptotic acinar cell (APOP). (B) Intercalated duct cells contain apical vacuoles (arrows) 
resulting from endocytosis of secretory proteins from the lumen (L) (with permission, from [13]).
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of secretory granules of PG acinar and duct cells showed alterations in the expression of 
several salivary proteins following spaceflight [12, 13] (Figure 5).
Compared to their habitat controls, expression of α-amylase, a digestive 
enzyme, was decreased in the parotid glands of mice flown on the space shuttles, 
but increased in mice flown on the Bion-M1 biosatellite. Parotid secretory protein 
(PSP), an antimicrobial protein [25, 26], was slightly increased in mice from the 
Bion-M1 flight. Proline-rich protein (PRP), a calcium and polyphenol binding 
protein [27, 28], was decreased in mice from STS-131, increased in mice from 
STS-135, and decreased, but not significantly, in mice from the Bion-M1 flight. The 
type II regulatory subunit of protein kinase A (PKA-RII), a stress marker secreted 
into saliva [29], was slightly decreased in mice from the 3 flights. Demilune cell and 
parotid protein (DCPP), secreted by intercalated duct cells and believed to have 
antimicrobial activity [30], was increased in mice from the STS-131 flight, but was 
unchanged in mice from STS-135 and Bion-M1 flights.
PKA-RII also is present in the nucleus, where it is involved in regulating several 
genes [31, 32]. No significant differences were seen in nuclear PKA-RII in parotid 
acinar cells of mice from the 3 flights (Figure 6).
Figure 5. 
TEM immunogold labeling for proline-rich protein (PRP) in PG acinar cells of (A) flight and (B) habitat 
ground control mice from STS-135. Secretory granules (SG). (C) Quantitative TEM immunogold labeling 
of secretory proteins in PG of mice flown on STS-131 and STS-135, and the Bion-M1 biosatellite. α-Amylase, 
parotid secretory protein (PSP), PRP and the type II regulatory subunit of protein kinase A (RII) are present 
in acinar cell secretory granules; demilune cell and parotid protein (DCPP) is present in intercalated duct cell 
secretory granules. Labeling results are shown as a percentage of the corresponding habitat control mice ± SEM. 
+, p = 0.065; *, p < 0.05; #, p < 0.01.
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The expression of SMG secretory proteins was essentially unchanged in mice 
from the 13–15-day space shuttle flights. However, mice from the Bion-M1 flight 
showed significantly increased expression of an acinar cell protein, salivary andro-
gen binding protein alpha (SABPα), a pheromone involved in mate selection [33], 
and the granular convoluted duct cell proteins epidermal growth factor (EGF) and 
nerve growth factor (NGF) (Table 1). PRP, present in acinar cell secretory granules 
of both sexes, and submandibular gland protein C (SMGC), present in terminal 
tubule cell secretory granules of female mice, were not significantly different from 
controls. In the SLG, PSP expression by demilune cells was significantly increased 
in mice from the space shuttle STS-131 flight, but not in mice from STS-135 [34]. 
The expression of both PKA-RII in demilune cells, and the acinar cell mucin Muc19, 
were increased, but not significantly.
2.2.2 Electrophoresis and Western blotting
Polyacrylamide gel electrophoresis (PAGE) is the separation of proteins based 
on mobility on a gel matrix, subjected to a charge differential between two sealed 
chambers, of a body fluid or tissue extract. This technique is frequently used to 
determine the distribution or banding pattern of protein groups in tissues under 
different conditions. Quantification of the intensity of the bands and their relative 
mobility by PAGE is carried out by densitometric analysis. Saliva is a convenient 
Figure 6. 
Quantitative TEM immunogold labeling of nuclear PKA-RII in PG of mice flown on STS-131 and STS-135, 
and the Bion-M1 biosatellite. Labeling results are shown as a percentage of the corresponding habitat control 
mice ± SEM.
STS-131 STS-135 Bion-M1
SABPα 114.6 ± 12.1 88.9 ± 26.3 221.9 ± 31.7*
PRP 111.1 ± 13.0 76.6 ± 9.0 134.4 ± 11.5
EGF 87.7 ± 12.4 36.3 ± 6.0 159.9 ± 4.6*
NGF 116.3 ± 23.3 89.9 ± 5.1 159.0 ± 10.6*
SMGC 83.0 ± 9.3 103.4 ± 5.3 —
Labeling results are shown as a percentage of the corresponding habitat control mice ± SEM.
*p < 0.01.
Table 1. 
Quantitative TEM immunogold labeling of secretory proteins in SMG of female mice flown on STS-131 and 
STS-135, and male mice flown on the Bion-M1 biosatellite.
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body fluid for measuring a variety of physiological conditions or responses on the 
basis of variations in protein content or distribution. For example, after testing 
more than 50 samples, PAGE separation of salivary proteins has shown that each 
individual pattern is unique. Namely, no superimposable patterns were found, 
therefore constituting essentially a salivary protein pattern fingerprint. Shown 
at the left in Figure 7, in duplicate, are the patterns of three (A, B, C) randomly 
selected individuals with the corresponding densitometric profiles at the right. 
Figure 7 also shows how normal chewing changes the amplitude of several protein 
peaks, but not the basic pattern.
The PAGE protein banding patterns of the STS mission samples showed a 
decrease of some of the higher molecular weight bands while the faster moving 
smaller bands increased when these were compared to vivarium controls. The 
changes were not consistent between missions and may in part be due to lack of 
stability of the tissue or of sample preparation.
Western blotting is a technique using antibodies generated to a specific protein 
for its identification among numerous others in the banding pattern. Proteins are 
transferred onto nitrocellulose membranes and stained with a washable dye to show 
the band distribution, then quantified by densitometry. The dye is removed and the 
membrane probed for reactivity with a specific antibody. These techniques were 
employed to test salivary gland extracts to measure protein patterns of flight animal 
samples when compared with those of ground control animals (Figure 8).
The results show that the RII peaks in the STS-135 flight samples (Figure 8) 
were significantly smaller than the corresponding band amplitude in either vivar-
ium or habitat controls, middle and bottom profiles, respectively. Western blotting 
experiments to determine the expression of α-amylase show a significant decrease 
in the flight and in the habitat controls.
These results indicate that on the shorter, STS-135 flight the expression of RII 
was decreased, while in the longer Bion-M1 flight (Figure 9) an apparent stabiliza-
tion or adjustment to the microgravity environment had occurred and the RII levels 
were not different, perhaps even increased from those of either of the controls. Both 
Bion-M1 and STS-135 flight and both control samples show a significant, but oppo-
site change of a faster moving band that may represent a small protein or peptide.
The findings regarding RII, generally thought to be a stress associated protein 
[35, 36] responding to the conditions of spaceflight [7], varied by methods of 
analysis but also between flights within a particular test measure from morpho-
metric analyses of immunogold labeling experiments. Bion-M1 Western blotting 
results showed no difference between RII in Bion-M1 flight and vivarium control 
Figure 7. 
Electrophoresis and densitometry of saliva from three randomly selected individuals (A, B, and C) from a pool 
of approximately 50 test subjects. The left ordinate on the gel pattern image shows molecular based migration 
rates of a mixture of proteins of known size. At the right of the polyacrylamide gel electrophoresis (PAGE) 
banding patterns are the corresponding densitometric measurements. The top row (−) prior to, the bottom row 
(+) after, chewing. The asterisks show the migration distance of RII that can be identified by Western blotting.
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mice. Measuring RII, therefore, may be a sensitive test for stress reactions during 
spaceflight.
The variability may be due to the sensitivity of responses affecting RII synthesis. 
Previous studies point to a rapid and transient increase in the cases of brief acute 
stress, for example lift off of a spacecraft, followed by long-term, perhaps low level, 
prolonged time under stress, decrease. For example, a 60-day to a year tour result-
ing in a decrease of RII and leveling off at concentrations below normal. Eventual 
physiologic adjustment to flight conditions may start to bring RII production 
toward normal. An apparent increase also may result from a rough landing that 
might have occurred in the Bion-M1 flight and the acute response obliterating any 
reduction due to chronic long-term flight conditions.
Tissue extract samples showed a large faster moving component, presumably an 
RII fragment. The fragments did resemble the densitometric changes in the flight 
versus the control. These differences did not completely account for the change of 
flight values compared to the control. There may have been smaller fragments not 
visible on the Western blot that could account for the decreases in flight RII.
Figure 8. 
Densitometric analysis of PAGE protein separation and anti-RII and anti-α-amylase reactivity in STS-135 
mice. (A) PG protein samples from mice housed in, top panel, flight; middle panel, habitat; and bottom 
panel, vivarium type cages. The lighter curve represents the protein profile; the shaded area is the reactivity to 
anti-RII antibody. The ordinate axes are integrated density values of the proteins on the left-hand axis, and 
the integrated density values for RII and the reactivity of RII fragment (Rfr) on the right-hand axis. (B) PG 
α-amylase Western blotting. The ordinate shows integrated density, and the error bars show ±5% error. C1, 
vivarium control; C2, habitat control; F, flight. The values on the ordinate axis (ID) are integrated density in 
arbitrary units (with permission, from [13]).
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2.3 Gene expression
Microarray analyses of the PG showed significant changes in the expression of 
numerous genes of flight mice compared to habitat ground control mice. In female 
mice flown on STS-135, the expression of 130 genes was significantly upregulated 
(log2 ratio ≥ 1), and 75 genes were downregulated (log2 ratio ≤ − 1), (Figure 10). In 
male mice flown on Bion-M1, the expression of 70 genes was upregulated, and 65 
genes were downregulated.
Figure 9. 
Electrophoresis and Western blotting of flight (F) and control (C) PG extracts from mice of the Bion-M1 
mission. (A) Protein banding patterns of the flight and control animals (F and C). The left lane (M) shows 
the relative mobilities of marker proteins of kilodalton (kD) size from 110 to 15 marked on the ordinate. 
Western blotting for RII is shown in the two right most lanes with two major bands, the first at an estimated 50 
kDa size (RII), the second deemed to be a fragment between 14 and 20 kDa (Rfr). (B) densitometric profile of 
the control banding pattern which was not distinguishable from that of the flight (with permission, from [13]).
Figure 10. 
Microarray analysis of secretory protein gene expression in PG of mice flown on STS-135 and the Bion-M1 
biosatellite. Results are expressed as log2 of the ratio of expression in flight mice to that in habitat control mice. 
Amy1, α-amylase; Bpifa2, PSP, Prpmp5, PRP; Prkar2a, RII.
Beyond LEO - Human Health Issues for Deep Space Exploration
62
mice. Measuring RII, therefore, may be a sensitive test for stress reactions during 
spaceflight.
The variability may be due to the sensitivity of responses affecting RII synthesis. 
Previous studies point to a rapid and transient increase in the cases of brief acute 
stress, for example lift off of a spacecraft, followed by long-term, perhaps low level, 
prolonged time under stress, decrease. For example, a 60-day to a year tour result-
ing in a decrease of RII and leveling off at concentrations below normal. Eventual 
physiologic adjustment to flight conditions may start to bring RII production 
toward normal. An apparent increase also may result from a rough landing that 
might have occurred in the Bion-M1 flight and the acute response obliterating any 
reduction due to chronic long-term flight conditions.
Tissue extract samples showed a large faster moving component, presumably an 
RII fragment. The fragments did resemble the densitometric changes in the flight 
versus the control. These differences did not completely account for the change of 
flight values compared to the control. There may have been smaller fragments not 
visible on the Western blot that could account for the decreases in flight RII.
Figure 8. 
Densitometric analysis of PAGE protein separation and anti-RII and anti-α-amylase reactivity in STS-135 
mice. (A) PG protein samples from mice housed in, top panel, flight; middle panel, habitat; and bottom 
panel, vivarium type cages. The lighter curve represents the protein profile; the shaded area is the reactivity to 
anti-RII antibody. The ordinate axes are integrated density values of the proteins on the left-hand axis, and 
the integrated density values for RII and the reactivity of RII fragment (Rfr) on the right-hand axis. (B) PG 
α-amylase Western blotting. The ordinate shows integrated density, and the error bars show ±5% error. C1, 
vivarium control; C2, habitat control; F, flight. The values on the ordinate axis (ID) are integrated density in 
arbitrary units (with permission, from [13]).
63
Oral Tissue Responses to Travel in Space
DOI: http://dx.doi.org/10.5772/intechopen.86728
2.3 Gene expression
Microarray analyses of the PG showed significant changes in the expression of 
numerous genes of flight mice compared to habitat ground control mice. In female 
mice flown on STS-135, the expression of 130 genes was significantly upregulated 
(log2 ratio ≥ 1), and 75 genes were downregulated (log2 ratio ≤ − 1), (Figure 10). In 
male mice flown on Bion-M1, the expression of 70 genes was upregulated, and 65 
genes were downregulated.
Figure 9. 
Electrophoresis and Western blotting of flight (F) and control (C) PG extracts from mice of the Bion-M1 
mission. (A) Protein banding patterns of the flight and control animals (F and C). The left lane (M) shows 
the relative mobilities of marker proteins of kilodalton (kD) size from 110 to 15 marked on the ordinate. 
Western blotting for RII is shown in the two right most lanes with two major bands, the first at an estimated 50 
kDa size (RII), the second deemed to be a fragment between 14 and 20 kDa (Rfr). (B) densitometric profile of 
the control banding pattern which was not distinguishable from that of the flight (with permission, from [13]).
Figure 10. 
Microarray analysis of secretory protein gene expression in PG of mice flown on STS-135 and the Bion-M1 
biosatellite. Results are expressed as log2 of the ratio of expression in flight mice to that in habitat control mice. 
Amy1, α-amylase; Bpifa2, PSP, Prpmp5, PRP; Prkar2a, RII.
Beyond LEO - Human Health Issues for Deep Space Exploration
64
Interestingly, significant changes in gene expression occurred in the PG of habitat 
ground control mice compared to vivarium housed mice. In ground control female mice 
housed in the NASA Animal Enclosure Modules, the expression of 50 genes was signifi-
cantly upregulated, and 33 genes were downregulated. For example, Western blotting 
of PG of STS-135 habitat control mice showed a decrease in the expression of α-amylase 
(Figure 8B). In ground control male mice housed in the Bion-M1 habitats, the expres-
sion of 42 genes was significantly upregulated, and 169 genes were downregulated. 
These results indicate that the effects of the habitats must be considered when assessing 
the overall effects of spaceflight on animal (as well as human) physiology.
Changes in the expression of secretory protein genes (Figure 10), for example, 
PKA-RII, largely paralleled the changes seen in protein expression as determined by 
immunogold labeling and Western blotting (e.g., PKA-RII expression in PG from 
STS-135 flight mice, Figure 8B).
There have been a few previous studies of salivary glands of rodents following space-
flight, and saliva collected from astronauts and cosmonauts before and after spaceflight. 
No changes in PG morphology were seen by light microscopy in mice flown for 12.5 days 
on Apollo 17 [37]. The SMG of rats flown for 18.5 days on Cosmos 936 and Cosmos 
1129 showed a reduced glycoprotein content as determined by light microscopic 
histochemical staining [38, 39]. The saliva of 18 astronauts making up the primary and 
backup crews for Skylab missions of 28-, 59- and 84-days was analyzed preflight and 
postflight for flow rate, electrolytes, protein, immunoglobulin A (IgA) and lysozyme 
[40]. Changes were minimal except for an increase in IgA and a decrease in lysozyme 
concentrations. α-Amylase in cosmonaut saliva was decreased following an 18-day 
flight (uncited statement in [41]). The use of saliva for monitoring drug absorption 
was proposed, and saliva levels of acetaminophen were determined in 1 astronaut [42]. 
Analyses of saliva of cosmonauts during long-term spaceflight showed levels of cortisol 
below baseline [43], whereas salivary cortisol biorhythms and concentrations were pre-
served in astronauts onboard Spacelab [44] and cosmonauts on the International Space 
Station (ISS) [45]. Transient increases in saliva urea and phosphate concentrations, 
monitored in 2 astronauts during 6 months on the ISS, were consistent with serum 
concentrations reported in earlier studies [46]. Although studied in astronaut plasma, 
not saliva, in the NASA Twin Study, EGF and NGF levels were altered during a 340-day 
flight and after landing [47]. Our studies and those cited above indicate the feasibility of 
using saliva to monitor astronaut physiology and health.
3. Effects of spaceflight on the mandible
3.1 MicroCT analyses
MicroCT was used to assess mandibular bone volume (BV) and bone mineral 
density (BMD) in mice from the STS-135 and Bion-M1 flights [48].
In the STS-135 mission no differences in BV or BMD were seen between the 
flight and habitat ground control mice. However, when compared to vivarium 
control mice, BV was greater in both flight mice and habitat ground control mice. 
Similarly, BMD was greater in both the flight and habitat control mice than the 
vivarium control mice, although only the habitat control values were statistically 
significant. The increased BV and BMD seen in the flight and habitat control mice 
may be due to the difference in composition and consistency of the NASA food 
bars [18] these mice consumed compared to the standard rodent chow eaten by the 
vivarium control mice. The food bars have about 20% less caloric value per gram 
than chow, requiring greater consumption and more masticatory effort for compa-
rable nutrition.
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In contrast, mandibular BV decreased in both flight and habitat control mice 
compared to vivarium control mice from the Bion-M1 mission [48]. No differences 
occurred in BMD among these three groups, however.
These changes in flight and habitat control mice are likely due to the difference 
in diet between these two groups and the vivarium mice [49, 50]. The soft paste diet 
consumed by the Bion-M1 flight and habitat control mice required considerably less 
masticatory force than chow. Previous studies have shown that reduced mechanical 
loading results in decreased growth of the mandible [51, 52]. The different age and 
sex (9 week old females vs. 15–16 week old males, respectively) of the STS-135 and 
Bion-M1 mice also may have contributed to the different results for BV and BMD. The 
STS-135 mice were skeletally immature [53, 54], and female mice are physically more 
active than males [55] and have a different pattern of chewing and biting activity [56].
Earlier studies examined the effects of spaceflight and simulated weightlessness 
on mandibular bone. Periosteal osteogenesis was reduced in areas of the mandible 
not covered by muscle (molar region) in rats flown for 18.5 days on Cosmos 1129 
[57]. Formation of alveolar bone was reduced on the modeling (mesial or anterior) 
side of the first molar, indicating a slowing of the normal distal (posterior) drift of 
rodent molars. There also was a decrease in alveolar bone mineral and collagen in 
fractions representing the most mature components, with a corresponding increase 
in the most immature fractions, suggesting a delay in maturation. The mandibles 
of rats flown for 12 days on Cosmos 1887 had relatively high Ca and Mg levels but 
otherwise a normal composition, although their hydroxyapatite crystals were 
smaller in size [58].
Studies of rodents subjected to hindlimb unloading (HU) for up to 4 weeks have 
been used as model of exposure to microgravity [5, 59, 60]. Although the effects on 
the spine and hindlimbs show similarities to changes seen in animals after space-
flight, effects on the mandible do not mimic those occurring after actual spaceflight. 
Ten to 14 days of HU did not alter maturation of mandibular bone matrix and 
mineral as seen in rats flown on Cosmos 1129 [61]. Similarly, 15 days of HU did not 
alter the total weight, ash weight, Ca content or Ca uptake of the mandible [62]. No 
significant effects on the mandible were seen after 28 days of HU [63]. An earlier 
study, however, found an increase in the dry and ash weights of the mandible after 
3 weeks of HU [64]. In HU, the mandible still closes against gravity [60], thus space-
flight induced changes in the mandible are most likely a result of hypogravity [61].
Ghosh et al. [8] studied mandibles from mice flown on STS-131 and STS-135 
(from the opposite side of the same STS-135 mice we studied [48]). They also 
found no difference in BV between the flight and habitat ground control mice from 
the 13-day STS-135 mission. However, mandibular BV was decreased in flight mice 
from the 15-day STS-131 mission. It is unlikely that the 2-day difference in flight 
length would result in a significant difference in BV. As noted by Ghosh et al., it is 
more likely that other factors are involved, such as the age difference and resulting 
skeletal maturation of the mice on the two flights (23 weeks vs. 9 weeks for STS-
131 and STS-135, respectively), slight differences in food consumption, and/or the 
relatively low statistical power due to the small number of animals. They found no 
difference in BMD between the flight and habitat ground control mice from the 
STS-131 mission, but similar to our results, BMD was increased in the flight mice 
from the STS-135 mission. The factors mentioned above also could contribute to 
the differences in BMD seen between the mice on the two shuttle flights. The dif-
ference in BV between the Ghosh et al. study and our results for the STS-135 mice 
may be due to the different methods used to assess BV. Ghosh et al. measured BV in 
a single section (6 μm) from each mandible. In our study the results from 10 serial 
sections (120 μm span) per mandible were averaged, providing a more representa-
tive measurement.
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Interestingly, significant changes in gene expression occurred in the PG of habitat 
ground control mice compared to vivarium housed mice. In ground control female mice 
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cantly upregulated, and 33 genes were downregulated. For example, Western blotting 
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sion of 42 genes was significantly upregulated, and 169 genes were downregulated. 
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Station (ISS) [45]. Transient increases in saliva urea and phosphate concentrations, 
monitored in 2 astronauts during 6 months on the ISS, were consistent with serum 
concentrations reported in earlier studies [46]. Although studied in astronaut plasma, 
not saliva, in the NASA Twin Study, EGF and NGF levels were altered during a 340-day 
flight and after landing [47]. Our studies and those cited above indicate the feasibility of 
using saliva to monitor astronaut physiology and health.
3. Effects of spaceflight on the mandible
3.1 MicroCT analyses
MicroCT was used to assess mandibular bone volume (BV) and bone mineral 
density (BMD) in mice from the STS-135 and Bion-M1 flights [48].
In the STS-135 mission no differences in BV or BMD were seen between the 
flight and habitat ground control mice. However, when compared to vivarium 
control mice, BV was greater in both flight mice and habitat ground control mice. 
Similarly, BMD was greater in both the flight and habitat control mice than the 
vivarium control mice, although only the habitat control values were statistically 
significant. The increased BV and BMD seen in the flight and habitat control mice 
may be due to the difference in composition and consistency of the NASA food 
bars [18] these mice consumed compared to the standard rodent chow eaten by the 
vivarium control mice. The food bars have about 20% less caloric value per gram 
than chow, requiring greater consumption and more masticatory effort for compa-
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consumed by the Bion-M1 flight and habitat control mice required considerably less 
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the spine and hindlimbs show similarities to changes seen in animals after space-
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mineral as seen in rats flown on Cosmos 1129 [61]. Similarly, 15 days of HU did not 
alter the total weight, ash weight, Ca content or Ca uptake of the mandible [62]. No 
significant effects on the mandible were seen after 28 days of HU [63]. An earlier 
study, however, found an increase in the dry and ash weights of the mandible after 
3 weeks of HU [64]. In HU, the mandible still closes against gravity [60], thus space-
flight induced changes in the mandible are most likely a result of hypogravity [61].
Ghosh et al. [8] studied mandibles from mice flown on STS-131 and STS-135 
(from the opposite side of the same STS-135 mice we studied [48]). They also 
found no difference in BV between the flight and habitat ground control mice from 
the 13-day STS-135 mission. However, mandibular BV was decreased in flight mice 
from the 15-day STS-131 mission. It is unlikely that the 2-day difference in flight 
length would result in a significant difference in BV. As noted by Ghosh et al., it is 
more likely that other factors are involved, such as the age difference and resulting 
skeletal maturation of the mice on the two flights (23 weeks vs. 9 weeks for STS-
131 and STS-135, respectively), slight differences in food consumption, and/or the 
relatively low statistical power due to the small number of animals. They found no 
difference in BMD between the flight and habitat ground control mice from the 
STS-131 mission, but similar to our results, BMD was increased in the flight mice 
from the STS-135 mission. The factors mentioned above also could contribute to 
the differences in BMD seen between the mice on the two shuttle flights. The dif-
ference in BV between the Ghosh et al. study and our results for the STS-135 mice 
may be due to the different methods used to assess BV. Ghosh et al. measured BV in 
a single section (6 μm) from each mandible. In our study the results from 10 serial 
sections (120 μm span) per mandible were averaged, providing a more representa-
tive measurement.
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Figure 11. 
Immunohistochemistry of mandibular bone and incisor teeth. (A) Sagittal section of a hemimandible from 
a Bion-M1 habitat control mouse, immunostained for osteocalcin. Bone (B), incisor (I), molars (M1-3), pulp 
(P). Note staining of odontoblasts lining the pulp chamber. (B) Sclerostin staining of osteocytes (arrows) in 
interseptal bone of a Bion-M1 flight mouse. A few osteocytes are unstained (arrowheads). Cementocytes (CC) 
in the cementum covering a molar root also stain for sclerostin. Periodontal ligament (PDL). (C) Osteocalcin 
staining of osteoblasts (arrows) of a Bion-M1 vivarium control mouse. (D) Immunostaining of dentin 
sialoprotein in odontoblasts (O) of a STS-135 flight mouse. Odontoblast processes (arrows) in predentin (PD) 
and dentin (D) are stained. Predentin and dentin stain less intensely. (E) Amelogenin staining of secretory 
ameloblasts (A) of a STS-135 vivarium control mouse. Tomes’ processes of ameloblasts (arrows) are stained 
intensely. Enamel matrix (EM).
3.2 Bone protein expression
The expression of the bone proteins sclerostin and osteocalcin in the mandibles 
of mice from the STS-135 and Bion-M1 missions was studied by immunohistochem-
istry (IHC) [48] (Figure 11A–C). Sclerostin is secreted by osteocytes and other cells 
embedded in mineralized tissues; it inhibits osteoblast proliferation and differentia-
tion and induces osteoblast apoptosis [65, 66]. No differences in the intensity of 
sclerostin staining of osteocytes were observed between the flight mice and their 
respective controls in either mission. The percentage of reactive osteocytes, how-
ever, varied between the 2 missions and among the 3 groups and locations within 
the mandible. Overall, the percentage of reactive osteocytes was greater in the 
STS-135 mice than in the Bion-M1 mice, and greater in flight mice than in control 
mice. The alveolar bone anterior to the first molar and the interradicular bone of the 
first molar showed the greatest percentage of reactive osteocytes, whereas the septal 
bone between the first and second molars had the lowest percentage.
Sclerostin synthesis is increased by mechanical unloading (i.e., rodent HU, 
human bed rest) [67, 68]. However, the percentage of sclerostin-positive osteocytes 
was unaltered in male mouse tibiae after 3 or 7 days of HU [67]. Sclerostin-positive 
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osteocytes increased in male rat femurs after 28 days of HU [69], and partial weight 
bearing (1/6G) for 21 days also increased their percentage in female mouse femurs 
[70]. No significant changes in serum sclerostin levels of astronauts and cosmonauts 
were observed after 4–6 months on the ISS [71, 72]. In the NASA Twins Study, a 
trend toward increased serum sclerostin levels was seen throughout the 340-day 
stay on the ISS [47].
Spaceflight also resulted in increases in the size of osteocyte lacunae, expres-
sion of matrix metalloproteinase (MMP) activity, and the percentage of osteocytes 
expressing tartrate-resistant acid phosphatase (TRAP) in pelvic bones of STS-131 
flight mice, indicating osteocytic osteolysis [73]. Empty lacunae indicating osteo-
cyte death doubled in number in the femoral cortex of Bion-M1 flight mice com-
pared to vivarium and habitat control mice [74].
Osteocalcin is a non-collagenous bone matrix protein produced by osteoblasts 
(and odontoblasts). It binds calcium and has long been thought to regulate 
mineralization [75, 76]. More recently osteocalcin has been recognized as a major 
bone hormone that participates in the regulation of energy metabolism, brain 
development and cognition, and male fertility [77, 78]. No differences were 
observed in the IHC staining intensity of osteoblasts, bone matrix or osteoid 
between the flight mice and their respective controls from the STS-135 and 
Bion-M1 missions [48].
Osteocalcin synthesis in rat long bones and vertebrae decreased after short-term 
spaceflight (4–14 days) [79–82]. Serum and urinary osteocalcin levels increased 
in cosmonauts during 1 month and 6 months spaceflight [83–85]. A trend toward 
increased serum osteocalcin levels was seen in astronauts and cosmonauts after 
4-6 months on the ISS [72], and during a 340-day flight on the ISS [47]. These find-
ings are consistent with decreased bone formation and increased bone resorption. 
The lack of apparent change in osteocalcin staining in the mandible, along with the 
lack of or small changes in bone volume, suggests that the continued mastication of 
food prevents significant bone resorption.
Osteocalcin gene and protein expression also have been studied in cultured 
osteoblasts or osteoblast-like cells flown in space. Production of osteocalcin message 
after 9 days of microgravity by human osteosarcoma cells stimulated with vitamin 
D3 and transforming growth factor beta was only 19% of that of similarly treated 
cells at unit gravity [86]. The steady-state levels of osteocalcin mRNA in human 
fetal osteoblast cells after 17 days of microgravity did not differ from controls [87]. 
Osteocalcin protein expression was slightly but significantly increased in cultured 
human osteoblasts flown for 11 days [88]. The different results for osteocalcin 
expression may be due to the different cell types, different culture conditions, and 
different flight lengths.
The percentage of alveolar bone surface occupied by TRAP-positive osteoclasts 
(Oc.S./B.S. %) was increased in the mandibles of Bion-M1 flight and habitat control 
mice [48], indicating increased bone resorption. This correlates with the decreased 
BV observed in these mice compared to vivarium controls. Osteoclasts were present 
mainly along the mesial (anterior) surfaces of the alveolar bone, consistent with the 
normal physiological distal (posterior) drift of rodent molars. No differences were 
seen among the STS-135 mice groups, although the overall Oc.S./B.S. % was greater 
in these mice than in the Bion-M1 mice. This likely was due to the younger age of the 
STS-135 mice, as well as the increased proportion of sclerostin-positive osteocytes in 
these mice, as sclerostin promotes increased osteoclast formation and size [66]. In rats 
flown for 18.5 days on Cosmos 1129, there was a slight but non-significant decrease in 
alveolar bone resorption immediately after flight [57]. However, after 6 and 29 days 
of post-flight recovery, a significant decrease in bone formation and resorption was 
observed, indicating a slowing of the normal distal drift of the molars.
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Figure 11. 
Immunohistochemistry of mandibular bone and incisor teeth. (A) Sagittal section of a hemimandible from 
a Bion-M1 habitat control mouse, immunostained for osteocalcin. Bone (B), incisor (I), molars (M1-3), pulp 
(P). Note staining of odontoblasts lining the pulp chamber. (B) Sclerostin staining of osteocytes (arrows) in 
interseptal bone of a Bion-M1 flight mouse. A few osteocytes are unstained (arrowheads). Cementocytes (CC) 
in the cementum covering a molar root also stain for sclerostin. Periodontal ligament (PDL). (C) Osteocalcin 
staining of osteoblasts (arrows) of a Bion-M1 vivarium control mouse. (D) Immunostaining of dentin 
sialoprotein in odontoblasts (O) of a STS-135 flight mouse. Odontoblast processes (arrows) in predentin (PD) 
and dentin (D) are stained. Predentin and dentin stain less intensely. (E) Amelogenin staining of secretory 
ameloblasts (A) of a STS-135 vivarium control mouse. Tomes’ processes of ameloblasts (arrows) are stained 
intensely. Enamel matrix (EM).
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embedded in mineralized tissues; it inhibits osteoblast proliferation and differentia-
tion and induces osteoblast apoptosis [65, 66]. No differences in the intensity of 
sclerostin staining of osteocytes were observed between the flight mice and their 
respective controls in either mission. The percentage of reactive osteocytes, how-
ever, varied between the 2 missions and among the 3 groups and locations within 
the mandible. Overall, the percentage of reactive osteocytes was greater in the 
STS-135 mice than in the Bion-M1 mice, and greater in flight mice than in control 
mice. The alveolar bone anterior to the first molar and the interradicular bone of the 
first molar showed the greatest percentage of reactive osteocytes, whereas the septal 
bone between the first and second molars had the lowest percentage.
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osteocytes increased in male rat femurs after 28 days of HU [69], and partial weight 
bearing (1/6G) for 21 days also increased their percentage in female mouse femurs 
[70]. No significant changes in serum sclerostin levels of astronauts and cosmonauts 
were observed after 4–6 months on the ISS [71, 72]. In the NASA Twins Study, a 
trend toward increased serum sclerostin levels was seen throughout the 340-day 
stay on the ISS [47].
Spaceflight also resulted in increases in the size of osteocyte lacunae, expres-
sion of matrix metalloproteinase (MMP) activity, and the percentage of osteocytes 
expressing tartrate-resistant acid phosphatase (TRAP) in pelvic bones of STS-131 
flight mice, indicating osteocytic osteolysis [73]. Empty lacunae indicating osteo-
cyte death doubled in number in the femoral cortex of Bion-M1 flight mice com-
pared to vivarium and habitat control mice [74].
Osteocalcin is a non-collagenous bone matrix protein produced by osteoblasts 
(and odontoblasts). It binds calcium and has long been thought to regulate 
mineralization [75, 76]. More recently osteocalcin has been recognized as a major 
bone hormone that participates in the regulation of energy metabolism, brain 
development and cognition, and male fertility [77, 78]. No differences were 
observed in the IHC staining intensity of osteoblasts, bone matrix or osteoid 
between the flight mice and their respective controls from the STS-135 and 
Bion-M1 missions [48].
Osteocalcin synthesis in rat long bones and vertebrae decreased after short-term 
spaceflight (4–14 days) [79–82]. Serum and urinary osteocalcin levels increased 
in cosmonauts during 1 month and 6 months spaceflight [83–85]. A trend toward 
increased serum osteocalcin levels was seen in astronauts and cosmonauts after 
4-6 months on the ISS [72], and during a 340-day flight on the ISS [47]. These find-
ings are consistent with decreased bone formation and increased bone resorption. 
The lack of apparent change in osteocalcin staining in the mandible, along with the 
lack of or small changes in bone volume, suggests that the continued mastication of 
food prevents significant bone resorption.
Osteocalcin gene and protein expression also have been studied in cultured 
osteoblasts or osteoblast-like cells flown in space. Production of osteocalcin message 
after 9 days of microgravity by human osteosarcoma cells stimulated with vitamin 
D3 and transforming growth factor beta was only 19% of that of similarly treated 
cells at unit gravity [86]. The steady-state levels of osteocalcin mRNA in human 
fetal osteoblast cells after 17 days of microgravity did not differ from controls [87]. 
Osteocalcin protein expression was slightly but significantly increased in cultured 
human osteoblasts flown for 11 days [88]. The different results for osteocalcin 
expression may be due to the different cell types, different culture conditions, and 
different flight lengths.
The percentage of alveolar bone surface occupied by TRAP-positive osteoclasts 
(Oc.S./B.S. %) was increased in the mandibles of Bion-M1 flight and habitat control 
mice [48], indicating increased bone resorption. This correlates with the decreased 
BV observed in these mice compared to vivarium controls. Osteoclasts were present 
mainly along the mesial (anterior) surfaces of the alveolar bone, consistent with the 
normal physiological distal (posterior) drift of rodent molars. No differences were 
seen among the STS-135 mice groups, although the overall Oc.S./B.S. % was greater 
in these mice than in the Bion-M1 mice. This likely was due to the younger age of the 
STS-135 mice, as well as the increased proportion of sclerostin-positive osteocytes in 
these mice, as sclerostin promotes increased osteoclast formation and size [66]. In rats 
flown for 18.5 days on Cosmos 1129, there was a slight but non-significant decrease in 
alveolar bone resorption immediately after flight [57]. However, after 6 and 29 days 
of post-flight recovery, a significant decrease in bone formation and resorption was 
observed, indicating a slowing of the normal distal drift of the molars.
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4. Effects of spaceflight on teeth
4.1 Incisor growth and development
The rodent mandible (and maxilla) contains, on each side, 1 incisor separated 
by a toothless region (diastema) from 3 molars (Figure 11A). The molars develop 
and erupt in a process similar to those of humans. The incisor, however, forms and 
erupts continuously, allowing the mandibular and maxillary incisors to maintain 
contact as the covering enamel and supporting dentin are worn away as the animal 
eats. The cells that form enamel, ameloblasts, originate from oral ectoderm; their 
stem cells are located in the cervical loop of the incisor, embedded within the bone 
of the mandible at the apical (posterior) end of the tooth. Ameloblasts initially 
deposit a partially mineralized matrix based mainly on the protein amelogenin. 
When the final thickness of the matrix is achieved, the ameloblasts undergo a 
morphologic and functional differentiation and begin to remove the matrix and add 
Ca and PO4 until the enamel is fully mineralized. The cells that form dentin, odon-
toblasts, are derived from craniofacial ectomesenchyme. Throughout the life of the 
tooth, odontoblasts continually form and mineralize dentin, which has a collagen-
based extracellular matrix. Odontoblasts also synthesize several non-collagenous 
proteins, including dentin sialoprotein (DSP), dentin phosphoprotein, osteocalcin, 
bone sialoprotein, osteopontin and dentin matrix protein-1 [89].
4.2 MicroCT analyses
Incisor teeth of flight and habitat ground control mice from the Bion-M1 mission 
had significantly greater enamel, dentin and overall volumes than the vivarium 
control mice (Figure 12). Enamel thickness in MicroCT sections at the 1st molar 
level was similar in all three mouse groups. In the flight and habitat control mice, 
however, the enamel had reached its full thickness at the 3rd molar level, and the 
thickness was greater in these 2 groups than in the vivarium control mice at both 
the 2nd and 3rd molar levels. Dentin thickness at all 3 molar levels in the flight 
and habitat control mice, as well as tissue density (mg hydroxyapatite/cm3), was 
greater than that of the vivarium control mice. Additionally, as visualized in 3D 
reconstruction images, incisor mineralization in the flight and habitat control mice 
began further posteriorly than in vivarium control mice (Figure 12G–H). These 
observations are consistent with a decreased incisor eruption rate in the flight and 
habitat control mice, most likely due to the soft paste diet consumed by these two 
groups [90–92]. In the STS-135 mice, there was a trend toward an increased incisor 
volume in the flight mice compared to the vivarium control mice, but no differences 
in enamel and dentin volumes, thicknesses or tissue densities.
Previous studies of spaceflight effects on tooth development have produced dif-
fering/conflicting results. In some investigations there were no differences between 
flight and control animals in Ca and P content of incisor dentin [58, 93, 94]. In other 
studies Ca and P concentrations were increased [57, 95, 96], or decreased [97]. 
These varying results are likely due to differences in age and sex of the animals, 
diet, length of the flight, the region of the tooth examined, as well as the methods 
used in these investigations.
4.3 Tooth protein expression
The expression of osteocalcin, DSP, amelogenin and PKA-RII was evaluated by 
IHC in the tissues and cells of the teeth [48]. Odontoblasts and some cementocytes 
of molar roots expressed strong reactivity for osteocalcin (Figure 11A); weaker 
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reactivity was seen in predentin and dentin. Semiquantitative analysis revealed 
no differences in staining intensities among any of the flight and control groups. 
Immunostaining for DSP was strong in odontoblasts (Figure 11D) and some 
cementocytes; weaker reactivity was observed in predentin, dentin, molar cemen-
tum, enamel matrix, osteoblasts and bone. Significant differences in DSP staining 
intensities were observed among the Bion-M1 mouse groups. Predentin and cel-
lular cementum (and bone) stained more intensely in flight mice than in vivarium 
controls. Secretory ameloblasts (Figure 11E) and enamel matrix (especially during 
enamel maturation) stained positively for amelogenin. Reactivity was significantly 
decreased in enamel matrix of Bion-M1 habitat control mice. Both odontoblasts and 
ameloblasts were immunoreactive for PKA-RII. Staining intensity was decreased 
in odontoblasts of Bion-M1 flight and habitat control mice compared to vivarium 
controls, and decreased in secretory ameloblasts of STS-135 flight and habitat con-
trol mice. In addition to effects due to microgravity, the observation of decreased 
amelogenin and PKA-RII reactivities in the habitat control mice suggest that the 
habitat environment may play a role in cellular and tissue responses.
5. Effects of spaceflight on other oral tissues
There are few reported studies of the effects of spaceflight on oral tissues other 
than bone and teeth. Histologic examination of periodontal tissues and oral mucosa 
Figure 12. 
MicroCT images of mandibles of flight (A, C, E, and G) and vivarium control (B, D, F, and H) mice from 
the Bion-M1 mission. Sections at the level of the 1st (A and B), 2nd (C and D) and 3rd (E and F) molars. 
Incisor dentin (D) and enamel (E), molar (M), pulp chamber (P). Note the earlier appearance of mineralized 
enamel (images E vs. F), thicker dentin and smaller central pulp chambers in the incisors of the flight mice. 
Three-dimensional reconstructions of the mandibles (G and H) show that incisor mineralization begins 
(arrows) further posterior in flight mice than in vivarium control mice. Habitat ground control mice showed 
the same features as flight mice. Scale bars = 1 mm.
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4. Effects of spaceflight on teeth
4.1 Incisor growth and development
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by a toothless region (diastema) from 3 molars (Figure 11A). The molars develop 
and erupt in a process similar to those of humans. The incisor, however, forms and 
erupts continuously, allowing the mandibular and maxillary incisors to maintain 
contact as the covering enamel and supporting dentin are worn away as the animal 
eats. The cells that form enamel, ameloblasts, originate from oral ectoderm; their 
stem cells are located in the cervical loop of the incisor, embedded within the bone 
of the mandible at the apical (posterior) end of the tooth. Ameloblasts initially 
deposit a partially mineralized matrix based mainly on the protein amelogenin. 
When the final thickness of the matrix is achieved, the ameloblasts undergo a 
morphologic and functional differentiation and begin to remove the matrix and add 
Ca and PO4 until the enamel is fully mineralized. The cells that form dentin, odon-
toblasts, are derived from craniofacial ectomesenchyme. Throughout the life of the 
tooth, odontoblasts continually form and mineralize dentin, which has a collagen-
based extracellular matrix. Odontoblasts also synthesize several non-collagenous 
proteins, including dentin sialoprotein (DSP), dentin phosphoprotein, osteocalcin, 
bone sialoprotein, osteopontin and dentin matrix protein-1 [89].
4.2 MicroCT analyses
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had significantly greater enamel, dentin and overall volumes than the vivarium 
control mice (Figure 12). Enamel thickness in MicroCT sections at the 1st molar 
level was similar in all three mouse groups. In the flight and habitat control mice, 
however, the enamel had reached its full thickness at the 3rd molar level, and the 
thickness was greater in these 2 groups than in the vivarium control mice at both 
the 2nd and 3rd molar levels. Dentin thickness at all 3 molar levels in the flight 
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groups [90–92]. In the STS-135 mice, there was a trend toward an increased incisor 
volume in the flight mice compared to the vivarium control mice, but no differences 
in enamel and dentin volumes, thicknesses or tissue densities.
Previous studies of spaceflight effects on tooth development have produced dif-
fering/conflicting results. In some investigations there were no differences between 
flight and control animals in Ca and P content of incisor dentin [58, 93, 94]. In other 
studies Ca and P concentrations were increased [57, 95, 96], or decreased [97]. 
These varying results are likely due to differences in age and sex of the animals, 
diet, length of the flight, the region of the tooth examined, as well as the methods 
used in these investigations.
4.3 Tooth protein expression
The expression of osteocalcin, DSP, amelogenin and PKA-RII was evaluated by 
IHC in the tissues and cells of the teeth [48]. Odontoblasts and some cementocytes 
of molar roots expressed strong reactivity for osteocalcin (Figure 11A); weaker 
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no differences in staining intensities among any of the flight and control groups. 
Immunostaining for DSP was strong in odontoblasts (Figure 11D) and some 
cementocytes; weaker reactivity was observed in predentin, dentin, molar cemen-
tum, enamel matrix, osteoblasts and bone. Significant differences in DSP staining 
intensities were observed among the Bion-M1 mouse groups. Predentin and cel-
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ameloblasts were immunoreactive for PKA-RII. Staining intensity was decreased 
in odontoblasts of Bion-M1 flight and habitat control mice compared to vivarium 
controls, and decreased in secretory ameloblasts of STS-135 flight and habitat con-
trol mice. In addition to effects due to microgravity, the observation of decreased 
amelogenin and PKA-RII reactivities in the habitat control mice suggest that the 
habitat environment may play a role in cellular and tissue responses.
5. Effects of spaceflight on other oral tissues
There are few reported studies of the effects of spaceflight on oral tissues other 
than bone and teeth. Histologic examination of periodontal tissues and oral mucosa 
Figure 12. 
MicroCT images of mandibles of flight (A, C, E, and G) and vivarium control (B, D, F, and H) mice from 
the Bion-M1 mission. Sections at the level of the 1st (A and B), 2nd (C and D) and 3rd (E and F) molars. 
Incisor dentin (D) and enamel (E), molar (M), pulp chamber (P). Note the earlier appearance of mineralized 
enamel (images E vs. F), thicker dentin and smaller central pulp chambers in the incisors of the flight mice. 
Three-dimensional reconstructions of the mandibles (G and H) show that incisor mineralization begins 
(arrows) further posterior in flight mice than in vivarium control mice. Habitat ground control mice showed 
the same features as flight mice. Scale bars = 1 mm.
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revealed no differences between mice flown on Apollo 17 for 12.5 days and ground 
control mice [37]. Histologic studies of the lingual mucosa of rhesus monkeys after 
30 days of simulated weightlessness showed no differences from control monkeys 
[98]. The masseter muscles of mice flown for 13 days on STS-135 showed no change 
in mass, fiber size distribution, signaling pathways, or the expression of genes 
associated with muscle atrophy compared to ground control mice [99]. Power out-
put was decreased about 40% in the masseter muscles of flight mice, but maximal 
shortening velocity was not affected. In contrast, tibialis anterior muscles of these 
flight mice underwent atrophy, with loss of mass, changes in signaling pathways 
and gene expression, and loss of strength. In a separate experiment, mice fed a 
liquid diet for 2 weeks showed a decrease in masseter muscle fiber size of more than 
40%. These results suggest that the load imposed by chewing hard food protected 
the masseter muscles from the microgravity-induced atrophy occurring in appen-
dicular muscles, but was insufficient to preserve muscle power.
6. Conclusions
Oral tissues, particularly the salivary glands, mandible and teeth, are affected by 
spaceflight. The 3 major salivary glands respond differently to the effects of micro-
gravity and the spaceflight habitats. The PG exhibits a number of morphological 
changes that are also seen following restriction of food, feeding of a liquid diet, 
and experimental diabetes. The expression of some secretory proteins is increased, 
whereas others are decreased; for some proteins the length of microgravity expo-
sure may be important. A number of genes also exhibit increased or decreased 
expression. The response of the SMG to spaceflight appears to differ between males 
and females, with male glands exhibiting increases in expression of several secre-
tory proteins and female glands remaining unaltered. The SLGs of female mice 
flown on the space shuttles showed a few changes in secretory protein expression. 
Interestingly, the expression of the stress protein PKA-RII and its gene was altered 
in the shorter space shuttle flights, but not the longer Bion-M1 flight. This may 
indicate an adaptation to the spaceflight environment, or a relatively rapid return 
to baseline during the longer period between landing and sample collection for the 
Bion-M1 mice. The ease of saliva collection makes it a potential alternative to blood 
for monitoring physiological responses to spaceflight and the health of astronauts 
and cosmonauts. Recent studies have documented substantial differences in male 
and female salivary gland gene expression in both mice [100] and humans [101]; 
therefore, additional, more comprehensive studies of the effects of spaceflight on 
the saliva proteome are needed.
Not considered in our studies, but important for overall oral health, are the 
minor salivary glands. Although they produce less than 10% of total saliva volume, 
these glands secrete continuously, providing mucins and antimicrobial substances 
that lubricate, moisten and protect the oral tissues, especially during periods when 
the major glands are inactive, such as during sleep. Microgravity induced alterations 
in their secretions could have significant effects on the teeth and oral mucosa.
The effects of spaceflight on the mandible, observed in our studies, are consis-
tent with the observations reported by others for non-weight bearing skeletal ele-
ments. Changes in BV and bone architecture are minimal in the mandible compared 
to long bones of the lower extremity and vertebrae. The decrease in BV seen in the 
Bion-M1 flight and habitat control mice most likely was due to the soft paste diet 
consumed by these mice. Microgravity probably also has an effect, considering the 
increased proportion of sclerostin-positive osteocytes and number of osteoclasts 
in the mandible seen in the flight mice. Similarly, the significant changes observed 
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in incisor tooth volume and mineralization appear to be related to the soft diet and 
slowing of the eruption rate. Changes in tooth protein expression may be a com-
bined result of microgravity, diet and the habitat environment. The change from 
“normal” conditions, the confined space, and different diet, must also be consid-
ered, and adequately controlled for in experimental studies.
Many of the reported animal and human studies, including ours, would be 
improved with a larger number of subjects, increasing statistical power and 
strengthening observed trends. Nevertheless, many significant changes have been 
documented, and should be considered in planning future animal studies and 
especially long-term human spaceflight. The recent NASA Twins Study [47] empha-
sizes the need for comprehensive studies of long-term exposure to the spaceflight 
environment. Advances in spacecraft and experimental design will resolve current 
limitations and improve outcomes of future travel in space.
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Abstract
Space radiation is an unavoidable health risk during space activities. 
Hematopoietic cells are sensitive to radiation including proton and oxygen radiation 
and so on. Understanding the mechanisms responsible for detrimental effects of 
space radiation is important to achieve countermeasures protecting hematopoietic 
stem cells (HSCs), which generates different hematopoietic populations. However, 
the biological effects of various sources of space radiation on HSCs are not under-
stood well. Induction of cellular apoptosis, reactive oxygen species (ROS), and DNA 
damage upon space radiation is believed to be critical mediators for HSC damage. 
In this chapter, we will mainly discuss the biological effectiveness of proton and 
oxygen radiation on the numbers and function of HSCs. Space radiation-induced 
apoptosis, ROS, and DNA damage were examined as well, which will provide 
foundation to develop novel strategies protecting HSCs from space radiation.
Keywords: space irradiation, proton irradiation, oxygen irradiation, apoptosis, 
reactive oxygen species, hematopoietic stem cells, bone marrow
1. Introduction
Human spaceflight and exploration began in the 1960s. Manned spaceflight 
activities have continually expanded in frequency and scope since that time, 
and plans are now forming for long-duration flights to deep-space destinations. 
However, numerous risk factors have potential to negatively affect the astronauts’ 
health during deep-space missions, especially microgravity and space radiation. 
Exposure of astronauts to space radiation is relatively unpredictable yet inevitable. 
Space radiation comes from two major sources: solar particle events (SPE) emanat-
ing from the sun and galactic cosmic rays (GCR) originating from sources outside 
the solar system.
SPE mainly includes protons and can lead to moderate- to high-dose rate 
exposures to ionizing radiation during long-term space mission [1, 2]. Astronauts 
may receive cumulative doses from 1 to 3 gray (Gy) during an SPE [3, 4]. Especially, 
proton radiation contributes to more than 80% of SPE [1, 2, 5].
GCR contains high atomic number and energy (HZE) particles, such as 56Fe, 
28Si, 16O, 12C, and so forth. HZE particles are characterized by dense tracks of 
ionization, a property quantified as high-linear energy transfer (LET). The proper-
ties of HZE particles are consistent with their stronger toxicities and higher energy 
to normal tissues than photon and proton radiation [6, 7]. Previous studies have 
documented that the value of RBE in relation to γ-ray radiation was 1.25 for 56Fe, 1.4 
for 28Si, and 0.99 for 12C using a mouse model [6, 8]. Among HZE particles, 56Fe has 
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Human spaceflight and exploration began in the 1960s. Manned spaceflight 
activities have continually expanded in frequency and scope since that time, 
and plans are now forming for long-duration flights to deep-space destinations. 
However, numerous risk factors have potential to negatively affect the astronauts’ 
health during deep-space missions, especially microgravity and space radiation. 
Exposure of astronauts to space radiation is relatively unpredictable yet inevitable. 
Space radiation comes from two major sources: solar particle events (SPE) emanat-
ing from the sun and galactic cosmic rays (GCR) originating from sources outside 
the solar system.
SPE mainly includes protons and can lead to moderate- to high-dose rate 
exposures to ionizing radiation during long-term space mission [1, 2]. Astronauts 
may receive cumulative doses from 1 to 3 gray (Gy) during an SPE [3, 4]. Especially, 
proton radiation contributes to more than 80% of SPE [1, 2, 5].
GCR contains high atomic number and energy (HZE) particles, such as 56Fe, 
28Si, 16O, 12C, and so forth. HZE particles are characterized by dense tracks of 
ionization, a property quantified as high-linear energy transfer (LET). The proper-
ties of HZE particles are consistent with their stronger toxicities and higher energy 
to normal tissues than photon and proton radiation [6, 7]. Previous studies have 
documented that the value of RBE in relation to γ-ray radiation was 1.25 for 56Fe, 1.4 
for 28Si, and 0.99 for 12C using a mouse model [6, 8]. Among HZE particles, 56Fe has 
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high-linear energy transfer that might heavily contribute to GCR in space [9]. There 
are many different components including ions, hydrogen, helium, and so on in 
spacecraft [10]. Based on measurements in the Mars Science Laboratory from 2011 
to 2012, the irradiation dose of GCR in the spaceflight was approximately 481 ± 80 
μGy per day [11]. For a 600- to 900-day Mars mission, the total radiation doses 
from GCR reside between 0.33 and 0.49 Gy. Therefore, the total radiation dose from 
SPE and GCR will reach to 1.0 Gy or above. Although doses and dose rates of space 
radiation are low, it will still result in space dose accumulation in the body and high 
risk to astronauts’ health during a long-term space mission [9, 12].
Radiation-induced tissue damage in the body has long been understood since 
Wilhelm Röntgen discovered X-ray in 1895 [13]. Hematopoietic and gastrointestinal 
systems have been shown to be the two most sensitive compartments of the body to 
radiation. It has been well-documented that radiation (including space radiation) 
also induces dysfunction of the brain, manifesting as behavioral and cognitive dis-
abilities [14, 15]. The detrimental effects of X-ray radiation in the body were firstly 
reported by Warren and Whipple [16] and Shouse et al. [13]. They reported that 
exposing dogs to high doses of X-rays resulted in death from severe hematopoietic 
suppression and damage. The detrimental effects of radiation on human health 
were heavily realized after the use of the first atomic bombs in 1945. Many people 
in Hiroshima and Nagasaki who survived the initial bomb blast later died from 
radiation exposure in the event. Long-term toxic impacts of the atomic bomb on 
humans were observed as well, such as the high risk of hematopoietic malignancies. 
Further studies proved that hematopoietic failure was one of the primary reasons 
in radiation-induced death when animals experienced a moderate to high dose 
of total-body irradiation. This is supported by a study in the 1940s showing that 
shielding the spleen or one entire hind leg with lead or transplantation of spleno-
cytes protected mice from the lethal effect of irradiation [17]. The importance of 
hematopoietic cells under radiation was also supported by studies showing that 
intravenous infusions of bone marrow (BM) cell suspensions protected mice from 
the effects of radiation [95]. Initially, investigators suggested that a humoral factor 
from the spleen and BM cell suspensions might benefit the radioprotective effects 
[18], while later studies proved that it was attributed to the transplanted hemato-
poietic cells [19–21]. When Till and McCulloch discovered hematopoietic stem cells 
(HSCs) in the 1960s, those cells protecting animals from IR-induced lethal hema-
topoietic damage were HSCs [22, 23]. Remarkable progress has been subsequently 
made in understanding of the mechanisms by which radiation causes hematopoietic 
damage.
However, the effects of space radiation on the hematopoietic system have yet to 
be fully understood, leading to a lack of effective countermeasure strategies thus 
far. In the present chapter, we mainly focus our discussion on the biological effec-
tiveness of space radiation, such as proton and oxygen, whereby space radiation 
induces HSC injury, and the implication of HSC injury to IR-induced BM suppres-
sion in mouse. In addition, genomic instability, malignancies, and intestinal, brain, 
behavioral, and cognitive effects induced by space radiation will not be discussed 
here, which were extensively discussed by other investigators [24, 25].
2. Composition of the mouse hematopoietic system
Hematopoietic stem cells often replenish the whole blood system throughout 
the life span of the body and maintain hematopoietic homeostasis. In Till and 
McCulloch’s landmark work [22, 23, 26], they utilized colony-forming unit-spleen 
(CFU-S) assay to identify functional HSCs even while these HSCs were a mixed 
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population with different proliferating and self-renewal abilities. This pioneering 
research not only provided strong evidence to show in vivo HSC existence but also 
stimulated many investigators to define and isolate HSCs and characterize their 
properties in mice and humans.
In the decades since Till and McCulloch’s study [22, 23, 26], multiple cell surface 
markers have been used to separate HSCs from other populations. For example, 
lineage cell surface markers, such as Ter119, CD4, CD8, B220, Gr-1, Mac-1, and 
NK1.1, are not detected neither in mouse multipotent progenitors (MPPs) nor in 
hematopoietic progenitor cells (HPCs). Both HSCs and MPPs express c-Kit and 
Scal-1, which are therefore named lineage negative (Lin-), c-Kit+, and Sca-1+ as 
LSK cells (Figure 1). HPCs express c-Kit, but not Sca-1, and are termed Lin−c-
Kit+Sca-1−. In 2005, Kiel et al. further utilized CD150 and CD48 surface markers to 
distinguish HSCs and MPPs [27]. HSCs express CD150, but not CD48, and termed 
CD150+CD48−LSK cells. MPPs are CD150+/−CD48+LSK cells. Investigators also 
used different strategies to identify HSCs. Combination of CD34 or ThyloFlk-2− 
with LSK surface markers was used to isolate HSCs, named as CD34−LSK and 
Thy1loFlk-2−LSK cells, respectively [26]. Trumpp’s group combined CD34, CD135, 
CD150, CD48, and LSK markers to further differentiate HSC into long-term 
HSCs (CD34−CD135−CD150+CD48−LSK cells) and short-term HSCs (CD34+ 
CD135−CD150+CD48−LSK cells). In addition, HSCs have a feature with highly 
expression of ATP-binding protein like ABCG2 and can efflux DNA-binding dye 
Hoechst 33342. The Hoechst-effluxing side population (SP) cells were therefore 
used to indicate HSC population in the case of some circumstances [28], such as 
5FU and radiotherapeutic stress conditions.
It is well-documented that the hematopoietic system is organized in a hierar-
chical manner (Figure 1). The rare long-term HSCs are located at the top of the 
hierarchy and have the capacity to self-renew, proliferate, and differentiate into 
various lineages of mature blood cells though immature MPPs and HPCs [29]. The 
most important feature of HSCs is quiescent to maintain their self-renewal ability 
Figure 1. 
Composition of mouse hematopoietic system. Long-term hematopoietic stem cell (LT-HSCs, 
CD34−CD135−CD150+CD48−LSK cells) is located at the top of the hierarchy and has the ability to self-renew, 
proliferate, and differentiate into short-term HSCs (ST-HSC, CD34+CD135−CD150+CD48−LSK cells) and 
multipotent progenitors (MPPs, CD34+CD135+CD150+/−CD48+LSK cells), which can further differentiate into 
different progenitors, such as common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs) and 
their progeny megakaryocyte/erythroid progenitors (MEPs), and granulocyte/monocyte progenitors (GMPs). 
Progenitors can proliferate different lineages of mature blood cells.
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high-linear energy transfer that might heavily contribute to GCR in space [9]. There 
are many different components including ions, hydrogen, helium, and so on in 
spacecraft [10]. Based on measurements in the Mars Science Laboratory from 2011 
to 2012, the irradiation dose of GCR in the spaceflight was approximately 481 ± 80 
μGy per day [11]. For a 600- to 900-day Mars mission, the total radiation doses 
from GCR reside between 0.33 and 0.49 Gy. Therefore, the total radiation dose from 
SPE and GCR will reach to 1.0 Gy or above. Although doses and dose rates of space 
radiation are low, it will still result in space dose accumulation in the body and high 
risk to astronauts’ health during a long-term space mission [9, 12].
Radiation-induced tissue damage in the body has long been understood since 
Wilhelm Röntgen discovered X-ray in 1895 [13]. Hematopoietic and gastrointestinal 
systems have been shown to be the two most sensitive compartments of the body to 
radiation. It has been well-documented that radiation (including space radiation) 
also induces dysfunction of the brain, manifesting as behavioral and cognitive dis-
abilities [14, 15]. The detrimental effects of X-ray radiation in the body were firstly 
reported by Warren and Whipple [16] and Shouse et al. [13]. They reported that 
exposing dogs to high doses of X-rays resulted in death from severe hematopoietic 
suppression and damage. The detrimental effects of radiation on human health 
were heavily realized after the use of the first atomic bombs in 1945. Many people 
in Hiroshima and Nagasaki who survived the initial bomb blast later died from 
radiation exposure in the event. Long-term toxic impacts of the atomic bomb on 
humans were observed as well, such as the high risk of hematopoietic malignancies. 
Further studies proved that hematopoietic failure was one of the primary reasons 
in radiation-induced death when animals experienced a moderate to high dose 
of total-body irradiation. This is supported by a study in the 1940s showing that 
shielding the spleen or one entire hind leg with lead or transplantation of spleno-
cytes protected mice from the lethal effect of irradiation [17]. The importance of 
hematopoietic cells under radiation was also supported by studies showing that 
intravenous infusions of bone marrow (BM) cell suspensions protected mice from 
the effects of radiation [95]. Initially, investigators suggested that a humoral factor 
from the spleen and BM cell suspensions might benefit the radioprotective effects 
[18], while later studies proved that it was attributed to the transplanted hemato-
poietic cells [19–21]. When Till and McCulloch discovered hematopoietic stem cells 
(HSCs) in the 1960s, those cells protecting animals from IR-induced lethal hema-
topoietic damage were HSCs [22, 23]. Remarkable progress has been subsequently 
made in understanding of the mechanisms by which radiation causes hematopoietic 
damage.
However, the effects of space radiation on the hematopoietic system have yet to 
be fully understood, leading to a lack of effective countermeasure strategies thus 
far. In the present chapter, we mainly focus our discussion on the biological effec-
tiveness of space radiation, such as proton and oxygen, whereby space radiation 
induces HSC injury, and the implication of HSC injury to IR-induced BM suppres-
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behavioral, and cognitive effects induced by space radiation will not be discussed 
here, which were extensively discussed by other investigators [24, 25].
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the life span of the body and maintain hematopoietic homeostasis. In Till and 
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(CFU-S) assay to identify functional HSCs even while these HSCs were a mixed 
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and potentially provide lifelong hematopoiesis. The dominant HSCs have ability to 
protect the whole blood system against different stress conditions [30]. Under sub-
lethal irradiation, HSCs have been long-term damaged, which can be easily ignored 
in clinic because of normal cell counts from the bone marrow and peripheral blood. 
Damaged HSCs induced by photon-irradiation have impaired self-renewing abil-
ity, leading to bone marrow failure and death [31]. However, whether low doses 
of space radiation trigger long-term HSC damage remains unknown. Comparing 
to HSCs, MPPs and HPCs have limit or lack self-renewal ability even though they 
are proliferating populations. The property of MPPs and HPCs with proliferation 
provides a beneficial role in case of normal hematopoiesis and stress hematopoiesis. 
For example, in case of blood loss or infection, MPP and HPC quickly proliferate to 
meet the requirement of mature cell production, trying to maintain normal hema-
topoiesis. Under radiotherapy and chemotherapy, MPPs and HPCs can be easily 
depleted with acute myelosuppression because of their proliferating feature. This 
will lead to HSC activation, proliferation, and differentiation to reestablish MPP and 
HPC populations and rebuild hematopoiesis, which might result in HSC exhaustion.
3. Proton radiation and hematopoietic stem cells
During spaceflight missions outside low Earth orbit, there remains the possibil-
ity of astronauts receiving damaging doses of space radiation. Because the dose-
depth distribution of SPE spectrum protons is relatively low [32], during an SPE the 
skin and organs near the surface of the skin will receive higher doses than deeper 
organs such as the bone marrow. In addition, compared to traditional radiation 
therapy with X-rays (photons) or electrons, proton therapy has potential benefit for 
clinical cancer treatment because of its favorable distribution of the radiation dose, 
leading to selectively increased radiation dose to the cancerous tissues while lower-
ing the dose to normal tissues [33, 34]. However, the hematopoietic system is highly 
sensitive to ionizing radiation, and exposure to even a relatively low dose of SPE 
may still be able to result in substantial damage to the system [35, 36]. Therefore, 
understanding the biological effects of proton radiation is immediately needed.
One of the characteristics of the radiation-induced hematopoietic syndrome 
is a decline in blood cell counts, resulting from radiation-induced cell killing in 
circulating blood cells and suppression of hematopoietic stem and progenitor cells 
in the bone marrow [37–39]. Studies have reported that whole-body exposure to 
protons causes acute effects on the hematopoietic system in animal models [40–45]. 
The decreased WBCs, lymphocytes, and neutrophils were detected starting at 
4 hours after 0.25–3 Gy proton radiation, with the lowest numbers observed on 
day 4 [43, 44]. The reduction in WBCs and lymphocytes was still evident in mice 
after exposure to 2.0 Gy of protons (230 MeV) [41]. This might be due to the high 
sensitivity of lymphocytes to proton radiation, which is consistent with the data 
from γ-radiation [46]. Two Gy of proton radiation induced the acute decrement of 
peripheral blood cells, which was shown completely recovered in the long term. The 
dynamic changes of peripheral blood counts might result in ignoring the negative 
effects of proton radiation on hematopoietic system. However, the abnormalities of 
splenic WBCs and lymphocytes were still detected at more than 100 days after low 
dose of proton radiation [47]. Taken together, proton radiation has not only acute 
injury but also long-term harmful effects on the hematopoietic system.
It has been well established that exposure to a significant dose of total-body 
γ-irradiation (TBI) induces not only the acute radiation hematopoietic syndrome 
but also long-term bone marrow injury [48, 49]. The acute radiation hematopoi-
etic syndrome induced by γ-irradiation is primarily attributed to the induction 
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of apoptosis of HPCs, while γ-irradiation-induced long-term BM suppression is 
mainly ascribed to the persistent damage to HSCs. While the effects of γ-irradiation 
on the hematopoietic system have been extensively documented, much less is 
known about the effects of proton irradiation [35, 36].
Previously, mice were exposed to two different doses (0.5 and 1.0 Gy) of proton 
radiation and examined the acute and long-term effects on BM HSPCs at 2 and 
22 weeks after proton radiation, respectively (Table 1). Results showed that expo-
sure of mice to 1.0 Gy of proton radiation resulted in a significant decrease in the 
number of WBCs and PLTs from peripheral blood 2 weeks after the exposure [50]. 
It was demonstrated that 1.0 Gy of oxygen ion radiation (16O TBI) significantly 
decreased the cell counts of peripheral blood leukocytes when measured 2 weeks 
after exposure in male C57BL/6 mice [51]. Interestingly, the decrease of peripheral 
blood cell counts was not observed 2 weeks after 0.5 Gy proton TBI or 0.1 and 
0.25 Gy 16O TBI [51]. The threshold dose of protons (50 or 70 MeV) to induce a 
decline in WBC counts in female ICR outbred mice was previously estimated to 
be between 0.25 and 0.5 Gy [43]. The threshold dose identified from this previous 
study is lower than the result from our study. It may have resulted in part from the 
use of different strains of mice, the time when the mice were studied after radiation 
or the difference in energies of protons between the two studies. For example, the 
linear energy transfer values for 50, 70, and 150 MeV protons would be 1.26, 0.96, 
and 0.55 keV/μm [52]. Because of the dose-depth distribution of SPE protons, only 
relatively large or higher-energy spectrum SPEs may lead to BM exposure to these 
doses of protons in astronauts. However, the doses of SPEs that can cause significant 
HSPC damage have been observed, raising the possibility that astronauts might 
experience reductions in circulating blood cell counts and BM HSPC damage if they 
encounter such an SPE. The dose-depth distribution in mice exposed to protons 
is different from that in humans [1]. It was found that a dose of 0.5 Gy protons 
(150 MeV) significantly reduced hematopoietic stem/progenitor cell function. The 
effects of protons at this energy and at doses below 0.5 Gy are unknown. Since the 
dose to the blood-forming tissues of human subjects will likely be low, future stud-
ies need to examine the hematopoietic effects of proton doses below 0.5 Gy.
Proton TBI can acutely induce the decrease of all lineages of peripheral blood 
cells, since all lineages of blood cells are generated from hematopoietic stem cells 
through their differentiation into various lineages of progenitors. We have shown 
that the exposure to both 0.5 and 1.0 Gy proton TBI damaged not only HPCs but 
also LSK cells, leading to the defect in their numbers and function, which were 
supported by the decreased abilities to form in vitro colonies including BFU-E, 
Table 1. 
Acute and long-term effects of proton irradiation on hematopoietic cells.
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depleted with acute myelosuppression because of their proliferating feature. This 
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HPC populations and rebuild hematopoiesis, which might result in HSC exhaustion.
3. Proton radiation and hematopoietic stem cells
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clinical cancer treatment because of its favorable distribution of the radiation dose, 
leading to selectively increased radiation dose to the cancerous tissues while lower-
ing the dose to normal tissues [33, 34]. However, the hematopoietic system is highly 
sensitive to ionizing radiation, and exposure to even a relatively low dose of SPE 
may still be able to result in substantial damage to the system [35, 36]. Therefore, 
understanding the biological effects of proton radiation is immediately needed.
One of the characteristics of the radiation-induced hematopoietic syndrome 
is a decline in blood cell counts, resulting from radiation-induced cell killing in 
circulating blood cells and suppression of hematopoietic stem and progenitor cells 
in the bone marrow [37–39]. Studies have reported that whole-body exposure to 
protons causes acute effects on the hematopoietic system in animal models [40–45]. 
The decreased WBCs, lymphocytes, and neutrophils were detected starting at 
4 hours after 0.25–3 Gy proton radiation, with the lowest numbers observed on 
day 4 [43, 44]. The reduction in WBCs and lymphocytes was still evident in mice 
after exposure to 2.0 Gy of protons (230 MeV) [41]. This might be due to the high 
sensitivity of lymphocytes to proton radiation, which is consistent with the data 
from γ-radiation [46]. Two Gy of proton radiation induced the acute decrement of 
peripheral blood cells, which was shown completely recovered in the long term. The 
dynamic changes of peripheral blood counts might result in ignoring the negative 
effects of proton radiation on hematopoietic system. However, the abnormalities of 
splenic WBCs and lymphocytes were still detected at more than 100 days after low 
dose of proton radiation [47]. Taken together, proton radiation has not only acute 
injury but also long-term harmful effects on the hematopoietic system.
It has been well established that exposure to a significant dose of total-body 
γ-irradiation (TBI) induces not only the acute radiation hematopoietic syndrome 
but also long-term bone marrow injury [48, 49]. The acute radiation hematopoi-
etic syndrome induced by γ-irradiation is primarily attributed to the induction 
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of apoptosis of HPCs, while γ-irradiation-induced long-term BM suppression is 
mainly ascribed to the persistent damage to HSCs. While the effects of γ-irradiation 
on the hematopoietic system have been extensively documented, much less is 
known about the effects of proton irradiation [35, 36].
Previously, mice were exposed to two different doses (0.5 and 1.0 Gy) of proton 
radiation and examined the acute and long-term effects on BM HSPCs at 2 and 
22 weeks after proton radiation, respectively (Table 1). Results showed that expo-
sure of mice to 1.0 Gy of proton radiation resulted in a significant decrease in the 
number of WBCs and PLTs from peripheral blood 2 weeks after the exposure [50]. 
It was demonstrated that 1.0 Gy of oxygen ion radiation (16O TBI) significantly 
decreased the cell counts of peripheral blood leukocytes when measured 2 weeks 
after exposure in male C57BL/6 mice [51]. Interestingly, the decrease of peripheral 
blood cell counts was not observed 2 weeks after 0.5 Gy proton TBI or 0.1 and 
0.25 Gy 16O TBI [51]. The threshold dose of protons (50 or 70 MeV) to induce a 
decline in WBC counts in female ICR outbred mice was previously estimated to 
be between 0.25 and 0.5 Gy [43]. The threshold dose identified from this previous 
study is lower than the result from our study. It may have resulted in part from the 
use of different strains of mice, the time when the mice were studied after radiation 
or the difference in energies of protons between the two studies. For example, the 
linear energy transfer values for 50, 70, and 150 MeV protons would be 1.26, 0.96, 
and 0.55 keV/μm [52]. Because of the dose-depth distribution of SPE protons, only 
relatively large or higher-energy spectrum SPEs may lead to BM exposure to these 
doses of protons in astronauts. However, the doses of SPEs that can cause significant 
HSPC damage have been observed, raising the possibility that astronauts might 
experience reductions in circulating blood cell counts and BM HSPC damage if they 
encounter such an SPE. The dose-depth distribution in mice exposed to protons 
is different from that in humans [1]. It was found that a dose of 0.5 Gy protons 
(150 MeV) significantly reduced hematopoietic stem/progenitor cell function. The 
effects of protons at this energy and at doses below 0.5 Gy are unknown. Since the 
dose to the blood-forming tissues of human subjects will likely be low, future stud-
ies need to examine the hematopoietic effects of proton doses below 0.5 Gy.
Proton TBI can acutely induce the decrease of all lineages of peripheral blood 
cells, since all lineages of blood cells are generated from hematopoietic stem cells 
through their differentiation into various lineages of progenitors. We have shown 
that the exposure to both 0.5 and 1.0 Gy proton TBI damaged not only HPCs but 
also LSK cells, leading to the defect in their numbers and function, which were 
supported by the decreased abilities to form in vitro colonies including BFU-E, 
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Acute and long-term effects of proton irradiation on hematopoietic cells.
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CFU-GM, and CFU-GEMM [50]. The in vivo functional defect of hematopoietic 
stem and progenitor cells after proton exposure will be further investigated through 
bone marrow transplantation in future studies. We have also reported that a 1.0 Gy 
dose of 16O TBI significantly decreased peripheral blood counts and BM HSPCs 
2 weeks after the exposure [51]. Therefore, the mechanisms of space radiation-
induced acute damage to the hematopoietic system should be investigated further.
In our previous studies, we firstly show that exposure to proton radiation causes 
long-term hematopoietic injury at 22 weeks after the exposure [53]. Our data 
provide the first direct evidence that exposure of mice to 1.0 Gy dose of proton 
radiation results in not only a sustained reduction in the frequency of BM HSCs 
but also in the long-term inhibition of HSCs clonogenic function to form BFU-E, 
CFU-GM, and CFU-GEMM colonies in vitro (Table 2). In contrast, the number and 
frequency of HPCs returned to normal levels at 22 weeks postradiation. Another 
question that needs to be addressed is whether proton radiation-induced HSC 
damage leads to hypoplastic syndrome after hematopoietic stress. Myeloid leukemia 
could be induced by low and/or moderate doses of γ-irradiation and 56Fe heavy ion 
radiation in mice [54, 55]. It has been shown that proton radiation induced minor 
myeloid leukemia but have high possibility to induce hepatocellular adenoma and 
malignant lymphoma in CBA mice [56], which is in contrast with the effects of 
γ-irradiation, showing that 3 Gy of γ-irradiation caused around 25% of CBA mice 
developing acute myeloid leukemia. These differences are due to the differential 
biological effectiveness between proton and γ-irradiation. To closely mimic space 
environment, investigators used minipig animal models to expose to electron solar 
particle event (eSPE) [57]. Comparing to eSPE, proton solar particle events (pSPE) 
have stronger negative effect on the numbers of peripheral WBCs, lymphocytes, 
neutrophils, and monocytes with a factor of 2.79. These data suggest that different 
hematopoietic populations have differential radiosensitivity to proton irradiation.
Protons have a higher linear energy transfer and are denser ionizing radiation 
than photon. Therefore, protons deposit high energy at the end of their range 
termed “Bragg peak” and cause heavily damage to the target tissues, cells, and mol-
ecules. Compared to γ-irradiation, proton radiation causes larger γ-H2AX foci [58], 
leads to hypermethylated DNA [59], has different transcriptome profiles [60], and 
modulates different signaling pathways [61]. More detailed investigation into what 
unique biological effects proton radiation has is called for to instruct proton studies.
Because an SPE contains protons of multiple energies below 150 MeV, some 
groups have developed cell culture or animal models of exposure to broad energy 
spectra of protons to better simulate an SPE. Previously, some differences were 
Table 2. 
Induction of cellular apoptosis, ROS, and DNA damage after proton irradiation.
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found in peripheral blood cell counts between mice exposed to one-energy protons 
(230 MeV, 2 Gy) and mice exposed to SPE-like protons at the same dose level [41]. 
Exposure of minipigs to SPE-like protons at a skin dose as low as 0.5 Gy (estimated 
dose to the BM: 0.42 Gy) caused decrement in peripheral blood cell counts up to 
at least 2 weeks after exposure [45]. Hence, further studies with SPE-like proton 
exposures at low doses are warranted. Since we used only two radiation doses 
(0.5 and 1 Gy), we were not able to prepare dose-response curves for the effects 
observed. In one of our separate studies, mice were irradiated with fully modulated 
beams containing particles from 0 energy to 150 MeV and a uniform dose versus 
depth profile. Doses of protons were 0.1, 0.25, and 0.5 Gy. Bone marrow cells were 
collected at 2 weeks after irradiation and examined as described in the current 
manuscript. We found a dose-dependent decrease in LSK cells, together with an 
increase in ROS levels and apoptosis in these cells (data not shown). In summary, 
our study has demonstrated that acute exposures to medium doses of proton TBI 
induced damage to HPCs and LSK cells in a mouse model.
Radiation-induced cell damage might be mediated by induction of apoptosis, 
DNA damage, and oxidative stress [48, 62]. We therefore assessed those parameters 
in HPCs and LSK cells 2 weeks after proton exposure [50]. Our data indicate that 
HPCs and LSK cells may respond differently to proton radiation. Exposure to 1.0 Gy 
protons resulted in an increase in cellular apoptosis in HPCs. Irradiated LSK cells, 
on the other hand, showed both increased apoptosis and oxidative stress. Neither 
of the two cell types showed enhanced DNA damage or cell cycling 2 weeks after 
proton exposure. Importantly, LSK cells in mice bone marrow from acute and 
long-term proton exposure cause the significant induction of oxidative stress [50, 
53]. In the previous studies, it has been reported that the long-term increase in ROS 
production in LSK cells was observed after 16O radiation and γ-rays [48, 63, 64]. 
For example, increasing levels of ROS production were detected at 2 months after 
6.0 Gy of total-body γ-irradiation, which might be related to irradiation-induced 
DNA damage, leukemia, and senescence in irradiated hematopoietic stem and 
progenitor cells. Both proton and gamma radiation may induce residual negative 
effects on the bone marrow, which might be mediated by overproduction of chronic 
reactive oxidative stress in HSCs [63, 65, 66]. Taken together, present data indicate 
that irradiation-induced oxidative stress in HSCs might be a critical factor in the 
hematopoietic cell response to space radiation.
Reactive oxygen species (ROS) plays an important role in determining the fate 
of normal stem cells. Low levels of ROS are required for stem cells to maintain their 
quiescence and self-renewal capacities. Increases in ROS production cause stem cell 
proliferation, differentiation, apoptosis, and cell death, leading to their exhaustion. 
Regulating ROS production in stem cells is important to maintain tissue homeostasis 
and repair damaged area during the life span of an organism. It has been reported 
that the levels of ROS were closely related to the proper functional hematopoietic 
stem cells. There are multiple different ways for ROS production in cells, such as 
mitochondria oxidative phosphorylation, glycolysis, NADPH oxidases (NOXs) 
enzyme, peroxisomal and cytochrome P450 metabolism, and so on. Mitochondria 
oxidative phosphorylation is not a major source to generate ROS in hematopoietic 
stem cells under homeostasis. This is because (1) HSCs locate bone marrow hypoxic 
niche with low levels of oxygen; (2) HSCs have small amount of mitochondrial 
and immature mitochondrial; (3) HSCs have high level of pimonidazole, which is a 
hypoxia marker; and (4) HSCs have capacity to response to hypoxia by increasing 
hypoxia-inducible factor 1α (HIF-1α) expression [67]. Subsequently, increasing 
levels of HIF-1α benefit HSCs to use anaerobic glycolysis, instead of mitochondrial 
oxidative phosphorylation, to produce energy along with reducing ROS produc-
tion. Previous studies have shown that increasing expression of NOX enzyme might 
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CFU-GM, and CFU-GEMM [50]. The in vivo functional defect of hematopoietic 
stem and progenitor cells after proton exposure will be further investigated through 
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γ-irradiation, showing that 3 Gy of γ-irradiation caused around 25% of CBA mice 
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biological effectiveness between proton and γ-irradiation. To closely mimic space 
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neutrophils, and monocytes with a factor of 2.79. These data suggest that different 
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Protons have a higher linear energy transfer and are denser ionizing radiation 
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termed “Bragg peak” and cause heavily damage to the target tissues, cells, and mol-
ecules. Compared to γ-irradiation, proton radiation causes larger γ-H2AX foci [58], 
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found in peripheral blood cell counts between mice exposed to one-energy protons 
(230 MeV, 2 Gy) and mice exposed to SPE-like protons at the same dose level [41]. 
Exposure of minipigs to SPE-like protons at a skin dose as low as 0.5 Gy (estimated 
dose to the BM: 0.42 Gy) caused decrement in peripheral blood cell counts up to 
at least 2 weeks after exposure [45]. Hence, further studies with SPE-like proton 
exposures at low doses are warranted. Since we used only two radiation doses 
(0.5 and 1 Gy), we were not able to prepare dose-response curves for the effects 
observed. In one of our separate studies, mice were irradiated with fully modulated 
beams containing particles from 0 energy to 150 MeV and a uniform dose versus 
depth profile. Doses of protons were 0.1, 0.25, and 0.5 Gy. Bone marrow cells were 
collected at 2 weeks after irradiation and examined as described in the current 
manuscript. We found a dose-dependent decrease in LSK cells, together with an 
increase in ROS levels and apoptosis in these cells (data not shown). In summary, 
our study has demonstrated that acute exposures to medium doses of proton TBI 
induced damage to HPCs and LSK cells in a mouse model.
Radiation-induced cell damage might be mediated by induction of apoptosis, 
DNA damage, and oxidative stress [48, 62]. We therefore assessed those parameters 
in HPCs and LSK cells 2 weeks after proton exposure [50]. Our data indicate that 
HPCs and LSK cells may respond differently to proton radiation. Exposure to 1.0 Gy 
protons resulted in an increase in cellular apoptosis in HPCs. Irradiated LSK cells, 
on the other hand, showed both increased apoptosis and oxidative stress. Neither 
of the two cell types showed enhanced DNA damage or cell cycling 2 weeks after 
proton exposure. Importantly, LSK cells in mice bone marrow from acute and 
long-term proton exposure cause the significant induction of oxidative stress [50, 
53]. In the previous studies, it has been reported that the long-term increase in ROS 
production in LSK cells was observed after 16O radiation and γ-rays [48, 63, 64]. 
For example, increasing levels of ROS production were detected at 2 months after 
6.0 Gy of total-body γ-irradiation, which might be related to irradiation-induced 
DNA damage, leukemia, and senescence in irradiated hematopoietic stem and 
progenitor cells. Both proton and gamma radiation may induce residual negative 
effects on the bone marrow, which might be mediated by overproduction of chronic 
reactive oxidative stress in HSCs [63, 65, 66]. Taken together, present data indicate 
that irradiation-induced oxidative stress in HSCs might be a critical factor in the 
hematopoietic cell response to space radiation.
Reactive oxygen species (ROS) plays an important role in determining the fate 
of normal stem cells. Low levels of ROS are required for stem cells to maintain their 
quiescence and self-renewal capacities. Increases in ROS production cause stem cell 
proliferation, differentiation, apoptosis, and cell death, leading to their exhaustion. 
Regulating ROS production in stem cells is important to maintain tissue homeostasis 
and repair damaged area during the life span of an organism. It has been reported 
that the levels of ROS were closely related to the proper functional hematopoietic 
stem cells. There are multiple different ways for ROS production in cells, such as 
mitochondria oxidative phosphorylation, glycolysis, NADPH oxidases (NOXs) 
enzyme, peroxisomal and cytochrome P450 metabolism, and so on. Mitochondria 
oxidative phosphorylation is not a major source to generate ROS in hematopoietic 
stem cells under homeostasis. This is because (1) HSCs locate bone marrow hypoxic 
niche with low levels of oxygen; (2) HSCs have small amount of mitochondrial 
and immature mitochondrial; (3) HSCs have high level of pimonidazole, which is a 
hypoxia marker; and (4) HSCs have capacity to response to hypoxia by increasing 
hypoxia-inducible factor 1α (HIF-1α) expression [67]. Subsequently, increasing 
levels of HIF-1α benefit HSCs to use anaerobic glycolysis, instead of mitochondrial 
oxidative phosphorylation, to produce energy along with reducing ROS produc-
tion. Previous studies have shown that increasing expression of NOX enzyme might 
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contribute to γ-irradiation-induced ROS production in HSCs [66], which was sup-
ported by increasing NOX4 expression, rather than other isoforms of NOXs in γ-ray 
irradiated HSCs [66]. Diphenyliodonium (a selective NOX inhibitor) treatment can 
partially restore the functional impairment in γ-ray irradiated HSCs by decreasing 
irradiation-induced ROS production in HSCs [66]. For space radiation circumstance, 
the higher level of NOX4 expression was observed in proton-irradiated HSCs than 
that in unirradiated HSCs. These data indicated that NOX enzyme, especially 
NOX4, might be involved in the induction of ROS production in proton-irradiated 
HSCs. The importance of ROS production in space radiation-induced HSC injury 
should further be assessed by using NOX4 inhibitor or other antioxidants, such as 
N-acetylcysteine and gamma-tocotrienol in future studies. There are some other 
potential unanswered questions including (1) whether these chronically oxidative-
stressed HSCs induced by proton radiation experience senescence, (2) whether these 
space-irradiated HSCs have chromosomal instability, and (3) whether the chro-
mosomal aberrant HSCs after space radiation result in the leukemia development, 
which was evidenced in mice after γ-irradiation exposure [38, 65, 68].
One of HSC properties is its self-renewal ability, which is sustained via its slow 
cycling and quiescence. By using BrdU-chasing assay and H2B-GFP mice model, it 
has been shown that dominant HSCs divide only once every 145 days, which ensures 
self-renewal capacity along with providing whole life blood homeostasis and avoid-
ing HSC exhaustion [69]. It was reported that loss of FOXO3a resulted in increasing 
ROS production and accelerating HSC cycling, which is along with the defect of 
HSC self-renewal capacity and the exhaustion of HSCs. N-acetylcysteine (NAC), 
an antioxidant, can protect FOXO3a mutant HSCs from oxidative stress and restore 
HSC dormancy. The same phenotype was also seen in the case of loss of Bmi-1 and 
TSC1 in mice [70–72], which is due to increasing ROS production and cycling in 
HSCs. Upon proton radiation, data have shown that there were far fewer HSCs in 
G0 phase and higher numbers of HSCs in G1 phase than nonirradiated controls. 
Proton radiation-induced HSC cycling is consistent with upregulation of positive 
cell cycle regulators cyclin D1 and cyclin D3. Although HSC proliferation might 
compensate for the decreased number of HSCs after proton radiation, it will be at 
risk of loss self-renewal of HSCs.
Additionally, it has demonstrated that the persistent increase of DNA damage 
in proton-irradiated HSCs, but not in HPCs, was associated with proton radiation-
induced ROS production in HSCs. Unrepaired DNA damage in proton-irradiated 
HSCs might negatively affect HSC self-renewal, proliferation, and differentia-
tion, leading to long-term functional damage in HSCs. Taken together, these 
findings provide strong evidence showing that proton TBI induces not only acute 
hematopoietic injury but also long-term BM suppression and HSC damage. These 
detrimental effects of proton radiation on hematopoietic cells are closely related to 
the induction of oxidative stress in irradiated HSCs. The proton exposure-induced 
acute and long-term hematopoietic damage might be ameliorated through using 
antioxidants, which should be investigated in the future.
4. Oxygen radiation and hematopoietic stem cells
As we discussed above, GCR contains various HZE particles including 56Fe, 28Si, 
16O, and 12C, which have more detrimental effects on normal tissues than do photon 
and proton radiations during spaceflight. Oxygen (16O) radiation has relatively 
high-charge and high-linear energy transfer (LET), leading to a high relative bio-
logical effectiveness. In this section, we will mainly discuss the biological negative 
effects of 16O on hematopoietic stem cells in long-duration space missions.
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Hematopoietic cells in the body are the most radiosensitive cells to radiation 
[73, 74]. Exposure to γ-irradiation causes both acute and long-term damage in 
hematopoietic stem and progenitor cells (HSPCs), which is due primarily to radia-
tion-induced cellular apoptosis and senescence in HSPCs [37–39, 65]. Using porcine 
and mice model, it has documented that proton radiation induced both acute and 
long-term hematopoietic damage. We have described the acute and residual effects 
of proton radiation on hematopoietic stem cells showing that numbers and function 
of bone marrow HSCs in mice were detrimentally affected. The negative effects of 
proton radiation mainly contribute to increasing the production of oxidative stress 
and DNA damage in irradiated HSCs [53]. 56Fe radiation causes significant altera-
tions in the expression of repetitive elements and DNA methylation, and 0.1-0.4 Gy 
of 56Fe radiation resulted in significant epigenetic changes in hematopoietic stem 
and progenitor cells in a mouse model [75]. Using cultured human hematopoietic 
stem and progenitor cells, it was found that 12C radiation induced chromosome 
aberrations and cellular apoptosis [76]. 0.3–0.9 Gy of 28Si radiation triggers a 
significant increase of cellular apoptosis in irradiated mice HSCs at 4 weeks after 
the exposure, which results in the deficiency of numbers and clonogenic function of 
irradiated HSCs [77]. These findings indicate that GCR, including different forms 
of ionizing radiation, induces acute and residual injury in hematopoietic stem cells. 
However, it remains elusive whether 16O radiation induces acute and long-term 
hematopoietic effects and what main factors are involved in the negative effects on 
HSCs under 16O exposure.
In one of our experiments, C57BL/6 J mice were exposed to 0.1, 0.25, and 1.0 Gy 
16O (600 MeV/n) total-body irradiation (TBI) and analyzed the effects of 16O 
radiation on peripheral blood and BM 2 weeks after the exposure [51] (Table 3). 
Since hematopoietic cells are known to be radiosensitive, it is not surprising that a 
significant decrease was observed in peripheral WBC and platelet counts in mice 
exposed to 1.0 Gy of 16O. In comparison to 16O radiation, peripheral blood cell 
counts, including numbers of WBCs and platelets, were almost recovered to normal 
levels at 2 weeks after 1.0 Gy of γ-ray radiation in BALB/c mice [78]. This might due 
to (1) different animal species used and (2) different biological effectiveness of 16O 
and γ-ray radiation along with high LET properties of 16O. 16O TBI causes cellular 
apoptosis in hematopoietic progenitors but not hematopoietic stem cells at 2 weeks 
postexposure. To monitor how fast HPCs recover from 16O TBI, apoptotic assay was 
performed at 3 months after 0.1, 0.25, and 1.0 Gy of 16O TBI, showing that the apop-
totic levels in HPCs and HSCs after the exposure are similar to those in nonirradiated 
mice. These data suggest that HPCs have a slower recovery than HSCs after 16O TBI.
Table 3. 
Acute and long-term effects of oxygen irradiation on hematopoietic cells.
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contribute to γ-irradiation-induced ROS production in HSCs [66], which was sup-
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which was evidenced in mice after γ-irradiation exposure [38, 65, 68].
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induced ROS production in HSCs. Unrepaired DNA damage in proton-irradiated 
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tion, leading to long-term functional damage in HSCs. Taken together, these 
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the induction of oxidative stress in irradiated HSCs. The proton exposure-induced 
acute and long-term hematopoietic damage might be ameliorated through using 
antioxidants, which should be investigated in the future.
4. Oxygen radiation and hematopoietic stem cells
As we discussed above, GCR contains various HZE particles including 56Fe, 28Si, 
16O, and 12C, which have more detrimental effects on normal tissues than do photon 
and proton radiations during spaceflight. Oxygen (16O) radiation has relatively 
high-charge and high-linear energy transfer (LET), leading to a high relative bio-
logical effectiveness. In this section, we will mainly discuss the biological negative 
effects of 16O on hematopoietic stem cells in long-duration space missions.
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Previous studies have demonstrated that the functional defect of mouse HSCs 
was observed under either radiation or chemotherapeutic drug treatment. For 
example, the reconstitution capacity of mouse HSCs has detrimental effects under 
1.0 Gy of total-body γ-ray radiation along with apparent myeloid bias differentia-
tion [78, 79]. One dose of 5-fluorouracil treatment significantly decreased the 
numbers and engraftment ability of mouse HSCs at day 10 after the exposure [80]. 
To investigate the effects of low doses of 16O TBI on HSC function, in vitro colony-
forming assays using bone marrow cells were performed at 2 weeks after 0.1–1.0 Gy 
doses of 16O exposure. It shows that low doses of 16O TBI not only decreases num-
bers of HSCs but also abates the in vitro colony-forming abilities, such as decreased 
numbers of BFU-E, CFU-GM, and CFU-GEMM from irradiated bone marrow cells. 
These data suggest that the function of HSC after 16O TBI was negative affected 
despite low doses of 16O used. Using in vitro cell culture model, previous studies 
have shown that 16O radiation has more dramatic effects on chromosomal aberra-
tions, micronuclei formation, cell survival, and apoptosis than photon radiation 
[81, 82]. It has been documented that 6.5 Gy total-body γ-irradiation decreased 
the numbers of bone marrow HSCs up to 50% at 2 weeks postexposure, which was 
observed at 2 weeks after 1.0 Gy of total-body 16O radiation [38]. These results 
indicate that 16O radiation has a higher RBE than photon radiation.
To explore long-term effect of 16O TBI on hematopoietic cells, 0.05, 0.1, 0.25, 
and 1.0 Gy 16O (600 MeV/n) radiations were used to irradiate C57BL/6 J mice. 
Irradiated mice were analyzed for the long-term effects of 16O radiation on periph-
eral blood cells and bone marrow cells 3 months postexposure [83]. Although there 
are the same numbers of peripheral blood cells at 3 months after 0.05 to 1.0 Gy of 
16O TBI as nonirradiated controls, numbers of HPC and HSCs from irradiated mice 
were significantly lower than those from nonirradiated controls. The changes of 
peripheral blood cell counts after oxygen radiation are similar to the effects of other 
types of ionizing radiation, such as 0.5 and 1.0 Gy of γ-TBI [84, 85]. Peripheral 
blood cell counts were back to normal levels 2 months after sublethal doses of γ-ray 
exposure [86]. Recovery of peripheral blood cell counts may neglect the effects of 
irradiation on bone marrow HSCs [84], which will result in overlooking the long-
term bone marrow suppression after radiation.
We have demonstrated that 0.1 to 1.0 Gy of 16O TBI, but not 0.05 Gy dose, 
resulted in a dramatic impairment in both numbers and function of bone marrow 
HSCs in mice at 3 months after exposure. Comparing to 16O TBI, exposure of mice 
to 0.5 and 1.0 Gy of γ-TBI did not negatively affect the numbers and function of 
HSC in mice at 3 months after exposure. The phenotype from 16O- and γ-TBI might 
be related to their RBE along with higher RBE levels of 16O TBI than γ-TBI [81]. 
The long-term detrimental effects of 16O TBI on bone marrow hematopoietic stem 
cells have also been seen in 6.5 Gy sublethal doses of γ-rays and 1.0 Gy low dose of 
proton radiation, showing a reduction in HSC reserves and a defect in HSC function 
[48, 85, 87, 88]. When comparing the effects of different radiation sources on HPCs, 
we have shown that acute exposure to low doses of 16O TBI triggered a significant 
reduction in numbers of HPCs at 2 weeks after exposure. However, numbers of 
HPCs in irradiated mice recovered back to normal levels 2 weeks after either γ-ray 
or proton exposure [51]. These data indicate that 16O-irradiated HPCs have a slower 
recovery than proton- and photon-irradiated HPCs.
We have previously demonstrated that exposure of mice to 1.0 Gy of 16O TBI 
leads to an increased rate of apoptosis at 2 weeks postexposure in irradiated HPCs 
but not HSCs. This is consistent with HPC colony-forming ability assay, showing 
lower numbers of BFU-E, CFU-GM, and CFU-GEMM when compared to those 
in nonirradiated controls [51]. When we further examined HPC colony-forming 
abilities at 3 months after same dose of 16O TBI, it showed that numbers of various 
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colonies were still much lower than those in nonirradiated controls [83]. Notably, 
the decreased colony-forming abilities after 16O TBI were in a dose-independent 
manner, which suggests “hit and damage.” These data suggest that oxygen irradia-
tion has features with a high-linear energy transfer and strong relative biological 
effectiveness.
A cobblestone area-forming cell (CAFC) assay is a surrogate in vitro hematopoi-
etic stem cell functional assay. We measured HSC in vitro CAFC-forming ability at 
3 months after 0.1, 0.25, and 1.0 Gy of 16O radiation, showing that irradiated mice 
HSCs had a significant reduction of CAFC numbers independent of radiation doses 
(Table 4). These unusual dose-response curves have also been seen in the studies of 
28Si radiation, such as effects of 28Si radiation on synaptic plasticity and contextual 
fear memory [89, 90]. However, when mice were exposed to 0.05 Gy of 16O TBI, 
numbers of CAFC were comparable to nonirradiated controls, indicating that HSC 
function was not affected after exposure to 0.05 Gy 16O TBI [83]. These long-term 
negative effects of 16O TBI on HSCs are also observed in other different types of 
ionizing radiation [53, 63, 91]. Mice were exposed to 1.0 Gy of proton total-body 
irradiation, leading to a significant decrease in the CAFC-forming ability in HSCs at 
22 weeks postexposure [53]. 6.5 Gy of γ-ray total-body irradiation caused a reduc-
tion in HSC colony-forming ability 2 months postexposure [38]. As we discussed 
previously, peripheral blood cell counts were back to normal levels at 3 months 
after low-dose 16O TBI, while the numbers and function of bone marrow HSCs were 
significantly decreased after exposure. Proliferation of progenitors (such as myeloid, 
lymphoid, and erythroid progenitors) might contribute to the recovery of peripheral 
blood cells after radiation. These results suggest that low doses of ionizing radiation 
can induce long-term HSC suppression, while 16O TBI has stronger abilities to induce 
the long-term HSC suppression than other types of ionizing radiation.
Cellular apoptosis and ROS production are crucial mediators in irradiation-
induced cell damage. We exposed mice to 1.0 Gy of 16O, and it triggered an aber-
rant increase in ROS production in HPCs and HSCs 2 weeks after exposure [51]. 
Meanwhile, increasing levels of apoptosis were significant in irradiated HPCs, but 
not LSK cells and HSCs, when compared to nonirradiated controls. Whether the 
different acute responses of HPCs and HSCs to 16O TBI are related to ROS pro-
duction has yet to be determined. Induction of ROS production persisted up to 3 
months after 16O TBI [83], which is congruent with the decreased expression of the 
antioxidant genes GPX2 and SOD3 in 1.0 Gy 16O-irradiated HSCs when compared 
to nonirradiated HSCs. Previous studies utilized proton and γ-ray radiation to 
prove that HSC functional impairment might be attributable to the accumula-
tion of residual ROS [53, 63, 92, 93]. This is evidenced by a decrease in in vivo 
Table 4. 
Induction of cellular apoptosis, ROS, and DNA damage after oxygen irradiation.
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engraftment capacity and in vitro colony-forming ability using bone marrow cells 
after radiation. The importance of ROS overproduction on functional HSCs was 
not only supported under radiation stress condition but also supported by other 
genetic animal models. Deletion of Foxo3, ATM, TSC1, and Bmi-1 in mice leads 
to the impairment of numbers and function of HSCs along with increasing ROS 
production. Application of antioxidants, such as N-acetyl cysteine (NAC), on these 
mutant mice significantly ameliorated the HSC functional deficiency [71, 94–96]. 
We have provided data showing 16O-irradiated HSCs had higher levels of ROS 
production than nonirradiated animals in both acute and long-term studies. It is 
well accepted that mitochondrial oxidative phosphorylation and NADPH oxidases 
are two main sources to produce ROS in mammalian cells. Because HSCs reside in 
hypoxic environmental niche in the bone marrow and have higher expression of 
HIF1α in response to hypoxia, HSCs produce ROS mainly through glycolysis and 
NOX enzyme. We have previously shown that proton and γ-ray radiation induced 
significantly upregulation of NOX4 in irradiated HSCs [53, 66]. The NOX4 inhibi-
tor diphenyliodonium can partially protect functional HSCs from γ-irradiation-
induced long-term damage. Therefore, antioxidants, such as NOX4 inhibitors and 
NAC, should be further tested whether inhibiting ROS production can decrease 
16O TBI-induced ROS production to accelerate the functional recovery of HPCs and 
HSCs after 16O irradiation exposure.
Under radiotherapy and chemotherapy stress conditions, dominant HSCs might 
be activated from quiescent status to provide the need for stressed hematopoietic 
system. However, frequent HSC activation might cause its loss of self-renewal 
ability, differentiation, and death with bone marrow failure syndrome [69, 97]. We 
have shown that proton and γ-irradiation can efficiently activate quiescent HSCs 
[53, 65], leading to the redistribution of different cell cycle phases and stem cell 
functional defects. Data from genetic mice models, such as depletion of FOXO3a 
and Lkb1, showed that HSCs had fast cycling with loss of HSC self-renewal ability 
and HSC exhaustion [94, 98–100]. There are fewer numbers of HSCs in G0 and 
higher numbers in G1/G2SM at 2 weeks after 16O TBI [51]. Additionally, we observed 
that around 15% of irradiated HSCs had more than two γH2AX foci per cell 2 weeks 
after 16O exposure [51], which is positively correlated with the increased ROS 
production in 16O TBI HSCs. Taken together, all of ROS production, DNA damage, 
and HSC cycling after 16O TBI might contribute to HSC defect induced by oxygen 
radiation, which will be tested in our future studies.
Note:
1. Due to the large difference in size between mice and human subjects, the dose-
depth distribution in mice exposed to protons is different from that in humans 
[1]. The dose to the blood-forming tissues in humans will be lower, whereas the 
dose to the blood-forming tissues in mice is likely very similar to the dose  
at the surface. This difference in dose-depth profile should be taken into 
considerations when translating risk of hematopoietic damage in response to 
space radiation in a mouse model to the human situation.
2. During long-term space flight (such as to Mars), astronauts will encounter 
either a chronic, fractionated dose of space radiation or they will accumulate 
1–3 Gy of radiation exposure. Presently, it is impossible to achieve chronic or 
fractionated doses of space radiation due to the limited access to the facili-
ties capable of producing synthetic space radiation. In most research to date, 
investigators have used either acute radiation exposure or higher doses of space 
radiation in animal models. Cautions should therefore be taken when applying 
those findings from animal studies to human.
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3. The protons and oxygen nuclei in the studies described here were all delivered 
within a few minutes, and most charged particle exposures during space flight 
occur at a very low-dose rate and/or are fractionated. Though we acknowledge 
that the high-dose rates we used are a limitation of our studies, low-dose rate 
exposures were not possible because of practical constraints. Future studies 
with low-dose rate or fractionated exposures should provide further insight 
into dose-rate dependence of hematopoietic stem/progenitor cell response to 
high-energy charged particle radiation.
5. Conclusion
In summary, proton and oxygen space radiation have detrimental effects on the 
hematopoietic system even with at low doses, which will have potential implica-
tions for health outcomes during long-duration space missions. Increasing ROS 
production might be a major mediator on space radiation-induced HSC damage. 
Knowledge gained from this chapter could aid in planning countermeasure strate-
gies to protect against hematopoietic effects of radiation exposure during space 
travel. To minimize the health negative effects of deep-space travel, decreasing 
oxidative stress might be a good approach to mitigate the adverse effects of proton 
and HZE particle exposure on the hematopoietic system.
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mutant mice significantly ameliorated the HSC functional deficiency [71, 94–96]. 
We have provided data showing 16O-irradiated HSCs had higher levels of ROS 
production than nonirradiated animals in both acute and long-term studies. It is 
well accepted that mitochondrial oxidative phosphorylation and NADPH oxidases 
are two main sources to produce ROS in mammalian cells. Because HSCs reside in 
hypoxic environmental niche in the bone marrow and have higher expression of 
HIF1α in response to hypoxia, HSCs produce ROS mainly through glycolysis and 
NOX enzyme. We have previously shown that proton and γ-ray radiation induced 
significantly upregulation of NOX4 in irradiated HSCs [53, 66]. The NOX4 inhibi-
tor diphenyliodonium can partially protect functional HSCs from γ-irradiation-
induced long-term damage. Therefore, antioxidants, such as NOX4 inhibitors and 
NAC, should be further tested whether inhibiting ROS production can decrease 
16O TBI-induced ROS production to accelerate the functional recovery of HPCs and 
HSCs after 16O irradiation exposure.
Under radiotherapy and chemotherapy stress conditions, dominant HSCs might 
be activated from quiescent status to provide the need for stressed hematopoietic 
system. However, frequent HSC activation might cause its loss of self-renewal 
ability, differentiation, and death with bone marrow failure syndrome [69, 97]. We 
have shown that proton and γ-irradiation can efficiently activate quiescent HSCs 
[53, 65], leading to the redistribution of different cell cycle phases and stem cell 
functional defects. Data from genetic mice models, such as depletion of FOXO3a 
and Lkb1, showed that HSCs had fast cycling with loss of HSC self-renewal ability 
and HSC exhaustion [94, 98–100]. There are fewer numbers of HSCs in G0 and 
higher numbers in G1/G2SM at 2 weeks after 16O TBI [51]. Additionally, we observed 
that around 15% of irradiated HSCs had more than two γH2AX foci per cell 2 weeks 
after 16O exposure [51], which is positively correlated with the increased ROS 
production in 16O TBI HSCs. Taken together, all of ROS production, DNA damage, 
and HSC cycling after 16O TBI might contribute to HSC defect induced by oxygen 
radiation, which will be tested in our future studies.
Note:
1. Due to the large difference in size between mice and human subjects, the dose-
depth distribution in mice exposed to protons is different from that in humans 
[1]. The dose to the blood-forming tissues in humans will be lower, whereas the 
dose to the blood-forming tissues in mice is likely very similar to the dose  
at the surface. This difference in dose-depth profile should be taken into 
considerations when translating risk of hematopoietic damage in response to 
space radiation in a mouse model to the human situation.
2. During long-term space flight (such as to Mars), astronauts will encounter 
either a chronic, fractionated dose of space radiation or they will accumulate 
1–3 Gy of radiation exposure. Presently, it is impossible to achieve chronic or 
fractionated doses of space radiation due to the limited access to the facili-
ties capable of producing synthetic space radiation. In most research to date, 
investigators have used either acute radiation exposure or higher doses of space 
radiation in animal models. Cautions should therefore be taken when applying 
those findings from animal studies to human.
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3. The protons and oxygen nuclei in the studies described here were all delivered 
within a few minutes, and most charged particle exposures during space flight 
occur at a very low-dose rate and/or are fractionated. Though we acknowledge 
that the high-dose rates we used are a limitation of our studies, low-dose rate 
exposures were not possible because of practical constraints. Future studies 
with low-dose rate or fractionated exposures should provide further insight 
into dose-rate dependence of hematopoietic stem/progenitor cell response to 
high-energy charged particle radiation.
5. Conclusion
In summary, proton and oxygen space radiation have detrimental effects on the 
hematopoietic system even with at low doses, which will have potential implica-
tions for health outcomes during long-duration space missions. Increasing ROS 
production might be a major mediator on space radiation-induced HSC damage. 
Knowledge gained from this chapter could aid in planning countermeasure strate-
gies to protect against hematopoietic effects of radiation exposure during space 
travel. To minimize the health negative effects of deep-space travel, decreasing 
oxidative stress might be a good approach to mitigate the adverse effects of proton 
and HZE particle exposure on the hematopoietic system.
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